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Abstract 
 
This thesis describes the generation and reactivity of functionalised organozinc 
carbenoids for cyclopropane synthesis with alkenes. 
In the introductory chapter, a brief overview of the different methods for preparation of 
heteroatom-functionalised cyclopropanes is presented, including [2+1] cycloaddition 
reactions using a carbene or carbenoid as a cyclopropanating agent with an alkene, ionic 
stepwise methods, and chemical modifications from existing cyclopropanes. The 
remainder of this chapter then focuses on previous work within our own group in this 
area. 
The second chapter presents the results obtained from different areas of research in the 
present study, the first of these being a deeper understanding and extension of the 
research work undertaken by my predecessor for the development of the 
cyclopropanation reaction using an “amidoorganozinc” carbenoid derived from N,N 
diethoxymethyloxazolidinones derivatives in the presence of a source of zinc and 
chlorotrimethylsilane. Thus, the chemoselectivity and stereoselectivtity of the reaction 
were fully studied, and a quadrant model was constructed to rationalise the 
stereochemistry of the products obtained. The second part of this section outlines the 
generation of new enantiopure organozinc carbenoids precursors derived from 
substituted chiral precursors followed by the synthesis of novel enantiopure highly 
functionalised N-cyclopropyl oxazolidinones. The intramolecular version of this 
cyclopropanation reaction was then successfully studied using diethoxylactam 
derivatives as organozinc carbenoid precursors. The methodology was then applied to 
the preparation of novel aminocyclopropyl functionalised compounds selected as 
interesting building blocks which can lead to the synthesis of natural and biologically 
active compounds. The fifth part of this chapter describes subsequent studies towards 
the design of new carbenoid precursors containing additional functional groups of 
interest. Finally, a brief study on the potential of an organozinc carbenoid to participate 
in a novel [2,3] sigmatropic rearrangement was investigated. 
The thesis concludes with a summary of the results obtained, a detailed description of 
the experimental procedures used and the characterization and analysis of the 
compounds prepared, together with a full bibliography. 
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1.0. Introduction 
1.0.1. Background 
 
The present thesis is concerned with the synthesis of heteroatom functionalised 
cyclopropanes and, in particular, aminocyclopropanes. For this reason, in the following 
introductory chapter, it is appropriate to provide a brief review of the synthetic methods 
which have been used in their construction. In a second section a concise overview of 
the chemistry which has been developed within our own group on the properties and 
reactivity of organozinc carbenoids will also be presented.  
 
1.0.2. Occurrence in nature and biosynthesis 
 
As reported in a review by Donaldson1, the cyclopropyl unit is present in a large 
number of biologically active natural products and pharmaceuticals.1,2 Two examples 
are illustrated below (Figure 1). 
 
 
Figure 1 
 
Heteroatom-substituted cyclopropanes are also present in a wide range of biologically 
active natural and unnatural compounds as illustrated below by the natural 
immunosuppressant and antibacterial belactosin A 33 and the alkoxycyclopropane 4, a 
potential inhibitor of PDE4 which is an isozyme present in abundance in inflammatory 
and immune cells,4 and 5, an agonist for group II metabotropic glutamate receptors.5 
The heteroatom-substituted cyclopropanes are used extensively in medicinal chemistry 
programmes due to their unique steric and electronic properties and their ability to 
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function as alkene bioisosteres without the associated metabolitic lability. Perhaps the 
most abundant naturally-occurring cyclopropyl compound is the aminocyclopropane 
carboxylic acid 6, a gem-disubstituted cyclic amino acid which is a key intermediate in 
the production of the plant hormone ethylene (Figure 2).2 
 
 
Figure 2 
 
Although the synthetic chemist has yet to rival nature, it is interesting to comment on 
some studies in this area. Thus a biosynthetic pathway for the synthesis of the 
cyclopropyl ring has been described by Cronan Junior et al. for the conversion of an 
unsaturated fatty acid (UFA) of the membrane lipid of bacteria into a cyclopropane fatty 
acid (CFA) in membrane lipids of bacteria by a 1,3 ring closure reaction. This catalytic 
insertion of a “methylene group” from AdoMet to a double bond enables the in situ 
modification of the bacteria’s lipidic membrane (Scheme 1).6 
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Scheme 1 
 
Moreover, it has also been reported that the synthesis of squalene, an intermediate in the 
biosynthesis of cholesterol, proceeded following a sequence of reactions including the 
formation of a cyclopropane ring as a key intermediate. The mechanism of this 
transformation involved farnesyl pyrophosphate as the starting material (Scheme 2).7 
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Scheme 2 
 
An enzyme containing a thiol group attacks 11 by nucleophilic substitution to form 12 
which reacts with another molecule of 11 to form the “П complex 13”. The loss of a 
proton from 13 leads to 14 which undergoes ionisation to give the primary carbocation 
15. Rearrangement leads to the formation of the tertiary carbocation 16 which can 
undergo ring opening to 17, which after reduction affords squalene 18. In the absence of 
the reducing agent NADPH, squalene is not formed and the cyclopropane can be 
isolated.8  
 
1.0.3. Synthetic studies 
 
The cyclopropyl unit has a wide appeal due to its occurrence in natural products as well 
as its use in synthetic and medicinal chemistry. As such, there have been numerous 
synthetic studies in the literature. They can be formed by photochemical reactions and 
enzymatic approaches, but in order to aid clarity in the discussion, we will focus in this 
section on the formation of heteroatom-substituted cyclopropanes. Three distinct 
approaches can be taken for the construction of heteroatom-functionalised 
cyclopropanes: by carbene and carbenoid [2+1] cycloaddition with an alkene, by ionic 
stepwise methods, or by functional group manipulation of existing cyclopropanes.  
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1.1. Carbenes and carbenoids 
 
A cyclopropane can be obtained by [2+1] cycloaddition between a carbene or carbenoid 
and an alkene. In this section, carbenes and carbenoids will be discussed as a function of 
the method used to generate them, followed by an overview of the methods available for 
the synthesis of heteroatom-substituted cyclopropanes using a carbene or a carbenoid. 
 
1.1.1. Carbenes as cyclopropanating agents 
 
Carbenes are neutral species containing a carbon atom with 6 valence electrons: with 
two pairs involved in the two σ bonds and two further nonbonding electrons. Carbenes 
are electron-poor entities which require another pair of electrons to complete their 
valence shell of electrons. Like carbocations, they are electrophilic but they are, of 
course, uncharged. This has consequences for the type of nucleophiles with which 
carbenes choose to react. Carbenes may therefore react with compounds that would not 
normally be considered as nucleophiles, such as simple alkenes, by taking electrons 
from the available HOMO.8  
Carbenes may be subdivided into two classes due to the two possible arrangements of 
electrons in the empty shells (spin states) which are termed triplet and singlet. The 
orbitals are the same in both cases but triplet carbenes have two unpaired electrons, one 
in each of the sp2 and p orbitals, whilst singlet carbenes have a pair of electrons in the 
nonbonding sp2 orbital and also possess a vacant p orbital (Figure 3).8 
 
C R
R
C R
R
triplet carbene singlet carbene
 
Figure 3 
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Carbene species react with alkenes to give a cyclopropane in two distinct ways 
depending on the electronic character of the carbene. Singlet carbenes add 
stereospecifically to alkenes and triplet carbenes react as diradicals and hence can give 
rise to nonstereospecific additions to alkenes (Scheme 3). 
 
Me Me Me Me
CR2
Me Me Me Me
triplet carbene
Me Me Me Me
singlet carbene
>99% cis
stereoselective
triplet carbene
CR2
CR2
stereospecific
singlet carbene
19
19
20
20 21
 
Scheme 3 
 
A singlet carbene can readily be obtained by treatment of an appropriate substrate via 
deprotonation with a base and α-elimination of the leaving group X from the same 
carbon. The resulting species can cyclopropanate an alkene by a [2+1] cycloaddition 
reaction as shown below (Scheme 4).  
 
 
Scheme 4 
 
In 1862 Geuther reported on the use of haloforms as dihalocarbene precursors.9 The 
mechanism involving the α-elimination of chloroform by treatment with a base to give 
dichlorocarbene was described in 1950.10 The α-elimination process is more facile if the 
substituents are capable of delocalising the negative charge. The reaction of a 
dichlorocarbene, formed in situ with an olefin leads stereospecifically to a 
dichlorocyclopropane (Scheme 5).11,12,13 
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Scheme 5 
 
Carbene reactivity increases as a function of the number of substituents and their 
increasing electronegativity, confirming their proposed electrophilic character and 
decreases with simple alkenes following the order tetra>tri>unsym-di>sym- di>mono 
alkyl substituted.10 In general syn (anti) addition occurs in most cases, except where a 
carbene is substituted with a heavy halogen atom. The reaction of cyclic strained 
alkenes may induce rearrangements and the cyclopropane product is often not isolable.14 
 
1.1.2. Carbenoids as cyclopropanating agents 
 
Free carbenes are typically highly reactive and are hence short-lived species. However, 
they can be stabilised by a metal making them more suitable for synthetic purposes as 
outlined below. In contrast to carbenes, carbenoids are defined as carbon species bonded 
to a metal and a leaving group. There are three principal sources of metallocarbenoid 
precursors: geminal haloalkanes used in the presence of metals, diazo compounds used 
in conjunction with transition metals such as rhodium, copper or palladium and Fisher 
carbenes as metal carbenoids. Those carbenoids formed from transition metals with 
available vacant d orbitals are often called alkylidenes (Scheme 6).8 
 
 
Scheme 6 
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1.1.2.1. Simmons-Smith reaction 
 
The most famous method for the stereospecific cyclopropanation of unsaturated 
compounds using a metallocarbenoid precursor such as a geminal dihaloalkane in the 
presence of a metal is the Simmons-Smith reaction discovered in 1958 using an 
organozinc carbenoid.  
 
The reagent is derived from the reaction between diiodomethane and a source of zinc. 
(Scheme 7).15 
 
CH2I2, Zn/Cu
I I
H H
I ZnI
H H
the Simmons-Smith reagent
Zn/Cu
the Simmons-Smith reaction
ZnI2 (Cu)
22 23
 
Scheme 7 
 
The key intermediate may be involved in a Schlenk type equilibrium (Scheme 8). 
 
I I
H H
I ZnI
H H
Zn/Cu I Zn I ZnI2
 
Scheme 8: Structure of the Simmons-Smith reagents 
 
The reaction is stereospecific, with respect to the geometry of the alkene. Studies 
indicated that diiodomethane forms a 1:1 complex with zinc (from a zinc-copper 
couple) which is capable of forming cyclopropanes with alkenes. A representation of 
the complex was proposed as shown below (Scheme 9).8 
 
CH2
I
ZnI
Zn/Cu
CH2I2
 
Scheme 9 
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The mechanism of this reaction has often been represented as proceeding via a 
“butterfly-type” transition state (Scheme 10).8 
 
I
Zn
I
C
I
Zn
H
H I
22 23
 
Scheme 10 
 
The zinc carbenoid reagent will behave as a weak electrophile and react more readily 
with electron-rich olefins. 
 
The cyclopropanation of a chiral allyl alcohol using the Simmons-Smith reaction is 
highly stereoselective with the new methylene group adding to the same face of the 
double bond as the alcohol group (Scheme 11).8 
 
HO HO
CH2I2,Zn/Cu
63%
d.r. >99%
24 25
 
Scheme 11 
 
Numerous variants of the original Simmons-Smith method have been reported in the 
literature, including the use of Zn/CuCl/CH2I2,16 Zn(Ag) couple/CH2I2,17 
Zn/TiCl4/CH2Br2,18 Zn/AcCl/CuCl/CH2Br219 and Zn/CH2Br2 under sonication20 in order 
to improve the reaction time and yields. 
 
To avoid use of heterogeneous conditions, Furukawa demonstrated that a 
cyclopropanating agent could be generated by an alkyl exchange reaction between 
diethyl zinc and a 1,1-dihaloalkane.21 The additional major advantages of Furukawa’s 
homogeneous system are that reagent formation is rapid under mild conditions, the 
reaction is suitable for the cyclopropanation of vinyl ethers and similar substrates that 
often undergo polymerisation under classic Simmons-Smith conditions, and finally that 
the reaction is not restricted to the formation of a non-functionalised cyclopropane and 
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thus can be applied to a wider range of reagents.21 For example, the reaction between 
cyclohexene and 1,1-diiodomethylbenzene gives a mixture of endo and exo isomers of a 
functionalised cyclopropane (Scheme 12). 
 
Et2Zn, Et2O
67 %
major isomer
shown
C6H5CHI2
endo:exo17:1
22 26
 
Scheme 12 
 
In a detailed study, Denmark and Edwards found that the (chloromethyl)zinc reagent, 
prepared from ClCH2I/Et2Zn, was even more reactive that the (iodomethyl)zinc 
analogue (Scheme 13).22 
 
Et2Zn (2 eq.), ClCH2I (4 eq)
DCE, 0 °C, 15 min
94 % (GC yield)
27 28
 
Scheme 13 
 
Compound 28 was obtained in 94% yield (according to GC analysis) compared to the 
12% obtained using CH2I2 as the dihalo compound under the same conditions.22 
 
Different studies were carried out on the organozinc reagents by Shi et al. who 
demonstrated that when the acidity of RXH increased, the reactivity of the novel 
organozinc species increased. Thus CF3CO2ZnCH2I as a cyclopropanating agent is 
generally very effective.23 
 
In a similar manner Charette et al. studied the reactivity of new reagents with 
ArOZnCH2I (RX = ArO) and found that carbenoids possessing electron-withdrawing 
groups on the aromatic ring (F, Cl or Br in position 2, 4 and 6) also gave cyclopropanes 
in higher yields (Scheme 14).24 
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OH
R
1. Et2Zn
2. CH2I2
OZnCH2I
R
OZnI
R1
R2R3
R1
R2
R3
 
Scheme 14 
 
Finally, it is interesting to note that Wittig reported a method for the generation of 
Simmons-Smith like reagents using diazoalkanes and zinc iodide. The cyclopropanating 
agent is formed by the addition of diazomethane to a suspension of zinc(II) halide 
(Scheme 15).25 
 
73%
ZnI2 CH2N2 ICH2ZnI
ICH2ZnI CH2N2 ICH2ZnCH2I
ICH2ZnCH2I
22 23
 
Scheme 15 
 
Other metals than zinc can also be used to generate metallocarbenoids for 
cyclopropanation reactions. Organolithium carbenoid can probably be formed in situ by 
an α-elimination of a primary alkyl halide such as 29 with a lithium base to induce a 
cyclopropanation reaction. The intermediate can trap an alkene to form a cyclopropane. 
Thus, cyclopropane 31 was obtained in 78% in a 2:1 syn/anti ratio, by reaction of p-
methoxybenzylchloride 29 with cis-butene 19 in the presence of LiTMP 30 at reflux 
(Scheme 16).26 
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Scheme 16 
 
1.1.2.2. Diazoalkanes as cyclopropanating agents 
 
Diazoalkanes can be used as carbenoid precursors and more specifically, diazomethane 
can transfer a methylene group to an alkene double bond via a metal catalysed reaction 
to form a cyclopropane. The process can be applied to a wide range of alkenes. 
Different metal catalysts, either chiral or achiral, such as copper, palladium, or rhodium 
have all been used for cyclopropanation using diazomethane. The transition metal 
catalyst reacts initially with the diazo compound liberating N2, thus generating a 
transient electrophilic carbenoid which is most often represented in the alkylidene form 
(Scheme 17).27,28 
 
LnM MLn
R
R
R
R
N2
R
R
-LnM R
R
N2+
N2
32
 
Scheme 17 
 
In general, α-diazoketones or α-diazoesters are more commonly employed as 
diazoalkanes to carry out cyclopropanation reactions, as they are sufficiently reactive, 
but much less dangerous to handle. The reaction is mediated by a wide range of chiral 
or non-chiral catalysts containing metals such as copper, palladium, rhodium, cobalt, 
ruthenium or osmium (Scheme 18).29 
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Ph
Ph
CO2Me
N2 MLn
Ph
Ph
CO2Me
33 34 35
 
Scheme 18 
 
The first intramolecular version of a cyclopropanation reaction using a diazoketone was 
published by Stork in 1961 using copper to obtain compound 37 (Scheme 19).30 
 
O
H
H36 37
O
N2 Cu bronze
 
Scheme 19 
 
Different examples using copper catalysts for the intramolecular reactions were initially 
reported that required high temperatures and demonstrated low selectivity.31 However 
dirhodium tetracarboxylate catalysts now appear to be the most active for 
cyclopropanation under mild reaction conditions and have hence become the reagents of 
choice for these transformations (Scheme 20).32 
 
Rh2(cap)4
O
O
H
100%
38 39
H
N2
 
Scheme 20 
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1.1.2.3. Fischer carbenes as cyclopropanating agents 
 
Pettit and Jolly were the first to suggest that transition metal carbenoid complexes might 
serve as carbene transfer reagents.33 Thus, the treatment of CpFe(CO)2CH2OMe with 
acid in the presence of cyclohexene produced norcarane 23 in 46% yield (Scheme 21).33 
 
Fe OMe
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Scheme 21 
 
In general terms, the carbenoid intermediate is similar to that formed during a 
cyclopropanation with diazo compounds. Fischer improved this reaction and found that 
the complexes (CO)5M=C(OMe)Ph, where M was chromium, molybdenum or tungsten 
(Fischer carbenes), also reacted with activated alkenes to give cyclopropanes.34,35,36  
In the final analysis however, such atom inefficient stoichiometric reagents often 
required high temperatures and pressures and competing metathesis reactions also 
proved problematic. In consequence, they have not been adopted within the synthetic 
community. 
 
1.1.3. Heteroatom-functionalised cyclopropane synthesis 
 
There are two strategically different methods used to obtain a heteroatom substituted 
cyclopropane via a [2+1] cycloaddition reaction with a carbene or carbenoid and an 
alkene. The first employs a heteroatom-functionalised alkene and a simple carbene or 
carbenoid species whilst the second uses a heteroatom-functionalised carbene or 
carbenoid and an alkene. The carbenoids are derived from either halo compounds, diazo 
compounds or Fisher carbenes (Scheme 22). 
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Scheme 22 
 
1.1.3.1. Reactions with heteroatom-functionalised alkenes 
 
1.1.3.1.1. Alkoxycyclopropanes 
 
The simplest example of this approach can be found in the the cyclopropanation of 
vinyl ether 40 in the presence of chloroform and potassium tert-butoxide which affords 
the dichloroalkoxycyclopropane 41 in 50% yield (Scheme 23).37 
 
 
Scheme 23 
 
The dihalocarbene intermediate was formed in situ by reaction of the base with 
chloroform and subsequent trapping of the vinylether to give the corresponding 
cyclopropane.  
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Other reagents can be used to form the dichlorocarbene in situ such as ethyl 
trichloroacetate and sodium methoxide. The choice of method used for the generation of 
the carbene depends on the nature of the vinyl ether. Ethyl trichloroacetate with sodium 
methoxide is preferred in the case of the cyclopropanation of an aryl vinyl ether. 37 
 
More recently, the Furukawa group has studied their variant of the Simmons-Smith 
reaction and demonstrated that the reactivity of vinyl ether towards zinc carbenoids was 
better than dichlorocarbene.38 Coordination of the oxygen atom of the vinyl ether to the 
zinc may stabilise the transition state and enhance the reactivity (Scheme 24).39 
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Scheme 24 
 
Other metals such as mercury can also be used to generate metallocarbenoids and hence 
alkoxycyclopropanes (Scheme 25)40 
 
AcOAcO Hg(CH2Br)2, benzene
23 days, 80-85°C
36%
42 43
 
Scheme 25 
 
The carbenoid can also be generated from a diazo compound for the cyclopropanation 
of vinyl ethers using metals such as copper41 and chromium.42 Thus, 
alkoxycyclopropane 45 was obtained in 79% yield, (but with with low selectivity), from 
vinyl ether 37 and the diazocyclopropanating agent 44 using a chromium based catalyst 
(Scheme 26).42 
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Scheme 26 
 
Examples with rhodium catalysts have also been reported.43 Electron-rich double bonds 
are preferred which demonstrates the electrophilic nature of the metal carbenoid formed 
during the reaction.42 
 
Non-regioselective cyclopropanation of alkoxy- and acetoxybuta-1,3-dienes in the 
presence of diazo compounds and a copper catalyst has also been reported (Scheme 
27).44,45 
 
 
Scheme 27 
 
The double bond which undergoes cyclopropanation in such reactions depends critically 
on the nature of the catalyst. For example, the less polar terminal double bond is 
cyclopropanated when a palladium catalyst was used (Scheme 28).44 
 
 
Scheme 28 
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An elegant tandem sequence involving the use of a Fisher carbene to afford an 
alkoxycyclopropane in a reaction with a vinyl ether is that shown by Ohe and Uemura et 
al. The reaction can be catalysed by different metal such as chromium, platinum, or 
rhodium (Scheme 29).46 
 
 
Scheme 29 
 
1.1.3.1.2. Aminocyclopropanes 
 
The reaction of an enamine with chloroform in presence of a base afforded a 
dihaloaminocyclopropane via in situ formation of a carbene (Scheme 30).47,48 
 
 
Scheme 30 
 
Another example is the treatment of the bicyclic enamide 55 with a phase transfer 
catalyst and an aqueous solution of sodium hydroxide to give the 
dihaloaminocyclopropane 56 in 85% yield (Scheme 31).47 
 
 
Scheme 31 
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The [2+1] cycloaddition between an enamine and a carbenoid such as an organozinc 
carbenoid using Simmons-Smith-Furukawa type conditions49,50 or derived from a diazo 
precursor49a,50,51 can also afford the corresponding aminocyclopropane (Schemes 32 and 
33). 
 
N
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Scheme 32 
 
 
Scheme 33 
 
A different catalyst such as a palladium salt can also be used. Hsung et al. have 
described the cyclopropanation of chiral oxazolidinones using dirhodium carbenoids 
formed in situ from a diazoester leading to the trans N-cyclopropyl oxazolidinone 58 as 
the major product. The mixture of cyclopropanes 58 and 59 was obtained in 66% in a 
4:1 (trans/cis) ratio (Scheme 34).52 
 
 
Scheme 34 
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1.1.3.1.3. Thiocyclopropanes  
 
Thiocyclopropanes are less common in the literature than their respective alkoxy and 
aminocyclopropane counterparts. This stems from their relative reactivity and the fact 
that the lone pairs of the sulfur atom can react with the carbene to give an ylide which 
then leads to alternative products. However, the reaction of unsaturated sulfides in the 
presence of a dichlorocarbene generated in situ to give thiocyclopropane has been 
reported. The thiocyclopropane 63 was synthesised in 61% yield via in situ formation of 
dihalocarbene by reaction of sodium methoxide and ethyl trichloroacetate (Scheme 
35).53,54,55 
 
 
Scheme 35 
 
Cyclopropanation of 4H-1-benzothiopyran 64 was achieved as well, leading to the 
corresponding dichlorocyclopropane 65 (Scheme 36).54 
 
 
Scheme 36 
 
In contrast, the cyclopropanation of vinyl sulfides using metallocarbenoids derived from 
diazo derivatives as cyclopropanating agents is not as effective as the related reactions 
with vinyl ethers and enamines. Under the usual cyclopropanation reaction conditions, 
the reaction can give two products, which are formed in competition: viz., the product 
of addition (cyclopropane) and a major product formed by insertion (Scheme 37).56,57 
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Scheme 37 
 
The insertion product 67 is obtained via the intermediate ylide formed by attack of the 
carbenoid on one of the lone pair electrons of the sulfur, followed by rearrangement. 
This reaction is favoured with the vinyl sulfide in comparison to the vinyl ether 
(Scheme 38).56,57,58, 
 
 
Scheme 38 
 
Moreover, the resonance form 70 reveals that vinyl sulfides are considered to be 
electron-rich. The structure 71 is also possible because of the ability of a sulfur atom to 
expand its valence shell and this contribution may enhance reactivity of sulfur atom 
toward a electrophilic carbene (Scheme 39).56,57 
 
 
Scheme 39 
 
This character may have an influence on the reactivity of the sulfur atom with the 
carbene. Moreover, it has been demonstrated that the carbene attacks the sulfur 2.5-5 
times quicker than the double bond.56 
Finally Ando et al. have reported the reaction of ethyl diazoacetate with phenyl vinyl 
sulfide to afford the corresponding cyclopropane exclusively.57 In this instance, as 
formation of the ylide is reversible and a subsequent intramolecular rearrangement is 
not possible, only the cyclopropane is formed (Scheme 40).  
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Scheme 40 
 
As outlined earlier, by using the Furukawa modification it is possible to use the 
organozinc carbenoid to cyclopropanate systems such as enamines or vinyl ethers. At 
present however, to the best of our knowledge, no sulfur atom-substituted cyclopropane 
has been synthesised by a Simmons-Smith or modified Simmons-Smith protocol. 
 
1.1.3.2. Cyclopropanation using heteroatom-functionalised carbenes or carbenoids 
 
Whilst addition to a heteroatom-substituted alkene is the classical approach, there are 
also a variety of methods in the literature for the formation of heteroatom-functionalised 
carbenes and carbenoids and, in particular, for the formation of amino-, alkoxy- and 
sulfur-substituted cyclopropanes. This has the advantage that there are a plethora of 
substituted alkenes that are commercially available or readily prepared. In contrast, their 
vinylic heteroatom substituted counterparts are few. In consequence, there has been 
considerable interest in the formation and reactivity of heteroatom-functionalised 
carbenes or carbenoids which can trap an olefin to form a heteroatom-substituted 
cyclopropane. 
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1.1.3.2.1. Aminocarbenes and carbenoids 
 
The first alkylaminocarbene was synthesised and isolated by Bertrand et al. in 2004. In 
this case, only tertiary alkyl aminocarbenes are stable due to potential 1,2 H-migration 
which occurres readily for singlet carbenes. The iminium salt carbene precursor 75 was 
synthesised by methylation of 74 despite the steric constrains and the reaction of 75 
with LiTMP 30 afforded the carbene 76 in 30% yield over 2 steps which could be 
recrystallised and stored indefinitely. Subsequent reaction of “nucleophilic” carbene 76 
with methyl acrylate 78 led stereoselectively to the syn-cyclopropane 79 in 85% yield 
(Scheme 41).59 
 
 
Scheme 41 
 
Another example of an aminocarbene, described by Afonso et al., was formed in situ 
from 80 and used in the intramolecular mode to furnish amidocyclopropanes 81 and 82 
(Scheme 42).60 
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Scheme 42 
 
Compound 80 was obtained by reaction of 4-acetoxyazetidinone with allyloxalyl 
chloride. The carbene was obtained by two-electron transfer from the phosphorus atom 
to the imide carbonyl oxygen. 
 
Aminocyclopropanes can also be synthesised in an unusual reaction involving an 
organosamarium aminocarbenoid generated from an amide as reported by Ogawa.61 
This reaction was successful however only in the presence of an excess of styrene 
(Scheme 43). In the presence of electron-deficient olefins like ethyl acrylate, reduction 
of the olefins by the couple Sm/SmI2 was preferred over the reduction of the amide. 
Electron-rich olefins like butyl vinyl ethers were likewise unsuccessful and only the 
deoxygenative coupling of amides was observed.  
 
Ar NR2
O
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Ph
33
 
Scheme 43 
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The diazo compound prepared from an α-nitro ester is a useful rhodium carbenoid 
precursor for trapping electron rich alkenes to afford nitrocyclopropanes (Scheme 
44)62,63,64   
 
 
Scheme 44 
 
This method of course gives access to nitrocyclopropanes and, in order to obtain the 
aminocyclopropanes, a further reduction step is necessary. 
 
To the best of our knowledge, the only direct addition of an α-amino functionalised 
carbenoid to an alkene was recently reported by Barluenga, who developed the first 
intermolecular cyclopropanation of Fischer dialkylaminocarbene complexes for the 
synthesis of 1-aminocyclopropanecarboxylic acid derivatives (Scheme 45).65 
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Scheme 45 
 
The reaction was applicable to a wide range of alkenes and generally proceeded with 
high diastereoselectivity. 
 
In summary, with the exception of the particular case of the Barluenga Fischer 
carbenoid and the isolated example of the generation of the organosamarium carbenoid 
from an amide there is no general method for the addition of aminocarbenes or 
carbenoids to alkenes. 
 
 
 
  Introduction 
38 
1.1.3.2.2. Alkoxycarbenes and carbenoids 
 
Alkoxycarbenes can be generated in situ by the classical approach involving treatment 
of an α-halo ether such as 84 with a strong non-nucleophilic base such as LiTMP 30 to 
give an organolithium carbenoid. This intermediate can subsequently be trapped by an 
alkene as shown for 83 to afford the alkoxycyclopropane 85 in 35% yield with low 
stereoselectivity (Scheme 46).66,67 
 
 
Scheme 46 
 
A dihalo ether can also be used for in situ formation of an alkoxy carbenoid by lithium 
halogen exchange as illustrated below (Scheme 47).14,66,67 
 
 
Scheme 47 
 
However due to the high toxicity of these ethers, these methods are not commonly used, 
but clearly demonstrate the possibility of this route.  
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1.1.3.2.3. Thiocarbenes 
 
In similar fashion, α-chloromethyl sulfides can be used as carbene precursors for 
preparation of thiocyclopropanes (Scheme 48).10, 68,69 
 
 
Scheme 48 
 
1.2. Ionic stepwise methods 
 
1.2.1. Ylide chemistry 
 
1.2.1.1. Definition 
 
Ylides react with electron-deficient double bonds which are susceptible to Michael 
additions such as α,β-unsaturated ketones, esters, amides and related systems, including 
nitriles, sulfones, sulfonamides and nitro compounds, to form cyclopropanes.8,70 The 
reaction of a sulfur ylide with a double bond can lead either to the formation of an 
epoxide or to a cyclopropane depending on the nature of the ylide (Scheme 49).8 
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Scheme 49 
 
“Stabilised” ylides such as 95 and sulfoxonium ylide prefer to react with the double 
bond to give the cyclopropane. Although the faster reaction will still be addition to the 
carbonyl group, this is reversible, hence preventing the formation of the epoxide. The 
1,4-addition which leads to formation of the cyclopropane is kinetically slower but 
thermodynamically more favorable and irreversible in the case of “stabilised” ylides.8 
Moreover the ylide can react selectively with the less hindered face of the alkene to give 
one cyclopropane.  
Thus, cyclopropane rings can be obtained by the stepwise reaction of a “stabilised” 
sulfur ylide or a sulfoxonium ylide with an electron deficient double bond (Scheme 50). 
 
 
Scheme 50 
 
1.2.1.2. Synthesis of heteroatom substituted cyclopropanes 
 
This section focuses on the cyclopropanation reaction of α,β-unsaturated systems which 
leads to heteroatom substituted cyclopropanes. Thus, aminocyclopropanes or 
nitrocyclopropanes can be obtained via 1,4 Michael addition of suitably constituted α-
amino unsaturated Michael acceptors (Scheme 51) or α,β-unsaturated nitroalkenes 
(Scheme 52).50,71,72,73 
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Scheme 51 
 
 
Scheme 52 
 
To the best of our knowledge no example of the synthesis of alkoxycyclopropanes or 
thiocyclopropanes using ionic, stepwise ylide chemistry have been reported in the 
literature. 
 
1.2.2. Titanium-mediated cyclopropanation 
 
A new method has recently been developed for the synthesis of aminocyclopropanes 
using a titanium-mediated reaction whose origin stems from the elegant work of 
Kulinkovich, who developed the reaction of carboxylic esters with Grignard reagents in 
the presence of titanium(IV) alkoxides leading to cyclopropanol derivatives. The 
original reaction was carried out by addition of a solution of ethylmagnesium bromide 
to an ester in the presence of a catalytic amount of titanium(IV) isopropoxide. The 
mechanism proposed is shown in Scheme 53 along with the catalytic cycle (Scheme 
53).74,75 
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Scheme 53 
 
The key step of the reaction is the formation of the organotitanium species which reacts 
with the ester to give the alkoxycyclopropane as the major product.  
 
Recently, de Meijere applied the original Kulinkovich hydroxycyclopropanation 
protocol to N,N-dialkylamides and thus developed a facile preparation of N,N-
dialkycyclopropylamines (Scheme 54).76 
 
 
  Introduction 
43 
R3
MgBr
XTi(OiPr)3
O
NR2R1
(iPrO)2Ti
R3
O
(iPrO)2Ti
R1
NR2
R3
(iPrO)2Ti
R3
+
-
R3
NR2
R1
X = OiPr or Me
-[TiO(OiPr)2]n
2
2
2
2
O R1
NR2
 
Scheme 54 
 
The de Meijere variant of the Kulinkovich reaction can be applied to a wide range of 
carboxamide and Grignard compounds. In principle, primary cyclopropylamines can be 
easily synthesised by hydrogenolysis of N,N-dibenzylcyclopropylamines. However, 
since cyclopropyl rings are also hydrogenated with ring opening, this method cannot be 
applied to all substrates, especially cyclopropanes substituted with an aromatic group  
A recent improvement of the protocol lies in the use of methyltriisopropyloxytitanium 
instead of tetraisopropyloxytitanium for cyclopropanation of an ester or a dialkylamide 
and is preferable in terms of yield.76c,76e  
A further development is the generation of a titanacyclopropane intermediates by 
alkene-ligand exchange which provides access to more highly substituted 
cyclopropylamines from cyclic and acyclic alkenes, alkadienes and even trienes. This 
method enables the formation of functionalised organotitanium species that cannot be 
obtained directly from a Grignard compound. This improvement was initially 
demonstrated by Kulinkovich for the cyclopropanation of esters.77,78,76e The 
titanacyclopropanes derived from cyclopentyl- and cyclohexylmagnesium halides 
appear to be the best for alkene ligand exchange (Scheme 55).76e,78 
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Scheme 55 
 
The titanium mediated approach can be also applied to nitriles giving, in the same 
fashion, the corresponding cyclopropylamines (Scheme 56).79 
 
 
Scheme 56 
 
In contrast with the reaction developed by De Meijere, the use of a Lewis acid is crucial 
for the ring-contraction giving the cyclopropane. 79a The reaction can be applied to a 
wide range of functionalised nitriles.79b,79c 
 
The intramolecular variants of this cyclopropanation reaction have also been applied to 
prepare polycyclic aminocyclopropanes from suitably tethered N,N-
dialkylcarboxamides and carbonitriles (Scheme 57).76a,76c,80 
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Scheme 57 
 
Although this method seems to be a most simple and direct route to access 
aminocyclopropanes, the process is limited to a relatively small number of substrates 
due to the incompatibility of Grignard reagents with other functional groups such as 
carbonyl groups and halides.  
 
1.2.3. 1,3-Ring-closure Reactions 
 
The construction of cyclopropanes by a 1,3-ring-closure reaction is a kinetically 
favoured process in spite of the strain generated. An approach which has often been 
used features a starting material containing an electron-withdrawing group and a leaving 
group in a 1,3-relationship. In the presence of a base the cyclopropane is then obtained 
by intramolecular displacement (Scheme 58). 
 
 
Scheme 58 
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1.2.3.1. Cyclopropanes bearing nitrogen functionality 
 
The formation of nitrocyclopropanes by intramolecular 1,3-ring-closure under 
Mitsonobu conditions using diethyl azodicarboxylate and triphenylphosphine has been 
reported, and when applied to the γ-nitroalkanol 103 led to inversion of configuration 
(Scheme 59). 81 
 
 
Scheme 59 
 
A major disadvantage of this method is that the synthesis of the nitroalkanols requires 
several steps. 
Other methods for the formation of nitrocyclopropanes by 1,3-ring-closure feature the 
use of bromonitromethane as a starting material (Scheme 60). The first of these 
reactions requires an electrophilic alkene bearing two electron withdrawing groups in 
the α- and β-positions, 82 whilst the second, developed by the Ley group, provides an 
elegant demonstration of organocatalysis leading to an enantiopure nitrocyclopropane 
(Scheme 60).83 
 
 
Scheme 60 
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Aminocyclopropanes can also be obtained directly in a similar fashion by treatment of 
chloro enamines with LiAlH4 (Scheme 61).50 
 
 
Scheme 61 
 
1.2.3.2. Thiocyclopropanes 
 
Both cyclopropyl sulfides and sulfones can be readily synthesised following classical 
methodology involving 1,3-ring-closure (Schemes 62 and 63).84,85 
 
 
Scheme 62 
 
 
Scheme 63 
 
1.2.3.3. Alkoxycyclopropanes 
 
In a similar fashion, an example of a 1,3-ring-closure is the treatment of 114 with 
magnesium in the presence of magnesium bromide as Lewis acid which affords the 
alkoxycyclopropane 115 (Scheme 64). 86 
 
 
Scheme 64 
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1.3. Functional group modifications leading to heteroatom 
substituted cyclopropanes from existing cyclopropanes 
 
Cyclopropanes bearing a heteroatom can also be synthesised by subsequent functional 
group manipulation from an existing cyclopropane, either by heteroatom nucleophilic 
displacement or by a functional group interchange. 
 
1.3.1. Direct displacement 
 
The direct displacement of an existing functionalised cyclopropane affording a 
heteroatom substituted cyclopropane is possible from a cyclopropane substituted by an 
appropriate leaving group. 
 
1.3.1.1. Cyclopropanes bearing a sulfur atom 
 
A cyclopropyl sulfide can be obtained by direct displacement of a substituted 
cyclopropane halide by a thiolate anion,87,14 via reaction of a metallated cyclopropyl 
anion with diorganyl disulfides,87 or elemental sulfur88,89 as illustrated by the following 
three examples (Scheme 65). 
 
 
Scheme 65 
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1.3.1.2. Cyclopropanes bearing an oxygen atom 
 
By using a similar concept to the sulfur substituted cyclopropanes, an alkoxy 
cyclopropane can also be obtained by classical Williamson ether synthesis (Scheme 
66).90 
 
 
Scheme 66 
 
1.3.1.3. Aminocyclopropanes 
 
A synthesis of aminocyclopropanes by direct displacement is described below and 
involves reaction of an aryl amine with a bromo-ethoxycyclopropane (Scheme 67).91 
 
 
Scheme 67 
 
The synthesis starts with the conversion of readily available 121 to the bromide 122 
which, after reaction with an aromatic amine to give the N-arylcyclopropylamine and 
reduction affords the aminocyclopropane. Unfortunately, intermediate 122 is not stable 
at room temperature and difficult to synthesise. 
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We note parenthetically that a better approach to N-arylcyclopropylamines is via 
palladium-catalysed C-N bond formation using aryl bromides and coupling them to 
commercially available cyclopropylamine, wherein the desired products are formed in 
moderate to excellent yield (Scheme 68).92 
 
 
Scheme 68 
 
This method requires the use of the commercially available cyclopropylamine and 
cannot afford aminocyclopropanes with other substituents on the cyclopropane ring. 
 
1.3.2. Functional group interchange 
 
Although trivial, standard chemical transformations have certainly been used to 
synthesise heteroatom substituted cyclopropanes. 
 
1.3.2.1. Sulfur substituted cyclopropanes 
 
Thus, vigorous reduction of a sulfone group with DIBAL-H has enabled preparation of 
the parent thiocyclopropane derivative 125 (Scheme 69).14,87b 
 
 
Scheme 69 
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1.3.2.2. Aminocyclopropanes 
 
The formation of aminocyclopropanes by functional group interconversion is by far the 
most commonly employed method in the literature, due in part to the variety of 
reactions that can be used to access the amino group either from carboxylic acid 
derivatives as in the Curtius,93 Hoffmann,94 or Schmidt reactions,95 as well as the 
reduction of a nitro group (Scheme 70).8 
 
R2
R1
R3
OH
O
Curtius
R2
R1
R3
NH2
O R2
R1
R3
NH2
Hoffman Br2 or Cl2
base
1) SOCl2
2) NaN3
R2
R1
R3
N=C=O H2O
H2SO4R
2
R1
R3
OH
O
R2
R1
R3
NH2
Schmidt
R2
R1
R3
NO2 H2, Pd/C
or Fe, HCl
R2
R1
R3
NH2
Reduction
HN3
 
Scheme 70 
 
The Curtius and Hoffmann rearrangements are based on conversion of the carboxylic 
acid derivatives into isocyanates. Treatment of the intermediate isocyanate with water 
generates the required amine derivative.93,94 The Schmidt reaction has also been 
employed whereby a primary amine is obtained by treatment of a carboxylic acid 
derivative with ammonia and sulfuric acid.95 
Weinstock96 developed an alternative method for the conversion of a carboxylic acid to 
an isocyanate using mixed anhydrides to replace thionyl chloride under milder 
conditions. To overcome the dangerous properties of sodium azide, Yamada et al. 
developed a modified Curtius reaction using diphenylphosphoryl azide (Scheme 71).97  
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Scheme 71 
 
The required cyclopropyl carboxylic acid used as the starting material for these 
reactions can readily be obtained by saponification of the corresponding cyclopropyl 
ester commonly obtained by classical method such as metal-catalysed decomposition of 
a diazo compound or the use of sulfur ylide chemistry (Scheme 72).50,98,99,100,101,102,103, 
 
 
Scheme 72 
 
As stated at the outset, the present thesis will focus on the synthesis of 
aminocyclopropanes, and as outlined in the preceding sections, there are numerous 
methods which already exist to prepare such compounds. Nevertheless, careful 
examination of the carbenoid approach reveals several disadvantages, particularly in 
terms of the use of precursors such as toxic gem dihalo compounds or explosive diazo 
precursors. Most of all, perhaps, in terms of synthetic disconnection, there appears to be 
no more general route to functionalised carbenoids possessing a nitrogen substituent on 
the carbenoid carbon. In consequence, the opportunities for using a wide range of 
stereochemically pure E or Z alkenes is lost, especially since this feature is generally 
translated into the stereochemistry of the product. 
In generation of organozinc carbenoids from carbonyl compounds and their congeners 
in various oxidation states there is therefore an attractive alternative, especially since 
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organozinc reagents are generally considered to be non-toxic, mild, and highly 
chemoselective.  
 
1.4. Previous research within our group 
 
Before addressing the previous work carried out in our own group, it is important to 
recognise the mechanistic parallel which exists with the classical Clemmensen 
reduction. 
 
1.4.1. Carbonyl compounds as cyclopropanating agents: The 
Clemmensen reduction 
 
The Clemmensen reduction using zinc amalgam and hydrochloric acid is one of the 
simplest methods for the reduction of a carbonyl group of ketones and aldehydes into a 
methylene group (Scheme 73).104 
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Scheme 73 
 
The mechanism of this reaction has been the subject of ongoing debate and is still not 
totally understood. The formation of a zinc carbenoid as an intermediate is now 
commonly accepted104 following work by Burdon in 1986 who proposed a mechanism 
involving the zinc carbenoid intermediate (Scheme 74).105 
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Scheme 74 
 
Products analysis and deuterium labelling experiments confirmed the intermediate 129 
as a zinc-carbenoid. Protonation of 129, followed by reduction leads to 130. The 
organozinc carbenoid 129 can be deprotonated to give a vinyl-zinc species 131 and 
converted into 132 by rearrangement, or trapped by an alkene to give a cyclopropane 
133. 
 
1.4.2. Carbonyl compounds as organozinc carbenoid precursors 
 
Whereas attempts by Burdon to capture the zinc-carbenoid intermediate with alkenes 
other than styrenes failed, possibly due to steric factors, the use of a carbonyl group as a 
precursor of an organozinc carbenoid in the presence of zinc and a Lewis acid had in 
fact already been demonstrated by earlier work. 
 
Thus, in 1969, Elphimoff-Felkin and Sarda published the cyclopropanation reaction of 
an alkene using an aldehyde as a zinc carbenoid precursor in the presence of metallic 
zinc and boron trifluoride diethyl etherate as a Lewis acid, which could serve as a 
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possible replacement for the proton source which was responsible for the rapid 
destruction of the carbenoid (Scheme 75).106 
 
H
O
BF3-OEt2, Et2O, r.t.
8 : 1
major isomer
shown
43%
, Zn(Hg)
22
134 26
 
Scheme 75 
 
The species 135 was proposed to be the intermediate involved in this reaction (Scheme 
76).106 
 
Ar H
O
H
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O
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F3B
BF3-OEt2
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Scheme 76 
 
The formaiton of organozinc carbenoid derived from a carbonyl compound in presence 
of Lewis Acid was then investigated in details in order to develop new reactions. 
 
1.4.3. Evolution of organozinc carbenoid chemistry as a 
cyclopropanating agent within our group 
 
Additionally, in 1973, Motherwell demonstrated the conversion of several 
cyclohexanone derivatives in the presence of zinc and chlorotrimethylsilane, to the 
corresponding cyclohexenes. The behaviour of cyclooctanone in particular provided 
strong presumptive evidence for the intermediacy of an organozinc carbenoid since 
bicyclo-[3.3.0]-octane is most reasonably derived by transannular C-H insertion 
(Scheme 77).107,108  
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Scheme 77 
 
Further studies within the group demonstrated that reductive McMurry-type dicarbonyl 
coupling of certain aryl and α,β-unsaturated carbonyl compounds to give alkenes can 
also be accomplished using chlorotrimethylsilane and zinc at low temperature. The 
mechanism was proved not to involve pinacolic coupling and diol deoxygenation but to 
proceed via a carbonyl ylide derived by trapping of the organozinc carbenoid with a 
second molecule of carbonyl compound (Scheme 78).108,109 
 
O
C4H9 C4H9
C4H9
ClMe2Si(CH2)2SiMe2Cl
Zn
72%
139 140
 
Scheme 78 
 
In both of the above reactions, it was thought that an organozinc carbenoid would be 
generated directly and efficiently from a carbonyl compound, by treatment with metallic 
zinc in the presence of a silicon electrophile. A mechanistic pathway involving a series 
of single electron transfer processes facilitated by the Lewis acidic silicon electrophile 
as an oxaphilic reagent can be considered as shown below (Scheme 79).110,111 
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Scheme 79 
 
The organozinc carbenoid intermediate 141 thus generated was also used for a useful 
range of reactions as described below. 
 
1.4.4. Inter and intramolecular cyclopropanation  
 
A variety of aryl and α,β-unsaturated carbonyl compounds, on treatment with zinc and a 
silicon electrophile afford organozinc carbenoids which may be trapped with alkenes to 
give cyclopropanes both in an inter- and intra-molecular fashion (Scheme 80).110,111,112 
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Scheme 80 
 
Following on from this concept, it was shown that acetals and ketals can also be used as 
direct precursors for organozinc carbenoid chemistry and can afford either 
cyclopropanes or C-H insertion products.113 In this case, and in contrast to the reactions 
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of carbonyl compounds, carbenoid formation does not require initial formation of a zinc 
oxygen bond on the surface, but could involve direct delivery of electrons from zinc to 
an oxocarbenium ion (148) as shown in Scheme 81. A typical cyclopropanation reaction 
is shown in Scheme 82.113 
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Scheme 81 
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Scheme 82 
 
As a logical consequence of the selection of acetals and ketals, the use of orthoformates 
as alkoxyorganozinc carbenoid precursors then provided a very simple and practical 
method for the preparation of alkoxycyclopropanes (Scheme 83).114 
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1.4.5. Synthesis of aminocyclopropanes 
 
More recent studies in the group have focused on the use of this organometallic 
chemistry because it is potentially more applicable to a stereocontrolled synthesis of 
amidocyclopropanes. 
The aim was to design an organozinc carbenoid with an amino group attached in order 
to have access to a wide range of functionalised aminocyclopropanes by a [2+1] 
cycloaddition from different alkenes and not only a methylene insertion (Scheme 84). 
 
 
Scheme 84  
 
By analogy with the earlier work on orthoformates, Mr. Guillaume Bégis initially 
worked on a new organozinc precursor containing an amino group such as 155 as the 
carbenoid precursor. Unfortunately the reaction was not conclusive (Scheme 85).115, 
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After investigation, Mr. G. Bégis demonstrated that the organozinc carbenoid attached 
to an amino group capable of trapping an alkene to form a cyclopropane could be 
obtained from a molecule containing an additional electron-withdrawing group α to the 
nitrogen atom in order to attenuate the strong electron-donating (nucleophilic) ability of 
the nitrogen lone pair. 
Thus, in an analogous fashion to ketals, acetals and orthoformates, an organozinc 
carbenoid containing amino functionality was obtained from N-diethoxymethylamide 
derivatives (Scheme 86). 
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Scheme 86 
 
Careful experimentation by my predecessor, Mr G. Bégis then established that the N-
diethoxymethyl derivative of pyrrolidinone 157 was preferred over the selection of an 
acyclic amide and that a useful range of alkenes could then undergo cyclopropanation 
using this reagent as a carbenoid precursor (Scheme 87).115, 116  
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Scheme 87 
 
Further studies then allowed him to carry out some preliminary work using the closely 
related but potentially more useful oxazolidinone system 158 (Scheme 88). 115,117 
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Scheme 88 
 
These studies paved the way for the present research programme. 
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Chapter 2: Results and Discussion 
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2.0. Introduction 
 
The discovery of the amidocyclopropanation and the closely related use of N-
diethoxymethyl oxazolidinones by my predecessor Mr Guillaume Bégis had laid a very 
strong foundation which indicated that this simple reaction was of considerable value for 
organic synthesis.115,116,117 
Nevertheless, at the outset of the present work, several aspects of the reaction required 
further study and clarification. Thus, it was necessary to explore the reaction in terms of 
its chemoselectivity and its tolerance to other functional groups. For these reasons, the 
following six alkenes (Figure 4) were selected as substrates for cyclopropanation.  
 
Si
OEt
O
O
MeO
Cl
O
EtO
160 161
163162
159
 
Figure 4 
 
The cyclopropanation of these alkenes was of particular interest to extend the range of 
chemoselectivity and stereoselectivity, as the alkene 159 contained both an electron-poor 
and an electron-rich double bond, the alkenes 160 and 161 possess silyl and chloride 
functionality and the alkenes 162 and 163 a cyclopropyl group, and an ester group which 
could potentially have a directing influence on the cyclopropane formation. 
 
A particular concern however, as we shall see later, was that it was not possible to predict 
the stereochemical outcome for any given reaction of an alkene and an amidoorganozinc 
carbenoid. A selection of the examples prepared by Mr Bégis is shown in Table 1 and 
illustrates the complexity involved with predicting the stereoselectivity of the 
cyclopropanation reaction.115,116 
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entry alkene Products 
1 
 
N
H
tBu
H
O
>95:5
 
 164 168 (61%a) 
2 
 
 
 22 169                         170 
             (66%a) 
3 
 
 
 165 171 (66%b) 
4 
 
 
 33 172                 173 
       (70%a,c) 
5 
 
HH
NO
HH
N
H
O
H
1:1
 
 166 174 175 
               (28b) 
6 
 
MeH
H
N
O
MeH
N
H
O
1.3:1
 
 167 175 177 
                (63a) 
Table 1 
a. Zn(Hg) method. b. Zn/CuCl method. c. The carbenoid precursor was added by syringe pump over 2 h. 
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For example, whilst cyclopropanation reactions with 164 and 22 favoured formation of the 
trans or exo cyclopropane (Table 1, entry 1 and entry 2), this trend seems to be reversed in 
the cyclopropanation of 165 (Table 1, entry 3) and is not observed for the closely related 
cases of styrene 33 (Table 1, entry 4), 166 (Table 1, entry 5) and dihydronaphtalene 167 
(Table 1, entry 6).115,116  
 
2.1. Oxazolidin-2-one derivatives as carbenoid precursors 
 
2.1.1. Synthesis of alkenes 
 
Alkenes 160, 161 and 162 are commercially available, alkene 163 was obtained in 65% 
yield from the reaction of commercially available (cyclopent-2-enyl)acetic acid 178 with 
ethanolic HCl (Scheme 89).118 
 
0 °C-68 °C, 4 h
AcCl, EtOH
O OH
O OEt
65 %
178 163
 
Scheme 89 
 
Diene 159 was synthesised from 6-methyl-5-hepten-2-one 179 by reaction with triethyl 
phosphonoacetate in the presence of sodium hydride in tetrahydrofuran.119 A mixture of 
(E) and (Z) isomers was obtained in 89% overall yield (75:25 E:Z). The pure E isomer was 
isolated by column chromatography and used for subsequent cyclopropanation reactions 
(Scheme 90). 
 
 
Scheme 90 
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2.1.2. A preamble on the assignment of stereochemistry 
 
The geometry of each cyclopropane synthesised was determined as trans, cis, exo or endo 
by 1H NMR spectroscopy analysis. According to the Karplus equation, the value of the 
coupling constant of vicinal protons is related to their dihedral angle (Figure 5).120 
28.0cos23 −= AKJ ab  for 0°C <A<90°C 
28.0cos' 23 −= AKJ ab  for 90°C <A<180°C 
 
 
Figure 5 
 
                                        
Figure 6 
 
3JHH = A cos2φ + B cos φ  + C 
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The value of the dihedral angle between two cis protons is 0 degrees and between two 
trans protons 145 degrees (Figure 6), thus according to the equation the value of the 
coupling constant of vicinal protons is larger for cis than for trans couplings.120  
Jcis (vicinal)> Jtrans (vicinal) 
Analysis of the N-CH proton of the cyclopropane unit and measurement of its coupling 
constant allowed easy determination of the geometry of the cyclopropane. 
For all the compounds synthesised, the range of values of the coupling constant measured 
between two trans cyclopropyl protons is 1.9 Hz < Jtrans< 5.5 Hz and the range of values 
of the coupling constant measured between two cis cyclopropyl protons is 6.2 Hz<Jcis< 9.0 
Hz. 
The signal observed for the CHN proton in the trans configuration is a doublet of triplets 
with a cis coupling constant and two trans coupling constant. The signal observed for the 
CHN proton in the cis configuration is a triplet of doublets with two cis coupling constants 
and one trans coupling constant.  
 
2.1.3. Cyclopropanation studies 
 
Diethoxymethyl oxazolidin-2-one 158 had previously been prepared in the laboratory by 
reaction of oxazolidinone and triethyl orthoformate in the presence of aluminium chloride 
and was used without further purification (Scheme 91).115,121 
 
O N
O
158
OEt
OEt
O NH
O
150 °C, 22 h
67%
AlCl3 (0.1 eq.), (EtO)3CH (15 eq.)
180
 
Scheme 91 
 
The cyclopropanation reaction was then carried out using zinc, copper chloride, zinc 
chloride and trimethylsilyl chloride in diethyl ether heated at 44 °C for 16 hours in the 
presence of the carbenoid precursor 158 and the mono-, di-, and trisubstituted alkenes 159, 
160, 161, 162 and 163 to obtain the corresponding N-cyclopropyloxazolidinones in 
stereoselective fashion in moderate to good yields. 
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Pleasingly, under the reaction conditions used, chemoselective cyclopropanation of the 
more electron-rich double bond was observed for the cyclopropanation of 159, confirming 
our hypothesis on the essentially electrophilic nature of the carbenoid. The cis 
cyclopropane 181 was the major product (38% yield) obtained with a ratio cis:trans 11:1 
based on the crude 1H NMR spectrum. The ester group was tolerated under the reaction 
conditions (Scheme 92). 
 
 
Scheme 92 
 
Based on the 1H NMR spectrum of the isolated products resulting from the 
cyclopropanation reaction of allyltrimethylsilane, 160, the trans N-cyclopropyl 
oxazolidinone 183 and the cis diastereoisomer 184 were obtained in a ratio of 2.5:1. The 
25% yield was calculated for the mixture of the two isomers obtained after purification by 
flash column chromatography (Scheme 93).  
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Scheme 93 
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We were pleased to note that, in spite of the electrophilic nature of some of the 
intermediates involved in carbenoid generation it was possible to use an allylsilane. 
 
The cyclopropanation of alkene 161 led in low yield (11%) to the formation of the 
cyclopropane 185 (the major isomer) in which the smaller halogen is adjacent to the amido 
group (Scheme 94).  
 
 
Scheme 94 
 
Once again, the ester and halogen group were tolerated under the reaction conditions. 
 
The major diastereoisomer resulting from the cyclopropanation of 162 was the endo 
cyclopropane 187 obtained in 58% yield (Scheme 95). 
 
 
Scheme 95 
 
According to 1H NMR spectroscopy studies, a strong preference for one (187) of the four 
possible diastereoisomers was observed. 
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The two major diastereoisomers obtained and isolated from the cyclopropanation reaction 
of 163, were the two exo cyclopropanes (188 and 189) obtained in a ratio 2.6:1 (based on 
the crude 1H NMR spectrum). The yield of the reaction (34%) was calculated from the 
total yield of isomers obtained after purification by flash column chromatography 
(Scheme 96). 
 
 
Scheme 96 
 
In this case, although four diastereoisomers could in principle be obtained. 1H NMR 
spectroscopy indicated a preference for only two of these. 
The ability of the ester group to coordinate the organozinc carbenoid and favour delivery 
to the more hindered face of the alkene in this reaction was noteworthy. 
 
First of all, in terms of the chemoselectivity of the reaction, the above results confirm the 
electrophilic character of the organozinc carbenoid, and prove that silyl, ester and halogen 
functionality are all tolerated under the reaction conditions using zinc and trimethylsilyl 
chloride.122 
The rationalisation of the stereochemical outcome in such reactions will be discussed later 
(vide infra). 
 
We also wished to investigate the cyclopropanation of allenic substrates since the 
formation of a methylene cyclopropane by amidocyclopropanation of an electronically 
differentiated allene could lead to further transition metal mediated cycloaddition reactions 
as shown below and could be used for the design of more complex molecules (Scheme 
97).14,123 
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Scheme 97 
 
Allene 190 had been synthesised previously in the laboratory by reaction of 3-
phenylpropanoyl chloride with ethoxycarbonylmethylphosphorane in presence of 
triethylamine in dichloromethane (Scheme 98). 124  
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Scheme 98 
 
The cyclopropanation reaction was carried out using our oxazolidin-2-one derivative 158 
as a carbenoid precursor. Unfortunately no evidence for cyclopropane formation was 
observed under the reaction conditions (Scheme 99). 
 
 
Scheme 99 
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The only product observed was the alkene 191, obtained by the reduction of one of the 
double bonds. The proposed mechanism explaining this result is shown below (Scheme 
100). 
 
 
Scheme 100 
 
The allene 190 was therefore reduced by two single electron transfers from zinc in the 
presence of a proton source which is encouraged by the formation of a conjugated zinc 
ester enolate. Unfortunately, reduction of one double bond of the allene was faster and 
more favourable than trapping by the organozinc carbenoid and led to 191. This result is 
different from the chemoselective cyclopropanation of the more electron-rich double bond 
of the diene 159 which yields a cyclopropane, and in which the unsaturated ester moiety 
did not react. 
The replacement of trimethylsilyl chloride by Et2AlCl as a Lewis Acid and proton 
scavenger would certainly be of interest as well as other allenes which do not contain the 
α,-β unsaturated ester unit.  
 
2.1.4. Stereochemistry 
 
As indicated earlier, our thoughts now focused on the more vexatious problem of 
rationalising the stereochemical outcome of these reactions. 
When taken together with the results obtained from the cyclopropanation of other alkenes 
which had previously been studied within our group from pyrrolidinone or oxazolidinone 
precursors, overall comparison of the different results clearly illustrates the complexity in 
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predicting the stereoselectivity of the cyclopropanation reaction which seems to depend on 
the nature of the alkene (Table 2).115,116 
 
Entry alkene Products 
1a 
 
N
H
tBu
H
O
>95:5
 
 164 168 (61% b) 
2 
 
 
 160 183 184       
              (25%c) 
3 
 
 
 163 188 189       
              (34%c) 
4a 
 
 
 22 169 170       
               (66%b) 
5a 
 
 
 165 171 (66%c) 
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6  
 
 
 161 184 186       
           (11%c) 
7a 
 
 
 33 172 173       
          (70%b,d) 
8a 
 
 
 166 174                         175       
          (28%c) 
9a 
 
 
 167 176 177       
               (63%b) 
10 
 
 
 162 187 (58%c) 
11 
 
 
 159                        181                          182       
                                 (38%c) 
 
a. Cyclopropanes synthesised previously in the group by Mr G. Bégis and Dr T. D. Sheppard b. Zn(Hg) 
method. c. Zn/CuCl method. d. The carbenoid precursor was added by syringe pump over 2 h. 
Table 2 
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In general, reaction with a monosubstituted alkene tends to favour formation of the trans 
product, and increasing bulk reinforces this behaviour (Table 2, entries 1 and 2). The 
trends for more substituted alkenes were more difficult to rationalise. The exo/trans 
cyclopropane was the major isomer observed in the case of the cyclopropanation of 
disubstituted alkenes 163 and 22 (Table 2, entry 3 and entry 4) and the trisubstituted 
alkenes 162 (Table 2, entry 10) whereas the endo or cis cyclopropane was the major 
isomer in the case of the cyclopropanation of the disubstituted alkenes 165 and 161 (Table 
2, entry 5 and entry 6) and the trisubstituted alkene 159 (Table 2, entry 11). Moreover 
cyclopropanation of other mono-, di- and trisubstituted alkenes showed virtually no 
stereoselectivity (Table 2, entry 7, entry 8 and entry 9). 
At first sight, there appeared to be little pattern in the observed results, so in order to gain 
insight we tried to explain the stereoselectivity using a quadrant model in which the 
quadrant A was largely unhindered, B sterically congested, and C and D moderately 
hindered (Scheme 101). During the cyclopropanation reaction with a monosubstituted 
alkene, R2
 
(which is a proton) fits well in the quadrant B (the most sterically hindered) and 
R1 in the quadrant A (the most unhindered) which leads to the formation of a trans or exo 
cyclopropane (Scheme 101, path A). Whereas for a cis disubstituted alkene, R2 would not 
fit well in quadrant B due to steric interactions and the alternative approach of the alkene 
would be preferred leading to the cis or endo cyclopropane (Scheme 101, path B).122 
 
 
Scheme 101 
 
Considering the related cyclopropanation using the oxazolidin-2-one 158 as an organozinc 
carbenoid precursor, two transitions state were proposed using the quadrant model and 
placing the zinc atom in quadrant D. Coordination of the zinc to the oxygen atom of the 
carbonyl group would then place the oxazolidinone ring in quadrant C, and the methylene 
group in quadrant B, leaving quadrant A empty. During the approach of a monosubstituted 
alkene, the R1 group would prefer to fit in quadrant A (R2 is a proton) giving rise to a trans 
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cyclopropane. However if a disubstituted alkene was cyclopropanated, the second 
transition state (ii) would be preferred to give the endo cyclopropane where R1 and R2 
would fit in the moderately sterically congested quadrants D and C respectively occupied 
by the zinc atom and the carbonyl group. This pathway would avoid the interaction 
between R2
 
and the methylene group alpha to the nitrogen atom which takes place in the 
exo transition state (i) (Figure 7). 
 
 
Figure 7 
 
Although semi empirical, this quadrant model manages to explain the different possible 
approaches of the alkene to the organozinc carbenoid. This model was an a posteriori 
explanation and confirmed most of the results observed. 
 
2.2. Chiral oxazolidin-2-one derivatives as carbenoid precursors 
 
On completion of the fundamental studies described above, we then moved to a second 
goal of our research programme which involves the design of a wider range of enantiopure 
functionalised organozinc carbenoid precursors in order to have access to a wider range of 
highly functionalised N-cyclopropyl oxazolidinone (Scheme 102). 
 
 
Scheme 102 
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2.2.1. Synthesis of chiral carbenoid precursors 
 
At this stage, the parent enantiopure oxazolidinone carbenoid precursor 197 had also 
previously been prepared within the group from commercially available (−)-2-amino-1,2-
diphenylethanol 195 in two steps by an analogous route to that used for the achiral 
compound 158 as outlined below (Scheme 103). 115,117,121 
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O N
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OEt
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PhHO
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197 EtO OEt
22 h, 150 °C
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AlCl3 (0.1 eq.), (EtO)3CH (15 eq.)
4 °C, CH 2Cl2
AlCl3 (0.15 eq.), (EtO)3CH (30 eq.)
68%
180
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Scheme 103 
 
Whilst the yields of the above reactions were sufficient to allow subsequent synthetic 
steps, the synthesis of other enantiopure carbenoid precursors carried out by Mr. G. Bégis 
had led to diminished yields and therefore posed a problem (Tables 3 and 4).115 
 
O
O NH
R
O
O N
R
OEt
OEt
(EtO)3CH3, AlCl3
155 °C, 22 h
 
Oxazolidinone R Yield Product 
198 CH2Ph 25% 200 
199 iPr 29% 201 
Table 3 
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O
O NH
R
O
O N
R
OEt
OEt(EtO)3CH3, AlCl3
155-165 °C, 16-18 h
 
Oxazolidinone R Yield Product 
202 PMP 26% 206 
203 Ph 33% 207 
204 CO2Et 55% 208 
205 CH2OTBDMS 60% 209 
Table 4 
 
As illustrated above, the conditions developed up to this point were capricious and not 
convenient. Moreover application on large scale tended to diminish the yield and the high 
boiling point of triethyl orthoformate made it difficult to remove any excess at the end of 
the reaction.115 
 
Accordingly a range of other methods were investigated in order to find better conditions 
for the formation of these precursors under milder conditions, with a smaller quantity of 
triethyl orthoformate and more moderate reaction temperatures. In the first instance, we 
elected to add acetyl chloride to the reaction mixture with the intention of facilitating the 
departure of one of the ethoxy groups of triethyl orthoformate as shown in Scheme 104 
and thus generating the more reactive halide 212 in situ. 
 
OEtO
OEt
Cl
O
OEtO
OEt
Et
O Cl- EtO
OEt
Cl
210 211 212
 
Scheme 104 
 
An initial result demonstrated that N-diethoxymethyl oxazolidin-2-one 158 could be 
obtained on a 10 g scale in good yield using a “catalytic amount” of acetyl chloride, and 
only 2.6 equivalents of triethyl orthoformate at room temperature (Scheme 105).122  
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Scheme 105 
 
With a similar objective in mind, we also investigated the addition of 
chlorotrimethylsilane in the presence of triphenylphosphine as a genuine catalyst. This 
combination was chosen since it is known that stereoselective epoxide ring opening to 
vicinal siloxychlorohydrins can be achieved at low temperature in the presence of a 
catalytic amount of triphenylphosphine in ethanol free chloroform (Scheme 106).125  
 
 
Scheme 106 
 
It was gratifying to note that N-diethoxymethyl pyrrolidin-2-one 157 was thus obtained in 
good yield using a catalytic amount of trimethylsilyl chloride and triphenylphosphine, and 
triethyl orthoformate in dichloromethane at room temperature (Scheme 107).122 
 
 
Scheme 107 
 
Following these initial studies on inexpensive systems, we then applied these results to the 
preparation of new chiral carbenoid precursors, in the hope of obviating the problems 
outlined above. 
The necessary chiral oxazolidin-2-one precursors were readily prepared in good to 
quantitative yield from natural amino acid derivatives (Table 5 entries 1-3) and from 
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commercially available unnatural amino acids derivatives (Table 5, entries 5 and 6) by 
standard literature protocols involving triphosgene and triethylamine (Table 5).  
 
HN O
O
R1
H2N OH
R1
triphosgene
Et3NR2
R2
 
Entry Aminoalcohol R1 R2 Yield Product 
1 216 iPr H 89% 199 
2 217 CH2 iPr H 99% 221 
3 218 CH2Ph H 99% 198 
4 219 CH3 Ph 99% 222 
5 220 C2H5 H 99% 223 
Table 5 
 
The oxazolidinone 226 was obtained in 75% over 2 steps by reduction of the 
oxazolidinone 225 obtained by treatment with phosgene of serine methyl ester 
hydrochloride 224 (Scheme 108) 
 
HN O
O
+H3N OH
O
MeO
MeO
1. KHCO3, H2O, r.t., 10 min
2. K2CO3, 10 % phosgene in toluene
2h, 0 °C
O
224 225
91 %
NaBH4
EtOH, 0 °C-r.t., 2 h
HN O
O
HO
82 %
226
Cl-
 
Scheme 108 
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As a result of the problems previously encountered in the synthesis of enantiopure 
carbenoid precursors and in light of the encouraging preliminary observations noted 
above, we therefore decided to investigate alternative conditions for the synthesis of other 
enantiopure precursors using three different chiral oxazolidinones (Tables 6, 7 and 8). The 
major problem of this reaction is that the corresponding orthoamide is not the exclusive 
product. 
 
2.2.1.1. Optimisation of reaction conditions using the oxazolidinone derived from L-
valine 
 
The synthesis of orthoamide 201 from oxazolidinone 199 was performed using a range of 
different catalytic systems with different ratios, temperatures and in different solvents 
(Table 6).  
 
199
N
H
O
O N
O
ON
O
O
EtO OEt O H
227201
(EtO)3CH eq. catalyst solvent t NMR observations
10
10
30
10
2.6
3
AcCl (1 eq.)
AlCl3 (0.15 eq.)
TMSCl (1.1 eq.)*
BF3 (1 eq.)
AlCl3 (0.15 eq.)
AcCl (2 eq.)
neat
neat
neat
toluene
2 h
1 h
16 h
16 h
16 h
16 h
50 °C
90 °C
100 °C
40 °C
40 °C
110 °C
mixture of 199/227 (1:2)
80 % conversion to 201
mixture of 199/227 (1:1.4:3)
decomposition
entry
1
2
3
4
5
6
T
CH2Cl2
CH2Cl2
mixture of 199/201/227 (4.8:2:1)
mixture of 199/201/227 (14.8:1:2)
 
               *PPh3 used as catalyst  (0.15 eq.) 
Table 6 
 
Under the conditions employed using the oxazolidinone derived from L-valine, the 
formation of 201 was observed only at high temperature (T>90 °C, Table 6, entries 2, 3 
and 6). Changing the Lewis acid used did not improve the conversion, and led to 
decomposition of the starting material in the case of BF3 (Table 6, entry 4). Finally the 
best result (Table 6, entry 6) was observed at high temperature (110 °C) with a catalytic 
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amount of aluminium chloride (0.15 eq.) as Lewis acid and 3 equivalents of triethyl 
orthoformate in toluene. 
 
2.2.1.2. Optimisation of reaction conditions using the oxazolidinone derived from L-
Leucine 
 
A similar study was also performed on the synthesis of orthoamide 229 through 
modification of the reactions conditions (Lewis acid, temperature, solvent and reaction 
time) (Table 7). 
 
221
N
H
O
O N
O
ON
O
O
EtO OEt O H
229228
(EtO)3CH eq. LA solvent reaction time NMR observations
30
4
4
6
AlCl3(0.15 eq.)
AlCl3 (0.15 eq.)
TiCl4 (1 eq.)
TiCl4 (0.15 eq.)
/
toluene
18 h
16 h
16 h
16 h
150 °C
40 °C
40 °C
110 °C
completion 48% yield
50% conversion
221
mixt. 221/229 (1.7:1)
6 BF3 (0.15 eq.) toluene 16 h110 °C no reaction
entry
1
2
3
4
5
T
CH2Cl2
CH2Cl2
 
Table 7 
 
Studies carried out with compound 221 and triethyl orthoformate again demonstrated the 
importance of high temperatures (table 7, entries 1 and 4). As before, catalytic aluminium 
chloride was the best Lewis acid found. 
 
Formamides 227 and 229 were formed either by hydrolysis of the corresponding 
diethoxymethylamide in the presence of a proton source and water during the work up or 
by nucleophilic attack using chloride anion (Scheme 109).122  
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O
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OEt
OEt
H+
Et
H2O
O
O N
R
O
H
Cl-
-EtCl
-EtOH
 
Scheme 109 
 
2.2.1.3. Optimisation of reaction conditions using the oxazolidinone derived from 2-
amino-1-butanol 
 
Finally, some experiments were performed on the oxazolidinone 223 using trimethylsilyl 
chloride as Lewis acid (Table 8). 
223
N
H
O
O N
O
O
EtO OEt
230
(EtO)3CH eq. solvent t NMR observations
2.6
2.6
6.5
3
1.1
3
4.25
1.1
Toluene
16 h
16 h
72 h
16 h
40 °C
40 °C
r.t.
51% conversion
61% conversion
88% conversion *
73% conversion *
6 6 16 h40 °C 50% conversion
entry
1
2
3
4
5
T
r.t.
*PPh3 used as catalyst (0.15 eq.)
TMSCl eq.
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
 
Table 8 
 
The side product formamide was never observed following these conditions. Surprisingly 
when oxazolidinone 223, derived from 2-amino-1-butanol 220 was used, good conversion 
was obtained at 40 °C using only trimethylsilyl chloride and triphenylphosphine in 
dichloromethane (Table 8, entry 3). This result was unexpected considering the small 
difference in the structure of the starting materials 223 compared to 199 (Tables 6 and 8). 
 
Despite further investigation into a range of reaction conditions no significantly better 
results than the current literature procedure was found.121 Due to time constraints, we 
therefore decided to continue our investigations using the classical methodology. 
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Finally, improved yields of the carbenoid precursors were achieved using a large excess of 
triethyl orthoformate (up to 40 equivalents) under acidic conditions at 165 °C for at least 
18 hours. Working on small scale with very pure starting materials (less than 10 mmol of 
the oxazolidin-2-one derivatives) was the best way to obtain the chiral carbenoid 
precursors in moderate to good yields. We found that it was important to remove excess 
triethyl orthoformate under high vacuum, prior to further purification, since it could not be 
completely separated from the desired product by flash chromatography (Table 9). 
 
O
O NH
R2R1
O
O N
R2R1
OEt
OEt
(EtO)3CH3, AlCl3
165 °C
 
Oxazolidinone R1 R2 Yield Product 
199 H iPr 55% 201 
221 H CH2iPr 63% 228 
198 H Bn 53% 200 
222 Ph Me 53% 231 
223 H Et 55% 230 
Table 9 
 
Carbenoid precursor 232 could not be synthesised using the literature conditions with 
aluminium chloride as the Lewis acid. Therefore 232 was synthesised in 22% yield from 
an alternative procedure using triethyl orthoformate and para-toluenesulfonic acid heated 
to reflux (Scheme 110). 
 
O
O N
O
OEt
H
O
O NH
OH
(EtO)3CH, p-TsOH
165 °C, 6 h
226 232
 
Scheme 110 
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Two diastereoisomers could have been obtained depending on the position of the ethoxy 
group (Figure 8). 
O N
O
O
H
OEt
H
O N
O
O
OEt
H
H
A B
 
Figure 8 
 
However, the isolated product was not stable and further NMR analysis could not be 
performed to determine the major isomer obtained. 
 
2.2.2. Synthesis of chiral N-cyclopropyloxazolidinones 
 
With the chiral carbenoid precursors in hand, we turned our attention towards the 
synthesis of N-cyclopropyl oxazolidinones via their reaction with different alkenes. 
 
Previously within the group, only two chiral oxazolidinone had been used as organozinc 
carbenoid precursors for preparation of enantiopure cyclopropanes from a limited 
selection of alkenes (Table 10).115,117 
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Entry Product (major) dra Yield 
1 N
H
PMB
H
O
Ph
Ph
O
 
87:9c 63%f 
 233 233:234 
 
2 N
H
Ph
H
O
Ph
Ph
O
 
56:28d:6c:6d 54%f 
 235 235:236:237:238 
 
3 
 
b
 76% f 
 239 
  
4 
N
H
H
O
Ph
Ph
O
NHFmoc
EtO2C
 
b
 70%f 
 240 
  
5 
 
b
 36%g 
 241 
  
6 N
H
SiMe2Bn
H
O
Ph
Ph
O
 
b 42%f 
 242   
a. Any diastereoisomers not observed by 1H NMR spectrum were considered to be <2%. b. only one 
diastereoisomer was observed / isolated. c The minor diastereoisomer was a trans/exo cyclopropane. d. The 
minor diastereoisomer was a cis/endo cyclopropane. f. Zn(Hg) was used. g. Zn/CuCl was used. 
Table 10 
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Thus, it was of interest to extend the range of both chiral carbenoid precursors and 
functionalised alkenes for cyclopropanation reaction (Tables 11 and 12). 
 
entry alkene Product(s) dra Yield 
1 
 
 
>90:10 42% b (33%b,d) 
 153 244 
  
2 
 
 
>90:10 40% b 
 165 245 
  
3 
 
N
H
H
O
O
 
>90:10 29% b 
 164 246 
  
4 
 
 
82:14e 13% b 
 243 247 247:248 
 
5 
 
 
59:37f 40% b, g 
 166 249 249:250 
 
6 
 
N
H
H
O
O
Ph
 
h 20% b 
 164 251   
Table 11 
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entry alkene Product(s) dr Yield 
1 
 
 
92:4e 44%b 
 153 254 
  
2 
 
N
H
Cy
H
O
O
 
>90:10 47%c 
 252 255   
3 
 
 
h 44%c 
 253 256 
  
4 
 
N
H
PMB
H
O
O
OH
 
h 23%b 
 253 257 
  
5 
 
 
82:14f 29%b,g 
 154 258 258:259 
 
6 
 
H H
H
N
O
O
OEt
O
Ph
 
 26%b,g 
 163 260   
Table 12 
 
Table 11 and Table 12: a. Any diastereoisomers not observed by 1H NMR were considered to be <2%. b. 
Zn/CuCl method. c. Zn(Hg) method. d. Reaction carried out as a one-pot procedure from the oxazolidinone 
199 and triethyl orthoformate. e. The stereochemistry of the minor diastereoisomer was not determined. f. 
The minor diastereoisomer was a trans/exo cyclopropane. g. yield calculated on the total of isomers obtained 
after purification by flash column chromatography. h. No other diastereoisomers were observed/isolated. 
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The cyclopropanes were obtained in moderate to good yield with good stereoselectivity. 
Examination of these results in the tables 11 and 12 reveals that similar 
diastereoselectivities were observed for the same alkene when cyclopropanated using 
different oxazolidinones (Table 11, entry 1 and Table 12 entry 1 and entry 5, Table 11, 
entries 3 and 6 and Table 12 entries 3 and 4). Even in the case of very hindered system the 
stereoselectivity of the reaction does not seem to be affected (Table 12, entry 5). In 
general monosubstituted alkenes led to the formation of the trans cyclopropane (Table 11, 
entries 1, 3, 4, 6, Table 12, entry 1-5). However, with more substituted alkenes, 
stereoselectivity was dependant on the nature of the alkene. When a cyclic disubstituted 
alkene was used, the endo cyclopropane was obtained as the major product (Table 11, 
entries 2, 5).  
As shown previously for the cyclopropanation reactions using a non chiral oxazolidinone 
precursor, functional groups such as ester are tolerated under the conditions reactions 
(Table 11, entry 4 and Table 12, entry 6). 
In most of the cases, only one product was isolated out of the four potential isomers. The 
minor products are different depending on the nature of the oxazolidinone and the alkene. 
The cyclopropanation of 153 gave an inseparable mixture of the two trans 
diastereoisomers 258 and 259 (Table 12, entry 5) after purification by column 
chromatography whereas the cyclopropanation of 166 gave a mixture of the endo 249 and 
the exo 250 isomers (Table 11, entry 5).126  
Cyclopropanation of the alkene 163 (Table 12, entry 6) could give eight possible 
diastereoisomers as shown in Figure 9. Unfortunately we were not able to isolate the 
major diastereoisomer in sufficient purity for characterization and instead only 
cyclopropane 260 (Table 12, entry 6) was isolated in pure form. The absolute geometry of 
the major diastereoisomer could not be therefore determined. The reaction was repeated 
using a large excess of the alkene to encourage the isolation of the major isomer but 
unfortunately none of diastereoisomers could be isolated pure.  
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Figure 9 
 
Three minor products were often present in the crude NMR spectrum and could not 
always be removed by purification. These were the formamide formed by “hydrolysis” of 
the unreacted carbenoid precursor during work up, the oxazolidinone which arose either 
from hydrolysis of the unreacted carbenoid precursor or organozinc carbenoid 
intermediate and the N-methyl oxazolidinone probably formed by protonation of the 
organozinc carbenoid (by traces of HCl present in the reaction) followed by its reduction 
by zinc (Scheme 111).126 
 
 
Scheme 111 
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From a practical point of view, it would be more convenient to avoid the preparation of 
the orthoamide derived carbenoid precursors. As both the introduction of the 
diethoxymethyl group itself and the subsequent cyclopropanation reaction were carried out 
in the presence of Lewis acids, we therefore investigated whether the two processes could 
be combined into a one-pot reaction. Pleasingly in a preliminary experiment the 
cyclopropane 244 was obtained in 33% yield directly from the oxazolidinone 199 using 
zinc, copper chloride, zinc chloride, chlorotrimethylsilane and triethyl orthoformate in one 
pot. This compares favourably to the 28% yield previously obtained over two steps 
(Scheme 112). 
 
 
Scheme 112 
 
Two modifications to the reaction procedure were then investigated in order to obtain the 
corresponding cyclopropane in one step from the oxazolidinone. 
Initially a mixture of zinc chloride, trimethylsilyl chloride, and oxazolidinone 199 were 
heated to 44 °C in order to activate the carbenoid precursor and make it more reactive to 
zinc, copper chloride and the alkene 153 in diethyl ether added later on. However at this 
stage the resulting mixture was a semi-solid unsoluble in diethyl ether. Triethyl 
orthoformate was then added dropwise over 6 hours to the resulting mixture in order to 
form the organozinc carbenoid in situ which could then react with the alkene 153. This 
modification led to formation of the N-cyclopropyl oxazolidinone 244 in 13% yield. In a 
second attempt, to obviate the problem of insolubility, addition of a solution of 
oxazolidinone 199 in triethyl orthoformate and dichloromethane dropwise over 6 hours to 
a mixture of zinc, copper chloride, zinc chloride, chlorotrimethylsilane and allylbenzene in 
diethyl ether followed by heating at reflux for 16 hours furnished N-cyclopropyl 
oxazolidinone 244 in 33 % yield.126 With the benefit of hindsight it might have been 
interesting to examine an experimental method involving the addition of 
triphenylphosphine in order to further aid the formation of the organozinc carbenoid 
during this one pot process. 
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The cyclopropanation reaction of the alkene 153 was also performed following the first 
procedure but using the cyclic urea, 1-benzyl-imidazolidin-2-one 268. A mixture of 
products was formed including the desired trans cyclopropane 269 and the cis 
cyclopropane 270, the starting material 268, N-formyl compound 271 and the alkoxy 
cyclopropane 272 formed via the normal formation of the alkoxy organozinc carbenoid 
(Scheme 113). 
 
 
Scheme 113 
 
The trans-cyclopropane was the major product formed, from 1H NMR spectroscopic 
analysis of the crude reaction mixture, but only 10% could be isolated in pure form after 
extensive chromatography. Due to time constraints however, this potentially interesting 
molecular scaffold was not pursued further.  
 
2.2.3. Stereochemistry 
 
The geometry of the cyclopropane was determined to be trans, cis, exo or endo by 1H 
NMR spectroscopy analysis. The examples shown below show again all the complexity of 
the stereoselectivity (Table 13).115,116,117,122,126 
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entry alkene Product(s) 
1a 
 
 
 33            235                  236                    23                  238  
                                          (63%c) 
2a 
 
 
 153                              273                       274 
    (57%b) 
3 
 
N
H
H
O
O
Ph
>90:10
 
 153 244 (42%b) 
4 
 
 
 153                        258                                   259 
                                         (29%b,f) 
5 a 
 
 
 153 241 (36%b) 
6 
 
 
 166 249 250        
                  (40%b,f) 
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7 
 
H H
N
H
O
O
>90:10
 
 165 245 (40%b) 
 
a. cyclopropane synthesised previously in the group. b. Zn/CuCl method. c. Zn(Hg) method. d. The minor 
diastereoisomer was a trans/exo cyclopropane. e. The minor diastereoisomer was a cis/endo cyclopropane. f. 
yield calculated on the total of isomers obtained after purification by flash column chromatography.  
Table 13 
 
As highlighted earlier in our examination of the results obtained for the cyclopropanation 
reaction using chiral organozinc precursors, monosubstituted alkenes seems to lead to the 
formation of the trans cyclopropane and with more substituted alkenes, stereoselectivity 
was dependant on the nature of the alkene. 
When the reaction was performed using a chiral carbenoid precursor for alkene 153 the 
selectivity seems to be greater than with non-chiral precursors (Table 13, entries 2, 3, 4 
and 5). Moreover, ancillary functionality in the chiral oxazolidinone influenced the 
selectivity (Table 13, entries 4 and 5) with the formation of the two possible trans 
diastereoisomers favoured. At this stage, the stereoselectivity of the reaction was not easy 
to predict. Therefore, we investigated a more advanced quadrant model to explain the 
results observed. Cyclopropanation of alkenes using chiral organozinc carbenoid can 
potentially afford four diastereoisomers. The stereochemistry of these isomers will be 
based on the geometry of the cyclopropane (cis/endo or trans/exo) and on the position of 
the cyclopropane formed, relative to the chiral group of the oxazolidinone (Scheme 
114).126 
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Scheme 114 
 
The R group of the oxazolidinone controls which face of the alkene was cyclopropanated: 
the alkene preferred to approach the carbenoid from the opposite face to the R group 
[transition state (i) and (ii)] which explained the strong preference for one of the 4 
diastereoisomers observed in most cases (Table 13).  
In the case of the cyclopropanation of a monosubstituted alkene (R2=H), transition state (i) 
is preferred with R1 fitting well in the less sterically hindered quadrant A, leading to the 
trans cyclopropane. In the case of a disubstituted alkene (R2≠H) the transition (ii) is 
preferred (R1 and R2 occupying quadrants C and D), to the transition states (i) and (iii) in 
which R2, in quadrant B, would undergo a steric interaction with the oxazolidinone ring. 
As outlined earlier, the minor products seem to depend on the nature of the oxazolidinone 
and the alkene (Table 13). The formation of the two possible trans cyclopropanes was 
favoured for the monosubstituted alkenes, except in the case of styrene 33 which showed a 
greater selectivity for the formation of the cis cyclopropane (Table 13, entry 1). The 
difference in the selectivity between the cyclopropane 241 and cyclopropanes 258, 259 is 
probably due to the difference in size of the susbstituent group on the oxazolidinone which 
is bigger in the case of the cyclopropane 241 (Table 13, entries 5 and 4). 
The geometry of the cyclopropanes were determined by 1H NMR spectrum analysis 
considering the coupling constant of the cyclopropyl protons. However the relative 
stereochemistry between the chiral centre of the oxazolidinone and those on the 
cyclopropane could not be determined from 1H NMR spectrum but was assigned by 
analogy with the X-ray crystal structures obtained for 247 and 239115,117 which also 
confirmed the absolute stereochemistry of the cyclopropane (Appendix 1). 
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In summary the synthesis of enantiopure N-cyclopropyl oxazolidinones was successful 
and the stereoselectivity of the reaction was rationalised by a further variant of our 
quadrant model. 
 
2.3. Intramolecular cyclopropanation 
 
In view of the significant number of antiviral, 127 antibacterial128  and antitumor 
compounds129 which contain an aminocyclopropyl ring within a polycyclic framework it 
was of particular interest to investigate the potential of the intramolecular variant of our 
organozinc carbenoid reaction on suitably substituted lactams (Scheme 115). 
 
m = 1, 2, 3
n = 1, 2
N
H
HH
m
n
N
OEt
EtO
m
n
Zn(Hg), Zn or Zn Cu(Cl)
O ZnCl2, Me3SiCl
N
Cl
ClZn
m
n
O
44 °C, Et2O, 16 h
O
 
Scheme 115 
 
In recent times, a variety of approaches for the preparation of polycyclic 
aminocyclopropranes via intramolecular reactions have been reported, including elegant 
variants of the Kulinkovich74,75 reaction developed by de Meijere76 using Ti(II) mediated 
coupling of tethered N,N-dialkylamides as shown in Chapter 1 Scheme 57.80 It should be 
noted however, as highlighted in Scheme 115, that the tricyclic products produced in the 
present method also contain useful lactam functionality for further elaboration, and that, in 
contrast to the titanium mediated intramolecular cyclopropanation of ω-vinylimides,80a a 
linearly fused tricyclic system is obtained. 
An alternative approach via intermolecular transition metal-mediated cyclopropanation of 
enamines has also been used to provide access to a limited range of such polycyclic 
systems. Thus, the reactions of enamide derivative with diazoacetates in the presence of a 
catalytic amount of copper-bronze, gave 3-oxo-2-azabicyclo [4.1.0] heptane derivatives 
with high exo-selectivity (Scheme 116).130  
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Scheme 116 
 
Other strategies such as ionic 1,3-ring closure reactions can also be used to access the 
same scaffold. However, this method requires the formation of a ring large enough to 
enable 1,3 ring closure thus restricting the scope of the reaction. 
 
For example, the synthesis of polycyclic product 275 containing a three membered ring by 
1,3 syn-substitution of an iodide from a bicyclic precursor has been reported (Scheme 
117).131 
 
 
Scheme 117 
 
In the case of the bicyclic compound 275, the cyclopropanation reaction occurred in 5 
minutes due to the favourable geometry between the proton and iodo group. These 2 
substituents are trans and can easily form the W-shaped transition state needed for a 1,3 
ring closure (Figure 10). 
 
 
Figure 10 
 
Another example using a trimethylstannyl group and an adjacent iminium ion has been 
reported by Hanessian et al. 132 Reaction of 275 with the Grignard reactant afforded a 
hemiaminal which when treated with TFA at 0 °C gave trans-cyclopropane 277. This 
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method required the presence of a stannane group on the molecule which required several 
steps to synthesise (Scheme 118).132 
 
 
Scheme 118 
 
2.3.1. Synthesis of the carbenoid precursors 
 
Five diethoxymethylamide carbenoid precursors were prepared in straightforward fashion 
by the reaction of cyclic imides with an excess of the appropriate Grignard reagent derived 
from either 4-bromobutene or 5-bromopentene. This synthesis gave firstly the magnesium 
salt which by further reduction, acidification and neutralisation affords the corresponding 
lactams in moderate to good yield (47%-73%).133 The lactams were then heated at 160 °C 
in triethyl orthoformate using a catalytic amount of aluminium chloride (0.15 eq.) to 
obtain the carbenoid precursors (Scheme 119). The yields for these steps are given in 
Table 14.121 
 
 
m= 1, 2 and n = 1, 2 
Scheme 119 
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An alternative procedure was used to synthesise the lactam 279 (m=0 and n=1) using the 
[2+2] cycloaddition of hexa-1,5-diene and chlorosulfonyl isocyanate.134 The 
corresponding diethoxymethylamide was then prepared as described above in 32% yield 
(Scheme 120). 
 
NH
O
1. ClSO2NCO, r.t., 7 days
2. Na2SO3, CH2Cl2, pH = 7-9
37%
278 279
 
Scheme 120 
 
Entry amide orthoamide 
1 
 
 
 280 (64 %) 285 (46 %) 
2 
  
 281 (73 %) 286 (59 %) 
3 
 
 
 
282 (47 %) 287 (90 %) 
4 
 
 
 283 (66 %) 288 (42 %) 
5 
  
 284 (68 %) 289 (55 %) 
6 
 
 
 279 (37 %) 290 (32 %) 
Table 14 
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2.3.2. Intramolecular cyclopropanation reactions 
 
With the carbenoid precursors in hand the cyclopropanation reaction was carried out using 
Zn(Hg), zinc or zinc/copper couple, trimethylsilyl chloride and zinc chloride, and heated 
at reflux in diethyl ether for 16 hours. After purification by flash column chromatography 
the polycyclic cyclopropanes were formed with good stereoselectivity in moderate to good 
yields. Traces of side products were present viz, the NH compound from hydrolysis of the 
unreacted carbenoid precursor or the organozinc carbenoid intermediate and the N-methyl 
oxazolidinone due probably to the protonation of the organozinc carbenoid (by traces of 
HCl present in the reaction) followed by its reduction by zinc (Table 15).135  
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Entry orthoamide product Yield 
1 
 
 
41%a 
 285 291 
 
2 
 
N
O
H
HH
 
41%b 
 286 292 
 
3 
 
N
O
H
HH
 
21%c 
 288 293 
 
4 
 
 
26%c 
 289 294 
 
5 N
O OEt
EtO
 
N
O
H
HH
 
21%c 
 290 295 
 
6 
 
 
not isolatedc 
 287         296                     297 
 
a. Zn(Hg) method. b. Zn dust without CuCl. c. Zn/CuCl method  
Table 15 
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It is noteworthy that the stereoselective formation of 6- and 7- membered rings was 
equally viable. Selection of a tethered γ-lactam derivative provided the highest yields 
(Table 15, entries 1 and 2) irrespective of whether the organozinc carbenoid was 
participating in formation of a bicyclo [4.1.0] (six membered ring) or a [5.1.0] (seven 
membered ring) subunit. In all cases, only one diastereoisomer was obtained. By way of 
contrast the use of either the more conformationally mobile tethered δ-lactams (Table 15, 
entries 3 and 4) or of the relatively rigid β-lactam (Table 15, entry 5) led to a significant 
reduction in yield. Attempted cyclisation of compound 287, containing a trisubstituted 
alkene tether (Table 15, entry 6) did not however lead to the formation of desired 
substituted cyclopropane ring. In this instance a mixture of the cyclic alkenes 296 and 297 
was observed as evidenced by NMR analysis of the crude reaction mixture. The following 
mechanism is suggested to explain their formation (Scheme 121). 
 
 
Scheme 121 
 
In this case, the cyclisation of the trisubstituted alkene onto the low energy N-acyl 
iminium cation 298 must be faster than two electron reduction by zinc presumably as a 
consequence of the favourable formation of a tertiary carbocation. Proton loss followed by 
Lewis acid mediated departure of the second ethoxy group will then furnish the 
conjugated acyl iminium ion 300, which can then be reduced to give the allylzinc species 
301. Protonation of 301 gave then a mixture of the two alkenes 296 and 297.135 
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The cyclopropanation reaction was also investigated from the lactams 280 and 283 
avoiding the synthesis of the orthoamide but in contrast to our earlier success in the 
intermolecular case, did not give satisfactory results. Only recovered starting material was 
obtained after the reaction (Scheme 122).  
 
 
Scheme 122 
 
2.3.3. Stereochemistry 
 
Due to steric constraints only a cis substituted cyclopropane can be formed and this was 
confirmed by 1H NMR spectroscopy studies. The H6b signal is a doublet of doublets of 
doublets with two cis coupling constants and one trans confirming the indicated 
stereochemistry. From a stereochemical standpoint, it was important to determine whether 
the cyclopropane unit was the more hindered endo isomer 291 i.e located on the more 
hindered concave face, as opposed to the sterically less congested exo diastereoisomer 302 
(Figure 11).  
 
 
Figure 11 
 
Since these two isomers were not likely to be distinguishable using simple NMR 
techniques, a combined NMR calculation and molecular modelling approach was used to 
determine which structural isomer provided the best fit with the NMR data. 
The analysis undertaken to identify the stereochemistry of product formed is detailed 
below, a similar process was applied to all compounds to assign the correct configuration. 
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A detailed comparison of the observed 1H-1H coupling constants and nuclear Overhauser 
enhancements (nOe) with values obtained from molecular mechanics calculations using 
the MMX force field136 followed by DFT calculations using B3LYP/6-31G(d) level of 
theory was done for each compound by Dr A. Aliev to determine the orientation of H3a 
related to the cyclopropane.137 Computational studies allowed prediction of the nOe ratios, 
dihedral angles, chemical shifts and coupling constants for both conformations (Table 16), 
showing two large 3J couplings on proton 3aH. Irradiation of proton H1’ enhanced protons 
H1, H3, H1a and H2’ and the corresponding enhancement ratio for protons 
H3/H2’(η1’→3/η1’→2’) was 3.4 (Figure 12). From the B3LYP/6-31G(d) optimised geometry, 
the internuclear distances, between H1’ and H3 and between H1’ and H2’ in the endo-C1,C3 
conformation were found to be 2.44 Å and 3.09 Å, respectively (Figure 12). Thus, using 
the initial rate approximation,138 based on the r–6 dependence of nOes as shown in the 
Figure 12, the expected enhancement ratio is 4.1 which compared well with the measured 
value of 3.4. The expected nOe ratio is only 0.1 in the alternative exo-C1,C3 conformation 
(Figure 12). 
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1
6b
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2'
2
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5
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This study compared with the experimental results confirms that we have the endo 
configuration of the 3-CH2 and the cyclopropane ring (noted endo-C1,C3).  
endo-C1,C3 exo-C1,C3
N
O
H3a
H1' H1
H2'
H3'
H3
H4'
H4
291 302
N
O
H3a
H1'
H1H2'
H3'
H3
H4'
H4
 
 NOE ratio Dihedral angles/° Coupling constants/Hz 
 η1’→3/ η 1’→2’ H3CCH3a H3aCCH4 J3,3a J3a,4 
Predicted for endo 291 4.1 177 154 11.8 (9.6) 10.3 (8.2) 
Predicted for exo 302 0.1 177 153 11.8 (9.6) 10.2 (7.9) 
Observed 3.4   11.5 8.8 
Table 16 
 
Table 16 NMR assignment of stereochemistry. The predicted values are for the B3LYP/6-
31G(d) optimised geometries. Vicinal 3JHH couplings were predicted using a Karplus-type 
equation,139 accounting for the dependence of 3JHH on both the dihedral angle and the 
substituent electronegativities. The values shown in brackets are from the B3LYP/6-
311+G(2d,p) calculations of the J-couplings. 
 
The preference for formation of the more hindered product may possibly be rationalised 
by consideration of the two possible transition states shown in Figure 13 both of which 
feature an “amidoorganozinc carbenoid” in which the oxygen atom of the lactam is 
coordinated to the zinc atom. The observed stereochemical outcome would result from the 
less strained and less sterically congested approach of the alkene to the carbenoid (A), 
rather than the somewhat more hindered approach (B) which would lead to the exo isomer 
(Figure 13). 135 
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Figure 13 
 
In a similar manner Dr Abil Aliev confirmed the geometry of the predominant 
conformation of each polycylic compound shown in Figure 14 by a detailed comparison of 
the observed 1H-1H coupling constants and nOe with values obtained from molecular 
mechanics calculations using the MMX force field136 followed by DFT calculations 
(Figure 14). 
 
                            
                                                 291                                           292 
 
 
                   293                                          294                                      295 
Figure 14 
 
Figure 14. The predominant conformations of polycylic compounds 291-295 determined 
from the combined analysis of the vicinal 1H-1H coupling constants, nOes and DFT 
calculations. 
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The results of this preliminary study clearly indicate that the amidoorganozinc carbenoids 
derived from suitably constituted N-diethoxymethyl lactams can successfully participate in 
intramolecular reactions with simple monosubstituted alkene tethers.  
 
2.4. Studies towards the preparation of novel aminocyclopropyl 
functionalised compounds 
 
In light of the good results obtained for the formation of N-cyclopropyl oxazolidinone in 
only two steps from readily available oxazolidinones, we decided to apply our 
methodology to the synthesis of other highly functionalised molecules which could in 
turn, be used to generate interesting structural skeletons containing an aminocyclopropyl 
unit. 
 
2.4.1. Amino acid derived building blocks 
 
The incorporation of a rigid aminocyclopropyl unit into a peptide backbone could provide 
a control clement for a particular conformation and thus enable the incorporation of 
specific functionalities in a selected direction. An example is shown in Figure 15. 
 
H2N
N
H
NH
O
O
HN
H
N
O
O
OH
303
 
Figure 15 
 
We therefore wished to explore cyclopropanes containing amino alcohol and amino acid 
units via ring opening of the enantiopure N-cyclopropyl oxazolidinone which had 
previously been prepared. 
The amino alcohols 304 and 305 and the cyclopropyl amino acid 306 were accordingly 
synthesised from N-cyclopropyl oxazolidinone 256 by the short sequence shown in 
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Scheme 123. After the deprotection of the methoxy group such compounds were of 
interest as unusual tyrosine analogues. 
 
N
H
H
O
O
LiOH, H2O
OMe
NR
H
H
OH
OMe
RuO2, NaIO4
NBoc
H
H
OH
OMe
O
304 R=H, 67% 306256
Boc2O
CH2Cl2
44 °C, 24h
EtOH, 44 °C
36 h
CCl4, MeCN,
H2O
r.t., 45 min
65%
305 R=Boc, 80%
 
Scheme 123 
 
Thus, oxazolidinone 256 was initially cleaved under basic conditions with LiOH to afford 
the amino alcohol 304 in good yield. The secondary amine thus obtained was then 
protected under standard conditions with Boc anhydride and the primary alcohol oxidised 
to afford the trans N-cyclopropyl substituted amino-acid 306.126 This compound could be 
used for further peptide coupling reactions. 
 
2.4.2. Carbocyclic nucleoside building blocks 
 
There are many reports of the activity of carbocyclic nucleosides as antiviral compounds 
in the literature.140,141142 Chu et al. investigated the biological activity of cyclopropyl 
carbocyclic nucleosides such as 312 and 313 (Scheme 124) as potential antiviral 
compounds. 143,144,145 In their research, the cyclopropanes were synthesised from (D)- 
glyceraldehyde acetonide using the Denmark variant of the Furukawa modification of the 
Simmons-Smith reaction as the key step on an alkene containing a dioxolane group which 
was then converted to the key aminocyclopropane protected with a cis-hydroxymethyl 
group (Scheme 124). 
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OH
OH
O
1. Ph3P=CHCOOMe
2. DIBAL-H
3. Zn(Et)2/ICH2Cl
ORO H
O
R = H , 48 %
R = TBDPSI 28%
1. RuO2/NaIO4
2. ClCO2Et, Et3N
3. NaN3
CON3O
H
O
58 %
1. Toluene, 100°C
2. NH3
HNO
H
O
38 % (over 4 steps from 309)
O
NH2
310
HO N
NHX
O
O
1. Toluene, BnOH, 100°C
2. H2, Pd/C
NH2O
H
O
83 %
311
312 X=Me, 51%
308 309
313 X=H, 39%
307
 
Scheme 124 
 
In the event, cyclopropane 308 required seven steps for elaboration to the N-cyclopropyl 
heterocycles 312 and 313. 143  
We therefore considered that it would be useful to reproduce this type of skeleton by 
applying our methodology to alkenes containing alcohol functionalities in order to obtain 
such carbocyclic analogues of the ribose unit since these new mimics could be interesting 
targets for anti-viral activity assays (Scheme 125). 
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Scheme 125 
 
We anticipated that these alkenes would be readily trapped by an organozinc carbenoid to 
give interesting amido and aminocyclopropanes functionalised with hydroxyl groups after 
deprotection. 
 
In consequence, the necessary alcohol 315 was synthesised in 70% yield following a 
literature procedure starting from triethyl phosphonoacetate and formaldehyde under basic 
conditions.146 The ester was converted to 2-methylenepropane-1,3-diol 316 by reduction 
using DIBAL-H in 89% yield. Diol 316 was then converted to the protected dibenzyl ether 
317 by treatment with sodium hydride and benzyl bromide (Scheme 126).147  
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Scheme 126 
 
The protected alcohol 322 was also synthesised by a literature procedure applied to the 
bromide 321,148 which itself was synthesised from acrolein and benzoyl bromide 
according to a literature method.149 The protected alcohol 323 was obtained as a side 
product (Scheme 127). 
 
 
Scheme 127 
 
With our alkene substrates in hand, we then attempted the cyclopropanation reactions 
using N-diethoxyoxazolidin-2-one 158 as the carbenoid precursor. The results of these 
reactions are shown in Table 17. 
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entry alkene NMR observations 
1 
 
Complex mixture  
No identified products 
+ 
 
 317 324 
2 
 
Complex mixture  
No identified products 
 316 
 
3 
 
Complex mixture  
No identified products 
 323 
 
4 
 
 
 322                325                        326 
5 
 
 
 321                325                        326 
Table 17 
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Unfortunately none of the expected cyclopropanes were obtained. To our surprise the 
protected alcohol 317 was mono deprotected under the reactions conditions (Table 17, 
entry1) and the previously observed N-formyl derivative of the oxazolidinone was the only 
detectable product from the carbenoid precursor. Cyclopropanation of 316 and 323 was 
also attempted but gave an intractable mixture of products and no identifiable products 
(Table 17, entry 2 and entry 3). The reaction undertaken with alkenes 322 and 321 led to 
the formation of the cyclopropanes 325 and 326, as determined from NMR analysis of the 
crude reaction product (Table 17, entries 4 and 5).  
Under the reaction conditions, 321 and 322 were initially converted to the alkenes 327 and 
328 before undergoing cyclopropanation. We propose the following mechanism to explain 
these results. In the alkenes 322 and 321 the allylic acetate and bromide groups were too 
labile under the reaction conditions and after reduction of the oxonium by zinc in presence 
of acidic proton gave alkenes 327 and 328 which afford the cyclopropanes 325 and 326 
(Scheme 128). 
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Scheme 128 
 
2.4.3. N-cyclopropyl heterocyclic carbenoids 
 
Molecules containing a nitrogen-based heterocycle attached through nitrogen to a 
cyclopropyl unit are potentially very interesting in drug discovery programmes.143,144,145 
As outlined in section 2.4.2, Chu et al. accessed such N-cyclopropyl heterocycle 
nucleoside mimics by construction of the heterocycle from an aminocyclopropyl 
unit.143,144 However Hegedus et al. have developed the cyclopropanation of electron-
deficient olefins using group 6 pyrrolocarbene complexes (Scheme 129). The 
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pyrrolocarbene complexe was obtained from the corresponding alkoxycarbene complexes 
by exchange with the lithium or potassium salt of the pyrrole. The cyclopropane was 
obtained as a mixture of diastereoisomers together with side products resulting from CH 
insertion (Scheme 129).150 
 
 
Scheme 129 
 
The free-radical scavenger, DBHT, was used to suppress polymerisation of the olefinic 
substrates.150 
The synthesis of N-cyclopropyl heterocycles by these two methods is not very convenient: 
the first synthetic route is long, whilst the second one is limited to electron deficient 
alkenes and requires the synthesis and use of the stoichiometric transition metal N-
heterocyclic Fischer carbenoid. Moreover the cyclopropanation reaction using the N-
heterocyclic carbenes has to be carried out under harsh conditions, in a sealed pressure 
tube heated at 100 °C. 
More recent studies were published on the direct N-cyclopropanation of heterocycles such 
as pyrroles or indoles employing a cyclopropylboronic acid151 or a cyclopropylbismuth 
reagent (Scheme 130).152 However, a major drawback of this approach is that they utilise a 
cyclopropyl ring that does not possess any substituents. The major disadvantage of this 
latter method relates to the preparation of the tricyclopropylbismuth reagent which is not 
stable for storage.151,152 
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N
H
10 mol % or 1 eq. Cu(OAc)2,
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B(OH)2
N
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N
H
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R R
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N
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X
Y
R
N
X
Y
R
X, Y = CH or N
36% to >99%
R1
N
C
Z
R2 R
1
Z = CH, N or CCO2Et
40-87%
 
Scheme 130 
 
To overcome the problems associated with these literature methods our idea was to use the 
methodology we had developed to access N-cyclopropyl heterocycles from N-
diethoxymethyl heterocycles as carbenoid precursors and functionalised alkenes. The 
desired N-cyclopropyl heterocycles containing substituents present on the cyclopropane 
ring could therefore be obtained in only two steps from the N-starting heterocycle 
(Scheme 131).  
 
 
Scheme 131 
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In the event, seven carbenoid precursors derived from readily-available N-heterocycles 
were synthesised using literature or modified literature procedures (Table 
18).153,154,155,156,157 The carbenoid precursors were obtained in moderate to good yield and 
were found to be stable at room temperature. As expected, heterocycles containing an 
electron-withdrawing group make the nitrogen atom more reactive which facilitates 
incorporation of the N-diethoxy methyl group (Table 18). 
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entry heterocycle Conditions Product(s) Yield 
1 
 
(EtO)3CH 10 eq. 
p-tosic acid 0.1 eq. 
85°C, 36 h 
 
42% 
 329  336 
 
2 
N
N
H
 
(EtO)3CH 1 eq. 
140°C, 16 h 
N
N
OEtEtO
 
50% 
 
 330  337 
 
3 N
H
 
(EtO)3CH 10 eq. 
160°C, 48 h 
N
OEtEtO
 
13% 
 
 331  338 
 
4 N
H
O
 
(EtO)3CH 15.4 eq. 
155°C, 24 h 
N O
OEtEtO
 
46% 
 
 332  339 
 
5 
N
N
H
 
(EtO)3CH 4.25 eq. 
p-tosic acid 0.03 eq. 
130°C, 16 h 
N
N
OEtEtO
 
45% 
 
 333  340 
 
6 
 
(EtO)3CH 10 eq. 
165°C, 6 days 
 
73% 
 334  341 
 
7 
 
(EtO)3CH 10 eq. 
165°C, 60 h N
OEtEtO
O
O
 
85% 
 
 335  342 
 
Table 18 
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The zinc/Me3SiCl-mediated cyclopropanation reaction was then attempted using a variety 
of alkenes. To our initial surprise however, only carbenoid precursor 342 was able to trap 
an alkene to form the desired cyclopropane (Table 19). 
 
Entry alkene Product Yield 
 
1 
 
 
18 % 
 153             343                        344 
 
2 
 
N
O
O
H
H
 
11 % 
 164 345 
 
3 
 
 
Not isolated 
 165 346 
 
Table 19 
 
Although these novel N-cyclopropyl heterocycles were only obtained in low yield, 
depending on the nature of the alkene, the overall sequence requires only 2 steps and 
hence is competitive with existing multistep alternatives. 
 
In order to increase the yield of the reaction, the reaction was attempted using a larger 
excess of the carbenoid precursor 342 (4 eq. instead of 2 eq.), but only the parent N-
heterocycle 335 was observed in the crude 1H NMR spectrum with no trace of 
cyclopropane. At the present time, in spite of several attempts to correlate the success or 
failure of the various N-diethoxymethyl heterocyclic systems prepared in terms of leaving 
group ability, acidity, or other parameters we have no satisfactory explanation for the 
above results.  
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The cyclopropanation reaction was also attempted directly from the N-heterocycles to 
avoid the synthesis of the N-diethoxymethyl heterocycles but the results obtained were not 
conclusive and only recovered starting material was obtained as evidenced by NMR 
examination of the crude reaction product (Scheme 132). 
 
 
Scheme 132 
 
2.5. A miscellany of novel carbenoid precursors 
 
2.5.1. More highly functionalised derivatives 
 
Previous research within our group had demonstrated that an amidocyclopropanation 
reaction using an N-formyl amide 347 as the carbenoid precursor was a viable route to a 
carbenoid but led to lower yield of the cyclopropane 348 than the reaction using the N 
diethoxymethyl derivative 157 (88%) (Scheme 133).115 
 
 
Scheme 133 
 
We therefore decided to investigate precursors derived from a cyclic imide and a cyclic 
amide or oxazolidinone and further functionalised by a second electron-withdrawing 
group such as the carboethoxy or trifluoroacetyl group.  
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Our inspiration for this idea came from an observation in the early literature by Brewster 
who reported that the reduction of phthalimides under Clemmensen reduction conditions 
using zinc and a source of protons led to lactam formation (Scheme 134).158 
 
 
Scheme 134 
 
Given that we now know that the combination of zinc and a silicon electrophile leads to 
the formation of an organozinc carbenoid from a carbonyl group, it was therefore 
reasonable to propose such an intermediate from the cyclic imide, and this is, of course, an 
α amidoorganozinc carbenoid.  
 
The idea was to use the same conditions to trap an alkene in the intramolecular mode to 
obtain a tetracyclic compound.  
Recently Bertus et al. have developed an intramolecular titanium- and Lewis acid-
mediated cyclopropanation of imides, but this of course proceeds via a different 
mechanism (Scheme 135).80a 
 
 
Scheme 135 
 
Therefore, cyclopropanation reactions were attempted on compounds 351 and 352 
containing an alkene and a carbenoid precursor group. Compound 351 was synthesised in 
85% yield by treatment of succinimide with sodium hydride and 5-bromopentene and 353 
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was synthesised previously in the lab by treatment of phthalimide with sodium hydride 
and 4 bromobutene (Scheme 136). 
 
 
Scheme 136 
 
In contrast to the Bertus procedure, the intramolecular cyclopropanation of the parent 
succinimide derivative 351 did not give any satisfactory results, and only starting material 
was recovered at the end of the reaction. However, the phthalimide congener led to the 
tetracyclic system 354 albeit in only 9% yield. This promising result needs further 
investigation to improve the yield and to understand the role of the aromatic ring in the 
process. This result adds further weight to our hypothesis that an organozinc carbenoid 
was probably an intermediate in the reduction of the phthalimide using a source of zinc 
under acidic conditions. However due to time constraints, this avenue was not pursued 
further. 
 
An additional electron-withdrawing group adjacent to the carbenoid should make it even 
more susceptible both to reduction and to formation of a tetrahedral centre both in the 
intermediates and in the cyclopropanated product. Furthermore, chiral oxazolidinones of 
the types 355 were considered to be of special interest as a potential source of a “chiral 
glycine” carbenoid (Scheme 137). 
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Scheme 137 
 
Carbenoid precursors 361 and 362 were accordingly synthesised from 2-oxazolidinone 
and 2-pyrrolidinone (Scheme 138).  
 
 
Scheme 138 
 
A range of conditions using different alkenes, Lewis acid and zinc were then investigated 
in order to synthesise cyclopropanes from these carbenoid precursors 361 and 362 and the 
observations are outlined below (Table 20).  
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N
X
alkene Lewis acid
O
O
O
O
Zn/ZnCl2
alkene 1 eq.,
L.A.,
Et2O , 44 °C, 16 h1.5 eq
entry reagents
1 Zn 13 eq./ZnCl2 1.5 eq.
Me3SiCl 6.4 eq. no reaction
2 Zn(Cu) 12.6 eq./ZnCl2 1.5 eq.
Me3SiCl 6.4 eq. no reaction
3 Zn(Hg) 12.5 eq./ZnCl2 3 eq. BF3 2 eq. NO
O
OEt
OH
O
4 Zn(Hg) 12.5 eq./ZnCl2 3 eq. BF3 6.4 eq. NO
O
OEt
OH
O
5 Zn(Hg) 12.5 eq./ZnCl2 3 eq. AlCl3 6 eq. NO
O
OEt
OH
O
6
MeO
1. Zn(Hg) 12.5 eq./ZnCl2 1.5 eq.
2. Zn 12.5 eq./CuCl 0.8 eq.
Me3SiCl 6.3 eq.
N
O
OEt
O
O
7 N
O
O
OEt
OH
O
1. Zn(Hg) 12.5 eq./ZnCl2 1.5 eq.
2. Zn 12.5 eq./CuCl 0.8 eq. Me3SiCl 6.3 eq.
8 Zn(Hg) 12.5 eq./ZnCl2 1.5 eq. Si2C6H16Cl2 6.4 eq. no reaction
N
X
O
O
O
R
366
NMR observationsX
CH2
O
O
O
O
CH2
O
O
x=O, 361
x=C, 362
x=O, 363
x=C, 364
252
252
164
153
153
253
164
252
365
365
365
365
 
Table 20 
 
To our disappointment, in all cases, the cyclopropane was not formed but the use of 
Zn(Hg) led to reduction of one carbonyl group to the alcohol (Table 20, entries 3, 4, 5, 7). 
The presence of the alcohol was clearly determined from the 1H NMR spectrum and was 
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also confirmed by a straightforward synthesis of the product via the alternative route 
shown in Scheme 139. 
 
NH
O
N
O
O
OH
O
NHO
O
EtO
O
O
AcOH, Toluene, r.t., 3 h
NO
O
O
OH
O
367
365
H
EtO
O
O
AcOH, Toluene, r.t., 3 h
H
85%
85%
180
215
 
Scheme 139 
 
The alkene possessing an activated aromatic ring (Table 20 entry 6) led surprisingly to a 
Friedel-Crafts type addition and so we investigated more substrates, reagents and 
conditions to confirm this initial finding (Table 21). 
 
NX
alkene L.A.
O
O
O
O
Zn/ZnCl2, alkene 1 eq., L.A.,
44 °C, Et 2O 16 h
1.5 eq
entry Zn/ZnCl2
1
O
Zn 13 eq./ZnCl2 1.5 eq. Me3SiCl 6.4 eq.
2 Me3SiCl 6.3 eq.
3 Zn(Hg) 12.5 eq./ZnCl2 1.5 eq. C6H16Cl2Si2 6.4 eq.
no reaction
O
Zn(Cu) 12.6 eq./ZnCl2 1.5 eq. no reaction
O
O
NO
O
OEt
O
O
O
NX
O
O
O
R1
R2
370
NMR observationsX
C
O
O
56%
x=O, 361
x=C, 362
368
368
369
 
Table 21 
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As in the case of reaction with allyl anisole (Table 20, entry 6) only very electronic rich 
aromatic compounds underwent the Friedel-Crafts reaction (Table 21). The successful 
reaction of the allyl anisole derivative (Table 20, entry 6) stands in contrast to the failure 
of anisole itself, and at this time, we have no satisfactory explanation for this particular 
observation. 
 
In order to confirm that the Friedel-Crafts reaction occurred via an N-acyl iminium cation, 
compound 367 was added to a solution of zinc chloride, trimethylsilyl chloride and 4-
allylanisole 253 (Scheme 140). As observed by 1H NMR spectroscopy, the same product 
resulted from this more classical Friedel-Crafts reaction. 
 
N
O
O
OH
O
ZnCl2, Me3SiCl
44 °C, Et 2O, 16 h
O
N
O
O
O
O
367 366
not isolated
N
O
O
H
O
253
 
Scheme 140 
 
In essence, these observations would seem to imply that two electron delivery from zinc to 
the desired carbonyl group is, as expected, a favourable process. Further evolution 
involving cleavage of the carbon oxygen bond appears to be much more problematic and 
hence the desired carbenoid reactivity is not observed and intermediate 371, on hydrolytic 
work up gives the observed alcohol 367 (Scheme 141). 
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Scheme 141 
 
The trifluoroacetyl derivative was also examined as a carbenoid precursor for 
cyclopropanation reaction and efforts were also made to prepare the functionalised 
diethoxytrifluoroethyl congener 373 (Scheme 142). 
 
O
O
NH TFAA, 40 °C, 24 h O N
O O
CF3
MeO
Zn(Hg), ZnCl2
44 °C, CH 2Cl2 16 h
O N
O O
CF3
1. (COCl)2, CH2Cl2, 0 °C to 45 °C, 18 h
O N
O
CF3
OEt
359
373
80%
359
N
H
PMP
CF3
O
O
2. Et3N, EtOH, r.t., 4 h
OEt
180
253 372
 
Scheme 142 
 
Unfortunately, in all of these cases, formation of the desired product was never observed. 
The attempted cyclopropanation of 359 gave a mixture of the 2-oxazolidinone 180 and 
recovered allyl anisole 253. Further investigations are therefore required to allow 
cyclopropanation using more substituted amidocarbenoid precursors. 
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Within the framework of such donor acceptor carbenoids we were also intrigued by a 
literature reaction in which a carbene species derived from an oxalamide substrate by 
treatment with triethylphosphite afforded a tricyclic compound containing an 
aminocyclopropyl group in an intramolecular reaction as shown in Chapter 1 Scheme 42 
and outlined again below (Scheme 143).59,159 
 
P(OEt)3, xylene
reflux, 9 h N
O
R1
N
O
R1
O
O
O
R2 R3
O
O
R2 R3
25-52%
 
Scheme 143 
 
We therefore applied our methodology to an imide 374, containing an electron-
withdrawing group (an ester) in the alpha position, as a carbenoid precursor. The 
carbenoid precursor 374 was synthesised from lactam 283 using sodium hydride and ethyl 
oxalyl chloride in 65% yield. When the intramolecular cyclopropanation reaction was 
attempted, a mixture of two products including the desired product was formed (Scheme 
144). Only a small amount of material was obtained (34 mg) after the first purification by 
flash chromatography and due to time constraints the reaction was not repeated and the 
desired cyclopropane could not be isolated. This reaction also requires further 
investigation. 
 
N
O
H
Zn, CuCl, ZnCl2,
Me3SiCl
NH
O
N
O
OEt
O
O
1.NaH
65%
O
OEt
analysed on crude
but not isolated
N
O
H
O
OEt
OH
283 374
2.ethyl oxalyl chloride
THF, 0 °C - r.t., 16 h Et2O, 44 °C, 16 h
375 376
 
Scheme 144 
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2.5.2. Sulfonamido organozinc carbenoids 
 
Instead of having a carbonyl group as the electron-withdrawing group on the carbenoid 
carbon we decided to design a new carbenoid precursor functionalised with a sulfonyl 
group. Zhu et al. have reported the N-cyclopropanation of sulfonamides by 
cyclopropylboronic acid to yield unfunctionalised sulfonamidocyclopropanes (Scheme 
145).151b 
 
10 mol % Cu(OAc)2, BiPy, Na2CO3
70 °C, DCE 2-6h
B(OH)2
X, Y = CH or N
S
O
O
NH2 S
O
O
NH S
O
O
N
378377 379
66% 10%
 
Scheme 145 
 
Using our methodology we could potentially obtain sulfonamide-functionalised three 
membered rings. A novel carbenoid precursor 382 was therefore synthesised and the 
cyclopropanation reaction was attempted (Scheme 146). 
 
 
Scheme 146 
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Compound 382 was synthesised in 40 % overall yield from benzylamine 380 via N-
benzyl-4-methyl-benzenesulfonamide 381160 and subsequently reacted with triethyl 
orthoformate in the presence of a Lewis acid. When the cyclopropanation reaction on 382 
was attempted, the crude 1H NMR spectrum showed signals indicating the presence of a 
cyclopropane (doublet of triplets at 1.83 ppm resulting from the NCH and two doublets of 
doublets resulting from the CH2Ph at 2.15 ppm and 2.6 ppm). Unfortunately we were 
unable to isolate the compound in pure form due to the very small amount of material 
obtained after the first purification by flash chromatography and because of time 
constraints, the reaction was not repeated. However this initial result was very 
encouraging. 
 
In similar vein, we were impressed by a recent publication from De Kimpe et al., who 
developed an asymmetric synthesis of N-cyclopropyl sulfinamides in good yield and with 
high diastereoselectivity from chiral N-sulfinyl α-chloro ketimines (Scheme 147).161 
 
 
Scheme 147 
 
Thus, we decided to examine our cyclopropanation methodology to gain access to a 
functionalised cyclopropyl unit from a carbenoid precursor containing a sulfinic acid 
group. Accordingly 4-methylbenzenesulfinic acid benzylamide 386 was synthesised in 
33% from 384.162,163 However when we investigated the conversion of 386 into a 
carbenoid precursor we obtained 387, 388 and a trace of the orthoamine 389. Therefore, 
the subsequent cyclopropanation was not attempted (Scheme 148). 
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Scheme 148 
 
2.6. Attempted rearrangement studies 
 
In a further extension of our work on amidoorganozinc carbenoids we wished to prepare a 
compound such as 390 which could pleasingly undergo a subsequent [2,3] sigmatropic 
rearrangement as outlined below and, in the ideal scenario, generate a chiral quaternary 
centre (Scheme 149). 
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Scheme 149 
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We therefore prepared 392 following an interesting literature procedure using a mixture of 
cobalt chloride, 2 methyl but-3ene-1 ol, and acetic anhydride in acetonitrile at 80°C for 48 
hours.164 The subsequent reaction with triethyl orthoformate then furnished the desired 
precursor 393 in acceptable yield. This product was then subjected to the same conditions 
as for the cyclopropanation reaction, but unfortunately, examination of the NMR spectrum 
of the crude product did not give any conclusive results and only the amide 392 was 
obtained. Under the reaction conditions attempted, either the orthoamide 393 did not lead 
to the formation of an organozinc carbenoid and was hydrolysed under the reactions 
conditions, or the organozinc carbenoid was formed but hydrolysed prior to intramolecular 
trapping of the alkene to give the expected amide 394 (Scheme 150).  
 
 
Scheme 150 
 
This reaction certainly requires much further investigation. It would also be interesting to 
try the reaction with a carbenoid precursor containing a stronger electron-withdrawing 
group alpha to the nitrogen atom in order to attenuate the reactivity of the lone pair and 
avoid hydrolysis.  
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3. Conclusions and future perspectives 
 
In summary, we have investigated the scope of the direct cyclopropanation of alkenes 
using racemic organozinc carbenoids derived from oxazolidinones in detail in terms of 
chemoselectivity and stereoselectivity, and as a consequence the results have been 
rationalised using a quadrant model to explain the observed geometry of the 
cyclopropane as a function of the nature of the alkene (Scheme 151). In terms of 
chemoselectivity, as expected more electron-rich alkenes are preferred over electron-
deficient ones. 
 
 
Scheme 151 
 
In order to study the asymmetric version of this cyclopropanation reaction, we prepared 
a wide range of highly functionalised zinc carbenoid precursors as their 
dialkoxymethylamide derivatives using both natural and unnatural amino-acid 
derivatives in moderate to excellent yield. From an experimental standpoint, the overall 
sequence is simple, inexpensive and robust and the zinc chlorotrimethylsilane mediated 
cyclopropanation reaction occurs under mild conditions, thus paving the way for the 
enantiopure preparation of novel highly functionalised N-cyclopropyl oxazolidinone 
systems that could not be readily obtained using existing methods (Scheme 152). 
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Scheme 152 
 
In most cases, only one diastereoisomer was isolated with diastereoselectivities of up to 
95:5. The particular stereoselectivity in these reactions was also rationalised using the 
quadrant model previously established for the racemic version. 
 
The direct synthesis of a N-cyclopropyl oxazolidinone without the need for preparation 
of the intermediate orthoamide derived carbenoid precursors was pleasing. The two 
processes were successfully combined into a one-pot reaction and the cyclopropane 256 
was obtained in 33 % yield from an oxazolidinone in one step (Scheme 153). Further 
optimisation of this protocol should certainly be considered. 
 
 
Scheme 153 
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This “one-pot process” was also a success for the synthesis of cylopropane 269 containing 
a functionalised urea group, and although only one example was studied, this represents an 
interesting molecular scaffold (Scheme 154). 
 
 
Scheme 154 
 
Moreover, for the sake of completeness, we include an initial result from Dr. Tom 
Sheppard who showed that the synthesis of a carbamate functionalised cyclopropane was 
possible using the same conditions from the carbamate 395. A mixture of rotamers of the 
trans-cyclopropane 396 was obtained (Scheme 155). 
 
 
Scheme 155 
 
The synthesis of a cyclopropane functionalised with a carbamate is, of course of great 
interest since they can potentially lead to an aminocyclopropane in one step by simple 
deprotection. 
 
These results are very encouraging and this approach for the direct preparation of amido 
and aminocyclopropanes from readily available amides or carbamates should be 
optimised in the future. 
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The investigation of new source of organozinc carbenoid from a carbonyl group attached 
to a nitrogen atom such a 361 and 362 did not give any satisfactory results in terms of 
intermolecular cyclopropanation reaction and the desired carbonyl group was reduced to 
an alcohol (Scheme 156). 
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Scheme 156 
 
The C-OSiMe3 bond seems difficult to break to form the organozinc carbenoid, hence it 
would be interesting to use ethyl 2-chloroooxoacetate or a sulfonyl chloride instead of 
trimethylsilyl chloride in order to encourage the formation of an organozinc carbenoid 
(Scheme 157). 
 
 
Scheme 157 
 
These conditions could also be interesting for investigation in the case of the imide 
functionalised with a trifluoroacetyl group 
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However, the generation of an organozinc carbenoid from the carbonyl group attached 
to the nitrogen atom of a cyclic imide can undergo intramolecular cyclopropanation in 
some cases (Scheme 158). At this stage however, this approach is not competitive with 
the Kulinkovich-based alternative. 
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Scheme 158 
 
As a “divertissement”, the discovery of the Friedel-Crafts reaction observed under the 
cyclopropanation conditions with electron-rich aromatic rings could be investigated for 
a wider range of substrates (Scheme 159). 
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Scheme 159 
 
It will also be interesting to know if this reaction works with an enantiopure substrate 
and to determine if there is any preferred stereoselectivity in the reaction (Scheme 160).  
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Scheme 160 
 
The possibility of intramolecular cyclopropanation using our methodology from 
diethoxymethyl lactams as organozinc carbenoid precursors was successfully achieved for 
the construction of a range of usefully functionalised polycyclic amidocyclopropane 
systems in moderate yield (21%-41%). The organozinc carbenoid was participating in 
formation of a bicyclo [4.1.0] (six membered ring) or a [5.1.0] (seven membered ring) 
subunit. In all cases thus for studied, only one diastereoisomer was isolated and the 
stereochemical preference was for formation of the cyclopropane on the more hindered 
concave face of the molecule (Figure 16). 
 
N
O
H
HH
N
O
H HH
N
O
H
HH
291 294 295
 
Figure 16 
 
The novel compounds obtained by the intramolecular variant of the 
amidocyclopropanation reaction could potentially afford a new range of products via 
subsequent stereoselective cycloaddition or ring-opening reactions (Scheme 161). 
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The further application of these results for the development of novel targets containing the 
aminocyclopropyl motif was also a success through the synthesis of cyclopropanes 
containing aminoalcohols, amino acid motifs and an N-cyclopropyl indole in two steps 
allowing the design of further complex compounds (Figure 17). 
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Figure 17 
 
Finally due to lack of time, the study of the rearrangement reaction could not be 
investigated in detail and was only tried once. It would be very interesting to prepare 
more material and also to try the reaction with other carbenoid precursors such as 397. 
The N-COO bond should be easier to break than the corresponding NC-C one and, 
although no longer a sigmatropic rearrangement, the reaction could give some 
satisfactory results (Scheme 162). 
 
 
Scheme 162 
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Experimental 
 
Melting points were determined using a Reichert hot-stage apparatus and are 
uncorrected. Optical rotations were measured using a Perkin-Elmer 241 polarimeter or a 
Perkin Elmer Model 343 Polarimeter (using the sodium D-line, 529 nm) and [α]
D
T
 
values are given in 10-1 deg cm2.g-1, concentration (c) in g per 100 ml. Infrared (IR) 
spectra were recorded on a Perkin-Elmer 1605 Fourier transform spectrometer or on a 
PerkinElmer spectrum 100 FT-IR spectrometer as thin films. Absorption maxima are 
reported in wavenumbers (cm-1). Only selected absorbances are reported. 
 
1H NMR spectra were recorded at 300 MHz on a Bruker AMX300 spectrometer, at 400 
MHz either on a Bruker AMX400 or Avance 400 spectrometer, at 500 MHz on a 
Bruker Avance 500 spectrometer or at 600 MHz on a Bruker Avance 600 spectrometer 
in the stated solvent using residual protic solvent CHCl3 (δ = 7.26 ppm, s), DMSO (δ = 
2.56 ppm, qn) or D2O (δ = 4.79, s) as the internal standard. Chemical shifts are quoted 
in ppm using the following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; qn, 
quintet; m, multiplet; br, broad or a combination of these. The coupling constants (J) are 
reported as measured and recorded in Hertz. Chemical shifts (δ) are quoted as parts per 
million relative to TMS (tetramethylsilane) downfield from δ TMS = 0 ppm. 
13C NMR spectra were recorded at 75 MHz on a Bruker AMX300 spectrometer, at 100 
MHz either on a Bruker AMX400 or Avance 400 spectrometer, at 125 MHz on a 
Bruker Avance 500 spectrometer or at 150 MHz on a Bruker Avance 600 spectrometer 
in the stated solvent using the central reference of CHCl3 (δ = 77.0 ppm, t), DMSO (δ = 
39.52 ppm, septet) as the internal standard. Chemical shifts are reported to the nearest 
0.1 ppm.  
 
Mass spectra and accurate mass measurements were recorded on a Micromass 70-SE 
Magnetic Sector spectrometer at the University College London Chemistry Department 
either by electrospray ionisation (ESI), fast atom bombardment (FAB) using a cesium 
ion gun in a thioglycerol matrix or were ionised electronically (EI) with an accelerating 
voltage of approximately 6 kV. 
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Elementary analyses were performed at University College London Chemistry 
Department. The X-Ray crystal structure was determined using a Diffractometer: 
Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit sphere) at 
the University of Southampton, School of Chemistry, EPSRC National Crystallography 
Service. 
Purification was carried out by column chromatography using silica gel BDH (40-60 
µm). Analytical thin layer chromatography was carried out using Merck Kieselgel 
aluminium-backed plates coated with silica gel 60 F254. Components were visualised 
using combinations of ultra-violet light, iodine, ceric ammonium molybdate and 
permanganate solutions. 
 
All reactions using dry solvents were carried out in oven-dried glassware under a 
nitrogen atmosphere. Diethyl ether, tetrahydrofuran, toluene and dichloromethane were 
used following purification from Anhydrous Engineering zeolite drying apparatus. N,N 
dimethylformamide was distilled under reduced pressure from calcium hydride and 
stored over 4Å molecular sieves. Triethylamine was distilled from potassium hydroxide. 
Petroleum ether refers to the fraction of petroleum ether that was distilled between 
40 °C and 60 °C. Chlorotrimethylsilane was distilled from calcium hydride immediately 
prior to use. 3-Carene was distilled prior to use. Sodium para-toluenesulfinate was dried 
under vacuum at 120 °C prior to use. Cobalt(II) chloride hexahydrate was dried at 
100 °C for 4 hours prior to use. 
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Zinc amalgam 
 
Zinc dust (10.0 g, 153 mol) was added to a vigorously stirred solution of mercury (II) 
chloride (2.0 g, 7.20 mmol) and a solution of hydrochloric acid (0.5 ml of a 12M 
solution) in water (30 ml). The mixture was stirred for 10 minutes, the zinc amalgam 
filtered off and then washed with water (3 x 20 ml), acetone (3 x 20 ml), ethanol (3 x 20 
ml) and diethyl ether (3 x 20 ml) before being dried under high vacuum. The zinc 
amalgam was thereafter stored under vacuum, and flame dried under a stream of 
nitrogen immediately prior to use. 
 
Zinc dust 
 
A suspension of commercially available zinc dust (5 g, 76.5 mmol) in 2% aqueous 
hydrochloric acid (15 ml) was stirred for 10 min, filtered and washed with water (3 × 20 
ml), acetone (3 × 20 ml), ethanol (3 × 20 ml) and diethyl ether (3 × 20 ml) and then 
dried under vacuum. 
 
  Experimental 
 
145 
Ethyl 2-(cyclopent-2-enyl)acetate 163118 
 
O O
 
 
Acetyl chloride (3.00 ml, 42.4 mmol, 2.7 eq.) was added dropwise to a solution of 
ethanol (30 ml) at 0 °C. 2-(Cyclopent-2-enyl)acetic acid 178 (2.00 g, 15.9 mmol, 1 eq.) 
was added dropwise to this solution at 0 °C, and the resulting mixture allowed to warm 
to room temperature then heated at reflux for 4 hours. After concentration under 
reduced pressure the residue was diluted with chloroform (15 ml) and concentrated 
again under reduced pressure to give a biphasic mixture. The mixture was extracted 
with dichloromethane (10 ml) and the organic layer was dried (MgSO4) and 
concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether: diethyl ether 4:1) to give the ester 163 as a pale 
yellow oil (1.6 g, 65%).  
 
 
IR (film): υmax 2907 (s), 1732 (s), 1614 (w), 1259 (s), 1148 (s), 1032 (s) cm-1; 1H NMR 
(500 MHz, CDCl3): δ 1.26 (t, J=7.2 Hz, 3H, CH3), 1.42–1.50 (m, 1H, CHHCHCH2), 
2.07–2.16 (m, 1H, CHHCHCH2), 2.25–2.33 (m, 2H, CH2C=O), 2.33–2.42 (m, 2H, 
CH2CH=CH), 3.04–3.12 (m, 1H, CHCH=CH), 4.14 (q, J=7.2 Hz, 2H, CH2CH3), 5.65–
5.68 (m, 1H, CH=CH), 5.74–5.78 (m, 1H, CH=CH); 13C NMR (125 MHz, CDCl3): δ 
14.3 (CH3), 29.6 (CH2), 31.8 (CH2), 40.5 (CH2), 41.8 (CH), 60.2 (CH2), 131.4 
(CH=CH), 133.7 (CH=CH), 173.0 (C=O); MS (EI) m/z (%): 153 (M-H, 33), 79 (75), 57 
(100); HRMS:M-H, found 153.09115, C9H13O2 requires 153.09101. 
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(E)-Ethyl 3,7-dimethylocta-2,6-dienoate 159119 
 
 
 
Sodium hydride (60% mineral oil dispersion, 0.31 g, 7.80 mmol, 1.3 eq.) was washed 
three times with hexane. The resulting solid was suspended in dry tetrahydrofuran (10 
mL) and cooled to 0 °C. A solution of triethyl phosphonoacetate (1.75 g, 7.80 mmol, 
1.3eq.) in tetrahydrofuran (6 ml) was added at 0 °C, and the mixture was stirred at this 
temperature for a further 30 min. A solution of 6-methyl-5-hepten-2-one 179 (0.74 g, 
5.90 mmol, 1eq.) in tetrahydrofuran (5 ml) was added and the resulting mixture was 
stirred at 0 °C for 1 hour and then allowed to warm to room temperature and stirred for 
16 hours. The reaction mixture was then poured into a mixture of diethyl ether (50 ml) 
and a saturated aqueous solution of ammonium chloride (20 ml). The ether layer was 
separated and the aqueous layer extracted with diethyl ether (2 × 20 ml). The combined 
organic extracts were dried (MgSO4) and concentrated under reduced pressure. The 
crude product (approximately 75:25 E:Z) was purified by column chromatography (3% 
tBuOMe in hexane) to give 1.03 g of a mixture of (E) and (Z) isomers (64:36 E:Z) as a 
colourless oil and 187 mg of the pure E isomer as a colourless oil (89% overall yield). 
The pure E isomer was used in the cyclopropanation reaction. 
 
 
IR (film): υmax 1643 (s), 1385 (w), 1223 (w), 1142 cm-1; 1H NMR (400 MHz, CDCl3): δ 
1.28 (t, J=7.1 Hz, 3H, CH3CH2), 1.60 (s, 3H, CH3CCH3), 1.68 (s, 3H, CH3CCH3), 2.15 
(s, 3H, CH3C=CH), 2.16 (m, 4H, 2 × CH2), 4.15 (q, J=7.1 Hz, 2H, CH2CH3), 5.03–5.1 
(m, 1H, CHCOO), 5.66 (br s, 1H, Me2C=CH); 13C NMR (125 MHz, CDCl3): δ 14.3 
(CH3), 17.7 (CH3), 18.8 (CH3), 25.7 (CH3), 26.0 (CH2), 40.9 (CH2), 59.5 (CH2), 115.6 
(CH=C), 123.0 (CH=C), 132.5 (C=CH), 159.8 (C=CH), 166.9 (C=O); MS (EI) m/z (%): 
196 (M+,10), 151 (33), 123 (60), 97 (52), 83 (100); HRMS: [M]+, found 196.14572, 
C12H20O2 requires 196.14632. 
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cis (E)-Ethyl 5-(2,2-dimethyl-3-(2-oxooxazolidin-3-yl)cyclopropyl)-3-methylpent-2-
enoate 181 
 
 
 
A solution of 3-diethoxymethyloxazolidin-2-one 158 (342 mg, 1.81 mmol, 2 eq.) in 
diethyl ether (3 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a vigorously 
stirred refluxing mixture of zinc dust (1.19 g, 18.2 mmol, 20 eq.), copper(I) chloride 
(119 mg, 1.20 mmol, 1.3 eq.), zinc chloride (1.0 M solution in diethyl ether, 1.8 ml, 1.8 
mmol, 2 eq.), chlorotrimethylsilane (1.16 ml, 9.00 mmol, 10 eq.) and (E)-ethyl-3,7-
dimethyl-octa-2,6-dienoate 159 (178 mg, 0.90 mmol, 1 eq.) in diethyl ether (10 ml). The 
reaction mixture was heated at reflux for 16 hours, then quenched by the addition of a 
saturated aqueous solution of sodium bicarbonate (15 ml), filtered and the solids washed 
with diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (3 ×15 
ml) and the combined organic extracts washed with brine (15 ml), dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude product (181:182 11:1 as 
determined by 1H NMR spectrum) was purified by column chromatography (diethyl 
ether:petroleum ether 1:1) to give the N-cyclopropyl oxazolidinone 181 as a pale yellow 
liquid (101 mg, 38%). 
 
 
IR (mixture of trans and cis, film): υmax 2955, 1759, 1709, 1643 (s) cm-1; 1H NMR (cis, 
500 MHz, CDCl3): δ 0.74 (ddd, J=8.9, 7.6, 5.4 Hz, 1H, CHCHN), 1.07 (s, 3H, 
CH3CCH3), 1.09 (s, 3H, CH3CCH3), 1.25 (br t, J=7.1 Hz, 3H, CH3CH2), 1.34–1.44 (m, 
1H, CHHCH2), 1.76– 1.84 (m, 1H, CHHCH2), 2.10 (d, J=7.6 Hz, 1H, CHN), 2.14 (s, 
3H, CH3C=CH), 2.16–2.22 (m, 1H, CHHC=CH), 2.23–2.31 (m, 1H, CHHC=CH), 
3.43–3.56 (m, 2H, CH2N), 4.12 (q, J=7.1 Hz, 2H, CH2CH3), 4.22–4.30 (m, 2H, 
CH2OC=O), 5.64 (br s, 1H, CHCOO); 13C NMR (cis, 125 MHz, CDCl3): δ 14.3 (CH3), 
14.9 (CH3), 18.9 (CH), 19.5 (CH3), 22.8 (C), 22.9 (CH2), 27.0 (CH3), 27.8 (CH), 40.9 
(CH2), 46.9 (CH2), 59.5 (CH2), 62.2 (CH2), 115.8 (CH=C), 159.5 (C=CH), 160.4 
(C=O), 166.7 (C=O); 1H NMR (trans, 500 MHz, CDCl3): δ 0.52-0.57 (m, 1H), 3.94 (dd, 
  Experimental 
 
148 
2H), 4.49 (dd, 2H); MS (FAB) m/z (%): 296 (MH+, 28), 250 (70), 219 (100), 163 (66), 
154 (72); HRMS: [MH]+, found 296.18541, C16H26O4N requires 296.18617. 
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trans 3-[2-((trimethylsilyl)methyl)cyclopropyl]oxazolidin-2-one 183 and cis 3-[2-
((trimethylsilyl)methyl)cyclopropyl]oxazolidin-2-one 184 
 
 
 
A solution of 3-diethoxymethyloxazolidin-2-one 158 (497 mg, 2.60 mmol, 2 eq.) in 
diethyl ether (2 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a vigorously 
stirred refluxing mixture of zinc dust (1.72 g, 26.3 mmol, 20 eq.), copper(I) chloride 
(172 mg, 1.74 mmol, 1.4 eq.), zinc chloride (1.0 M solution in diethyl ether, 2.6 ml, 2.6 
mmol, 2 eq.), chlorotrimethylsilane (1.67 ml, 13.2 mmol, 10 eq.) and 
allyltrimethylsilane 160 (0.20 ml, 1.26 mmol, 1 eq.) in diethyl ether (5 ml). The reaction 
mixture was heated at reflux for 16 hours, then quenched by the addition of a saturated 
aqueous solution of sodium bicarbonate (15 ml), filtered and the solids washed with 
diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (3 ×15 ml) 
and the combined organic extracts washed with brine (15 ml), dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude product was purified by column 
chromatography (diethyl ether:petroleum ether 3:2) to give the trans N-cyclopropyl 
oxazolidinone 183 as a pale yellow liquid (41 mg, 15%) and the cis N-cyclopropyl 
oxazolidinone 184 as a pale yellow solid (26 mg, 10%)  
 
 
IR (trans, film): υmax 2953 (w), 1748 (s), 1483 (w), 1417, 1246, 1037, 835 (s); 1H NMR 
(trans, 500 MHz, CDCl3): δ 0.01 (s, 9H, 3 × CH3), 0.33 (dd, J=14.8, 8.4 Hz, 1H, 
CHHSi), 0.48-0.52 (m, 1H, CHHCHN), 0.75 (dd, J=14.8, 6.1 Hz, 1H, CHHSi), 0.87 
(ddd, J=9.3, 5.5, 3.6 Hz, 1H, CHHCHN), 0.92-0.99 (m, 1H, CHCHN), 2.15 (dt, J=6.8, 
3.4 Hz, 1H, CHN), 3.42-3.52 (m, 2H, CH2N), 4.22 (t, J=8.0 Hz, 2H, CH2O); 13C NMR 
(trans, 125 MHz, CDCl3): δ – 1.5 (3 × CH3Si), 14.6 (CH2), 15.0 (CH), 20.1 (CH2), 33.5 
(CH), 45.7 (CH2), 61.7 (CH2), 158.3 (C=O);  
  Experimental 
 
150 
M.p. 93-96 °C (Et2O); IR (cis , film): υmax 2956 (w), 1744 (s), 1430 (w), 1243 (s), 1136, 
1082, 1033 (s), 839 (s) cm-1; 1H NMR (cis, 500 MHz, CDCl3): δ 0.02 (s, 9H, 3 × CH3), 
0.04-0.08 (m, 1H, CHHSi), 0.38-0.44 (m, 1H, CHHCHN), 0.95-1.04 (m, 3H, CHHSi, 
CHCHN, CHHCHN), 2.41 (td, J=7.3, 4.3 Hz, 1H, CHN), 3.58 (td, J=8.7, 7.2 Hz, 1H, 
CHHN), 3.64 (td, J=8.7, 7.1 Hz, 1H, CHHN), 4.26-4.30 (m, 2H, CH2O); 13C NMR (cis, 
125 MHz, CDCl3): δ – 1.5 (3 × CH3Si), 12.1 (CH2), 13.9 (CH), 14.7 (CH2), 30.3 (CH), 
46.6 (CH2), 61.9 (CH2), 159.4 (C=O);  MS (CI+) m/z (%): 214 (MH+, 82), 198 (100), 
159 (20), 144 (27); HRMS: [MH]+, found 214.12740, C10H20O2NSi requires 214.12633. 
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cis Methyl 3-(1-chloro-2-(2-oxooxazolidin-3-yl)cyclopropyl)-2,2-dimethyl-
propanoate 185  
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A solution of 3-diethoxymethyloxazolidin-2-one 158 (427 mg, 2.26 mmol, 2 eq.) in 
diethyl ether (4 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a vigorously 
stirred refluxing mixture of zinc dust (1.48 g, 22.6 mmol, 20 eq.), copper(I) chloride 
(148 mg, 1.50 mmol, 1.3 eq.), zinc chloride (1.0 M solution in diethyl ether, 2.2 ml, 2.2 
mmol, 2 eq.), chlorotrimethylsilane (1.45 ml, 11.3 mmol, 10 eq.) and methyl 4-chloro-
2.2-dimethylpent-4-enoate 161 (200 mg, 1.13 mmol, 1eq.) in diethyl ether (8 ml). The 
reaction mixture was heated at reflux for 16 hours, then quenched by the addition of a 
saturated aqueous solution of sodium bicarbonate (15 ml), filtered and the solids washed 
with diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 ×15 
ml) and the combined organic extracts washed with brine (15 ml), dried (MgSO4), 
filtered and concentrated under vacuum. The crude product (185:186 16:1 as determined 
by 1H NMR spectrum) was purified by column chromatography (diethyl 
ether:petroleum ether 1:1) to give the N-cyclopropyl oxazolidinone 185 as a colourless 
solid (33 mg, 11%). 
 
 
M.p. 46–49 °C (petroleum ether); IR (film): υmax 1634 (s), 1427 (w) cm-1; 1H NMR 
(trans, 500 MHz, CDCl3): δ 1.28 (s, 3H, CH3CCH3), 1.29 (s, 3H, CH3CCH3), 1.36 (dd, 
J=9.0, 7.9 Hz, 1H, CHHCHN), 1.59 (ddd, J=7.9, 5.5, 1.0 Hz, 1H, CHHCHN), 2.01 (d, 
J=15.2 Hz, 1H, CHHCCHN), 2.11 (dd, J=15.2, 1.0 Hz, 1H, CHHCCHN), 2.51 (dd, 
J=9.0, 5.5 Hz, 1H, CHN), 3.56–3.64 (m, 1H, CHHN), 3.68 (s, 3H, CH3O), 3.74–3.80 
(m, 1H, CHHN), 4.25–4.37 (m, 2H, CH2OCO); 13C NMR (cis, 125 MHz, CDCl3): δ 
22.0 (CH2), 25.8 (CH3), 25.8 (CH3), 36.7 (CH), 42.2 (C), 44.5 (C), 45.6 (CH2), 48.5 
(CH2), 51.9 (CH3), 61.9 (CH2), 158.5 (C=O), 177.1 (C=O); MS (CI+) m/z (%): 278 
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(MH+ 37Cl, 5), 276 (MH+ 35Cl, 15), 244 (28), 216 (100), 180 (16); HRMS: [MH]+, found 
276.09988, C12H19O4NCl requires 276.10025. 
 
  Experimental 
 
153 
8-endo-(2-Oxooxazolidin-3-yl)-1,4,4-trimethyltricyclo[5.1.0.0]octane 187 
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A solution of 3-diethoxymethyloxazolidin-2-one 158 (568 mg, 3.00 mmol, 2 eq.) in 
diethyl ether (4 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a vigorously 
stirred refluxing mixture of zinc dust (1.96 g, 30.0 mmol, 20 eq.), copper(I) chloride 
(196 mg, 1.98 mmol, 1.3 eq.), zinc chloride (1.0 M solution in diethyl ether, 3.0 ml, 3.0 
mmol, 2 eq.), chlorotrimethylsilane (1.90 ml, 15.0 mmol, 10 eq.) and 3-carene 162 (200 
mg, 1.50 mmol, 1 eq.) in diethyl ether (10 ml). The reaction mixture was heated at 
reflux for 16 hours, then quenched by the addition of a saturated aqueous solution of 
sodium bicarbonate (15 ml), filtered and the solids washed with diethyl ether (10 ml). 
The biphasic mixture was extracted with diethyl ether (2 × 15 ml) and the combined 
organic extracts washed with brine (15 ml), dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude product (187 and minor undetermined 
diastereoisomers) was purified by column chromatography (ethyl acetate:petroleum 
ether 1:4) to give the N-cyclopropyl oxazolidinone 187 as a colourless solid (205 mg, 
58%). 
 
 
M.p. 60– 64 °C (petroleum ether); [α] 20D –27.1 (c 1, CHCl3); IR (mixture, film): υmax 
2864 (w), 1755, 1634, 1404 cm-1; 1H NMR (endo, 500 MHz, CDCl3): δ 0.37 (td, J=9.4, 
3.2 Hz, 1H, CHCMe2), 0.43 (td, J=9.4, 3.2 Hz, 1H, CHCMe2), 0.77 (s, 3H, CH3CCHN), 
0.82 (m, 1H, CHCHN), 0.98 (s, 3H, CH3CCH3), 1.02 (s, 3H, CH3CCH3), 1.30 (dd, 
J=15.7, 3.2 Hz, 1H, CHHCCH3), 1.63 (ddd, J=15.7, 5.8, 3.2 Hz, 1H,CHHCHCHN), 
2.08 (d, J=7.7 Hz, 1H, CHN), 2.27 (dd, J=15.7, 9.4 Hz, 1H, CHHCCH3), 2.28 (dd, 
J=15.7, 9.4 Hz, 1H, CHHCHCHN), 3.63 (t, J=7.8 Hz, 2H, CH2N), 4.24–4.28 (m, 2H, 
CH2O); 13C NMR (cis, 125 MHz, CDCl3): δ 13.9 (CH2), 15.1 (CH3), 16.1 (CH), 16.9 
(C), 17.1 (C), 17.7 (CH), 20.3 (CH2), 21.3 (CH), 26.5 (CH3), 27.8 (CH3), 38.1 (CH), 
46.5 (CH2), 62.4 (CH2), 159.8 (C=O); MS (CI+) m/z (%): 236 (MH+, 43), 149 (100), 
  Experimental 
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100 (22), 88 (48); HRMS: [MH]+, found 236.16482, C14H22O2N requires 236.16505. 
Anal. Calcd for C14H21O2N: C, 71.46; H, 8.99; N, 5.95. Found: C, 71.54; H, 9.12; N, 
5.90.  
 
  Experimental 
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(±)-Ethyl 2-((1R,2S,5S,6R)-6-(2-oxooxazolidin-3-yl)bicyclo[3.1.0]hexan-2-yl)acetate 
188 and (±)-ethyl 2-((1R,2R,5S,6R)-6-(2-oxooxazolidin-3-yl)bicyclo[3.1.0]hexan-2-
yl)acetate 189 
 
 
 
A solution of 3-diethoxymethyloxazolidin-2-one 158 (491 mg, 2.60 mmol, 2 eq.) in 
diethyl ether (4 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a vigorously 
stirred refluxing mixture of zinc dust (1.70 g, 26 mmol, 20 eq.), copper(I) chloride (170 
mg, 1.72 mmol, 1.3 eq.), zinc chloride (1.0 M solution in diethyl ether, 2.6 ml, 2.6 
mmol, 2 eq.), chlorotrimethylsilane (1.66 ml, 13.1 mmol, 10 eq.) and ethyl 2-cyclopent-
2-enyl-acetate 163 (200 mg, 1.30 mmol, 1 eq.) in diethyl ether (7 ml). The reaction 
mixture was heated at reflux for 16 hours, then quenched by the addition of a saturated 
aqueous solution of sodium bicarbonate (15 ml), filtered and the solids washed with 
diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 × 15 ml) 
and the combined organic extracts washed with brine (15 ml), dried (MgSO4) and 
concentrated under vacuum. The crude product was purified by column chromatography 
(diethyl ether:petroleum ether 9:1) to give pure N-cyclopropyl oxazolidinone 188 as a 
yellow oil (24 mg) and a mixture of 188, 189 and other diastereoisomers (80 mg). This 
mixture was further purified by column chromatography (ethyl acetate:petroleum ether 
4:1) to give N-cyclopropyl oxazolidinone 189 (28mg, >90% purity) as an pale yellow 
oil (combined yield of diastereoisomers 104 mg, 34%). 
 
 
IR (188:189 mixture 2.6:1, film): υmax 2954, 1732 (s), 1417 (s) cm-1; 1H NMR (188, 500 
MHz, CDCl3): δ 1.20 (t, J=7.2 Hz, 3H, CH3), 1.28–1.33 (m, 1H, CHHCHCH2), 1.35–
1.45 (m, 1H, CHHCHCH2), 1.45–1.49 (m, 1H, CHCHCH2), 1.69–1.72 (m, 1H, 
CHCHN), 1.78–1.84 (m, 1H, CHHCHCHN), 1.84–1.91 (m, 1H, CHHCHCHN), 2.20 
(dd, J=15.1, 8.2 Hz, 1H, CHHCOO), 2.28 (t, J=1.9 Hz, 1H, CHN), 2.32 (dd, J=15.1, 7.1 
Hz, 1H, CHHCOO), 2.62 (br q, J=7.5 Hz, 1H, CHCH2CO), 3.47–3.51 (m, 2H, CH2N), 
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4.14 (q, J=7.2 Hz, 2H, CH2CH3), 4.22–4.27 (m, 2H, CH2OCON); 13C NMR (188, 125 
MHz, CDCl3): δ 14.2 (CH3), 24.7 (CH), 24.8 (CH2), 27.0 (CH2), 29.7 (CH), 33.4 (CH), 
36.5 (CH), 39.8 (CH2), 45.7 (CH2), 60.3 (CH2), 61.8 (CH2), 158.3 (C=O), 172.5 (C=O).  
1H NMR (189, 500 MHz, CDCl3): δ 0.68–0.77 (m, 1H, CHHCHCH2), 1.26 (t, J=7.1 Hz, 
3H, CH3), 1.60–1.65 (m, 1H, CHCHCH2), 1.69–1.73 (m, 1H, CHCHN), 1.73–1.79 (m, 
1H, CHHCHCH2), 1.79–1.88 (m, 1H, CHHCHCHN), 1.95 (dd, J=12.9, 8.1 Hz, 1H, 
CHHCHCHN), 2.28 (br t, J=1.9 Hz, 1H, CHN), 2.40 (dd, J=15.2, 7.1 Hz, 1H, 
CHHCOO), 2.46 (dd, J=15.2, 7.6 Hz, 1H, CHHCOO), 2.56–2.65 (m, 1H, CHCH2CO), 
3.43–3.51 (m, 2H, CH2N), 4.14 (q, J=7.1 Hz, 2H, CH2CH3), 4.19–4.28 (m, 2H, 
CH2OCON); 13C NMR (189, 125 MHz, CDCl3): δ 14.3 (CH3), 25.5 (CH), 27.0 (CH2), 
27.6 (CH2), 28.9 (CH), 30.8 (CH), 36.6 (CH), 37.8 (CH2), 45.7 (CH2), 60.3 (CH2), 61.8 
(CH2), 158.4 (C=O), 173.0 (C=O); MS (CI+) m/z (%): 254 (MH+, 100), 208 (95), 166 
(60), 88 (14); HRMS: [MH]+, found 254.13872, C13H20O4N requires 254.13923. 
 
  Experimental 
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(S)-4-Isopropyloxazolidin-2-one 199165 
 
HN O
O
 
 
Triphosgene (6.0 g, 20 mmol, 0.35 eq.) was added portionwise to a suspension of L-
valinol 216 (6.0 g, 58 mmol, 1 eq.) and triethylamine (18.0 ml, 129 mmol, 2.2 eq.) in 
dry dichloromethane (210 ml) at 4 °C. The reaction mixture was stirred for 15 min at 
this temperature and then allowed to warm to room temperature and stirred for 16 hours 
before being quenched with a saturated aqueous solution of ammonium chloride (200 
ml). The aqueous layer was separated and the organic layer washed with water (100 ml). 
The aqueous layer was extracted with dichloromethane (150 ml) and the combined 
organic extracts dried (MgSO4), filtered and concentrated under reduced pressure to 
give the title oxazolidinone 199 as a yellow solid (6.68 g, 89%) used without further 
purification. 
 
 
M.p. 65-68 °C, lit.,165 67-70 °C (Et2O); [α]
D
16
 +8.92 (c 1.1, CHCl3), lit.,165 [α]
D
26
 + 15.5 (c 
5.2, CHCl3); IR (film): νmax 3300 (w), 2963, 1753 (s), 1240 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 0.90 (d, J=6.8 Hz, 3H, CH3CHCH3), 0.96 (d, J=6.8 Hz, 3H, CH3CHCH3), 
1.73 (octet, J=6.8 Hz, 1H, CHMe2), 3.53-3.65 (m, 1H, CHNH), 4.10 (dd, J=8.7, 6.3 Hz, 
1H, CHHO), 4.44 (t, J=8.7 Hz, 1H, CHHO), 5.98 (br s, 1H, NH); 13C NMR (75 MHz, 
CDCl3): δ 17.6 (CH3), 18.0 (CH3), 32.7 (CH), 58.3 (CH), 68.6 (CH2), 160.1 (C=O); MS 
(CI+) m/z (%): 130 (MH+, 100), 102 (2), 86 (7); HRMS: [MH]+, found 130.08634, 
C6H12O2N requires 130.08680. 
 
  Experimental 
 
158 
(S)-4-Isobutyloxazolidin-2-one 221166 
 
HN O
O
 
 
Triphosgene (1.77 g, 5.97 mmol, 0.35 eq.) was added portionwise to a suspension of L-
leucinol 217 (2.0 g, 17.0 mmol, 1 eq.) and triethylamine (5.23 ml, 37.4 mmol, 2.20 eq.) 
in dry dichloromethane (60 ml) at 4 °C. The reaction mixture was stirred for 15 min and 
then allowed to warm to room temperature before being quenched with a saturated 
aqueous solution of ammonium chloride (25 ml). The aqueous layer was separated and 
the organic layer washed with water (25 ml). The aqueous layer was extracted with 
dichloromethane (50 ml) and the combined organic extracts dried (MgSO4), filtered and 
concentrated under reduced pressure to give 221 as a yellow oil (2.47 g, 99%) used 
without further purification 
 
 
[α]
D
16
 −11.6 (c 1, CHCl3), lit.,166 (R)-isomer, [α]
D
22
 +11.9 (c 0.6, CHCl3); IR (film): νmax 
3336 (s, br), 2980, 2871, 1750 (s), 1408 (w), 1235 (w), 1028 (w) cm-1; 1H NMR (300 
MHz, CDCl3): δ 0.91 (d, J=4.1 Hz, 3H, CH3CHCH3), 0.94 (d, J=4.1 Hz, 3H, 
CH3CHCH3), 1.34-1.44 (m, 1H, CHMe2), 1.50-1.71 (m, 2H, CH2CHMe2), 3.89-4.00 
(m, 2H, CHNH, CHHO), 4.49 (t, J=7.4 Hz, 1H, CHHO), 6.21 (br s, 1H, NH); 13C NMR 
(75 MHz, CDCl3): δ 22.1 (CH3), 22.9 (CH3), 25.1 (CH), 44.4 (CH2), 51.0 (CH), 70.7 
(CH2), 159.9 (C=O); MS (EI) m/z (%): 143 (M+, 23), 130 (5), 86 (100); HRMS: [M]+, 
found 143.09423, C7H13O2N requires 143.09462. 
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(S)-4-Benzyloxazolidin-2-one 198167 
 
HN O
O
 
 
Triphosgene (1.0 g, 3.5 mmol, 0.35 eq.) was added portionwise to a suspension of L-
phenylalaninol 218 (1.5 g, 9.9 mmol,  1 eq.) and triethylamine (3.02 ml, 21.7 mmol, 2.2 
eq.) in dry dichloromethane (30 ml) at 4 °C. The reaction mixture was stirred for 15 min 
and then allowed to warm to room temperature and stirred for 2 hours before being 
quenched with a saturated aqueous solution of ammonium chloride (20 ml). 
Dichloromethane (40 ml) was added to the reaction which was then stirred for 20 min. 
The aqueous layer was separated and the organic layer washed with a saturated aqueous 
solution of sodium bicarbonate (25 ml) and brine (25 ml). The organic layer was dried 
(MgSO4), filtered and concentrated under reduced pressure to give 198 as a pale yellow 
solid (1.71 g, 99%). A sample was purified by column chromatography (petroleum 
ether:ethyl acetate 6:4). 
 
 
M.p. 84-88 °C (petroleum ether) lit.,167 85-87 °C (CH2Cl2) ;[α]
D
23
 - 63.1 (c 1.02, CHCl3), 
lit.,167 [α]
D
25
 −62.0 (c , 1.0, CHCl3; IR (film): νmax 3261, 1751 (s), 1738 (s), 1700 (s), 
1407, 1247, 1095 cm-1; 1H NMR (500 MHz, CDCl3): δ 2.84 (dd, J=13.6, 8.2 Hz, 1H, 
CHHPh), 2.90 (dd, J=13.6, 5.8 Hz, 1H, CHHPh), 4.05-4.12 (m, 1H, CHN), 4.16 (dd, 
J=8.7, 5.6 Hz, 1H, CHHO), 4.49 (t, J=8.3 Hz, 1H, CHHO), 4.99 (br s, 1H, NH), 7.16-
7.20 (m, 2H, H-Ar), 7.26-7.30 (m, 1H, H-Ar), 7.33-7.37 (m, 2H, H-Ar); 13C NMR (125 
MHz, CDCl3): δ 41.7 (CH2), 53.9 (CH), 69.8 (CH2), 127.4 (CH-Ar), 129.0 (CH-Ar), 
129.2 (CH-Ar), 136.0 (C-Ar), 158.9 (C=O). 
 
  Experimental 
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(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one 222168 
 
HN O
O
 
 
Triphosgene (1.22 g, 4.11 mmol, 0.35 eq.) was added portionwise to a suspension of  
(1R, 2S)-(-)-norephedrine hydrochloride (2.20 g, 11.7 mmol,  1 eq.) and triethylamine 
(5.23 ml,  37.5 mmol, 3.2 eq.) in dry dichloromethane (40 ml) at 4 °C. The reaction 
mixture was stirred for 30 min and then allowed to warm to room temperature and 
stirred for 2 hours. The Et3N hydrochloride precipitate was removed by filtration and 
washed with dichloromethane (2 × 20 ml). The resulting filtrate was washed with a 
saturated aqueous solution of ammonium chloride (20 ml), then sodium bicarbonate (20 
ml) and brine (20ml). The resulting organic extract was dried (MgSO4), filtered and 
concentrated under reduced pressure to give the title oxazolidinone 222 as a pale yellow 
oil (2.12 g, 99%). A small sample was purified by column chromatography (petroleum 
ether:ethyl acetate 1:1) to give 222 as a pale yellow solid. 
 
 
M.p. 116-119 °C (petroleum ether) lit.,168 116-117 °C ; [α]
D
23
 −163.8 (c 1.02, CHCl3), 
lit.,168 [α]
D
20
 −170 (c 1.2); IR (film): νmax 3269, 1719 (s), 1383, 1353, 1238 cm-1; 1H 
NMR (600 MHz, CDCl3): δ 1.07 (d, J=6.6 Hz, 3H, CH3), 4.19-4.25 (m, 1H, CHCH3), 
5.19 (br s, 1H, NH), 5.74 (d, J=8.0 Hz, 1H, CHO), 7.32 (d, J=7.3 Hz, 2H, H-Ar), 7.35-
7.39 (m, 1H, H-Ar), 7.42 (t, J=7.3 Hz, 2H, H-Ar); 13C NMR (150 MHz, CDCl3): δ 17.6 
(CH3), 52.3 (CH), 81.0 (CH), 125.9 (CH-Ar), 128.6 (CH-Ar), 134.8 (C-Ar), 158.9 
(C=O). 
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(S)-4-Ethyloxazolidin-2-one 223169 
 
HN O
O
 
 
Triphosgene (5.82 g, 19.6 mmol, 0.35) was added portionwise to a suspension of S-(+)-
2 amino-1-butanol 220 (5.00 g, 56.6 mmol, 1 eq.) and triethylamine (17.2 ml, 123 
mmol, 2.20 eq.) in dry dichloromethane (60 ml) at 4 °C. The reaction mixture was 
stirred for 15 min and then allowed to warm to room temperature before being quenched 
with a saturated aqueous solution of ammonium chloride (50 ml). The aqueous layer 
was separated and the organic layer washed with water (50 ml). The aqueous layer was 
extracted with dichloromethane (50 ml) and the combined organic extracts dried 
(MgSO4), filtered and concentrated under reduced pressure to give 223 as a yellow oil 
(3.9 g, 60%) used without further purification 
 
 
[α]
D
20
 −7.24 (c 0.76, CHCl3), lit.,169 [α]
D
30
 −5.3 (c 0.6, CHCl3); IR (film): νmax 2247 (w), 
1749, 1248 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 0.94 (t, J=7.5 Hz, 3H, CH3CH2), 
1.55-1.65 (m, 2H, CH2CH3), 3.76-3.85 (m, 1H, CHNH), 4.02 (dd, J=8.5 Hz, 6.1 Hz, 1H, 
CHHO), 4.48 (t, J=8.5 Hz, 1H, CHHO), 6.28 (br s, 1H, NH); 13C NMR (75 MHz, 
CDCl3): δ  9.3 (CH3), 28.2 (CH2), 53.9 (CH), 70.0 (CH2), 160.3 (C=O); MS (CI+) m/z 
(%): 116 (MH+,100), 99 (4), 86 (8); HRMS: [MH]+, found 116.07058, C5H10O2N 
requires 116.07115. 
 
  Experimental 
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(S)-Methyl-2-oxazolidinone-4-carboxylate 225170 
 
HN O
O
O
O
 
 
Serine methyl ester hydrochloride 224 (10.0 g, 64.3 mmol, 1 eq.) and potassium 
bicarbonate (6.69 g, 66.9 mmol, 1.04 eq.) were dissolved in water (100 ml) and the 
solution stirred at room temperature for 10 min. Potassium carbonate (9.38 g, 67.8 
mmol, 1.05 eq.) was added to the solution which was then cooled to 0 °C and treated 
with a 20% solution of phosgene in toluene (44.3 ml, 84.0 mmol, 1.3 eq.) over 10 min. 
The resulting mixture was stirred for 2 hours at 0 °C. The toluene layer was separated 
from the aqueous layer which was evaporated to dryness. The resulting colourless solid 
was extracted with dichloromethane (60 ml) and the extract dried (MgSO4), filtered and 
concentrated under reduced pressure to give 225 as a colourless oil (8.5 g, 91%) used 
without further purification. 
 
 
[α]
D
20
 –19.2 (c 4.59, CH2Cl2), lit.,170 [α]
D
25
 –18.6 (c 4.52, CH2Cl2); IR (film): νmax 3416 
(s, br), 1738 (s), 1617 (w), 1436 (w), 1410 (w), 1231, 1059 (w) cm-1; 1H NMR
 
(400 
MHz, CDCl3): δ 3.82 (s, 3H, CH3O), 4.42 (dd, J=9.1, 4.6 Hz, 1H, CHCH2O), 4.52 (dd, 
J=9.1 Hz, 4.6 Hz, 1H, CHHO), 4.62 (t, J=9.1 Hz, 1H, CHHO), 6.05 (br s, 1H, NH); 13C 
NMR (75 MHz, CDCl3): δ  53.1 (CH3), 53.6 (CH), 66.6 (CH2), 158.6 (C=O), 170.4 
(C=O); MS (EI) m/z 145 (M+, 36), 115 (3), 84 (100); HRMS: [M]+, found 145.03789, 
C5H7O4N requires 145.0375.  
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(R)-4-(Hydroxymethyl)oxazolidin-2-one 226170 
 
HN O
O
HO
 
 
Sodium borohydride (177 mg, 4.69 mmol, 1.05 eq.) was added portionwise to a solution 
of the ester 225 (650 mg, 4.48 mmol, 1 eq.) in ethanol (10 ml) at 0 °C. The reaction 
mixture was allowed to warm to room temperature over 2 hours, then treated with a 
saturated aqueous solution of ammonium chloride (51 ml) and stirred at room 
temperature for 30 min. The colourless solid was removed by filtration and the filtrate 
concentrated under reduced pressure to give 226 as a colourless solid (0.43 g, 82%). 
 
 
M.p. 77-81 °C, lit.,170 96-99 °C (CHCl3); [α]
D
20
 +29.2 (c 1.0, MeOH), lit.,170 [α]
D
25
 +32.25 
(c 1.044, MeOH); IR (film): νmax 3276 (br, s), 1732 (s), 1418, 1259, 1037, 939 cm-1; 1H 
NMR
 
(400 MHz, D2O): δ 3.58 (dd, J=12.0, 4.4 Hz, 1H , CHHOH), 3.67 (dd, J=12.0, 3.7 
Hz, 1H, CHHOH), 4.03-4.09 (m, 1H, CHCH2O), 4.29 (dd, J=9.0, 5.1 Hz, 1H, CHHO), 
4.56 (t, J=9.0 Hz, 1H, CHHO); 13C NMR (75 MHz, D2O): δ  53.8 (CH), 62.6 (CH2), 
68.1 (CH2), 159.9 (C=O);  MS (EI) m/z (%) 118 (MH+, 45), 106 (12), 97 (25), 91 (7), 86 
(100); HRMS: [M]+, found 117.04312, C4H7O3N requires 117.04259. 
 
  Experimental 
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(S)-3-Diethoxymethyl-4-isopropyloxazolidin-2-one 201 
 
N O
O
O
O
 
 
A mixture of the oxazolidinone 199 (195 mg, 1.51 mmol, 1 eq.) and triethyl 
orthoformate (2.5 ml, 15 mmol, 10 eq.) was heated at 160 °C for 48 hours. The reaction 
mixture was cooled to room temperature before being quenched with a saturated 
aqueous solution of sodium bicarbonate (5 ml). The separated aqueous phase was 
extracted with diethyl ether (2 × 5 ml) and the combined organic extracts washed with 
brine, dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
product was purified by column chromatography (petroleum ether:ethyl acetate 4:1) to 
give 201 as a pale yellow oil (192 mg, 55%). 
 
 
[α]
D
19
 +35.9 (c 1.18, CHCl3); IR (film): νmax 3493, 2976, 2878, 1755 (s), 1634 (s), 1487, 
1414, 1234, 1063 (s) cm-1; 1H NMR
 
(500 MHz, DMSO): δ  0.86 (d, J=7.0 Hz, 3H, 
CH3CHCH3), 0.89 (d, J=7.0 Hz, 3H, CH3CHCH3), 1.19 (t, J=7.0 Hz, 3H, CH3CH2), 
1.22 (t, J=7.0 Hz, 3H, CH3CH2), 2.16-2.24 (m, 1H, CHMe2), 3.52-3.73 (m, 4H, 2 × 
OCH2CH3), 3.97 (ddd, J=9.0, 4.8, 3.3 Hz, 1H, CHCH2O) 4.20 (dd, J=9.0, 4.8 Hz, 1H, 
CHHO), 4.31 (t, J=9.0 Hz, 1H, CHHO), 5.71 (s, 1H, CH(OEt)2); 13C NMR (125 MHz, 
DMSO): δ 14.1 (CH3), 14.7 (CH3), 14.7 (CH3), 17.6 (CH3), 29.0 (CH), 55.8 (CH), 61.9 
(CH2), 62.2 (CH2), 63.1 (CH2), 102.1 (CH), 157.1 (C=O); MS (EI) m/z (%): 254 (MNa+, 
100), 186 (68), 184 (10), 172 (79); HRMS: [MNa]+, found 254.13712, C11H21O4NNa 
requires 254.13712. 
 
  Experimental 
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(S)-3-Diethoxymethyl-4-isobutyloxazolidin-2-one 228 
 
N O
O
O
O
 
 
A mixture of the oxazolidinone 221 (1.38 g, 9.64 mmol, 1 eq.), aluminium chloride 
(182 mg, 1.36 mmol, 0.14 eq.) and triethyl orthoformate (55.0 ml, 330 mmol, 34 eq.) 
was heated at 155 °C for 18 hours. The reaction mixture was cooled to room 
temperature before being quenched with a saturated aqueous solution of sodium 
bicarbonate (15 ml). The separated aqueous phase was extracted with diethyl ether (2 × 
25 ml) and the combined organic extracts washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude product was purified by column 
chromatography (petroleum ether:ethyl acetate 9:1) to give 228 as a yellow oil (1.48 g, 
63%). 
 
 
[α]
D
15
 +38.1 (c 1.05, CHCl3); IR (film): νmax 2960 (s), 1743 (s), 1533 (w), 1470, 1410 (s), 
1248 (s), 1067 (s), 899 (w) cm-1; 1H NMR
 
(400 MHz, DMSO): δ  0.91 (d, J=6.6 Hz, 3H, 
CH3CHCH3), 0.93 (d, J=6.6 Hz, 3H, CH3CHCH3), 1.20 (q, J=7.1 Hz, 6H, 2 × CH3CH2), 
1.37-1.46 (m, 1H, CHHCHMe2), 1.56-1.69 (m, 1H, CHMe2), 1.82-1.90 (m, 1H, 
CHHCHMe2), 3.50-3.69 (m, 4H, 2 × CH2CH3), 3.97-4.06 (m, 2H, CHHO, CHCH2O), 
4.48-4.52 (m, 1H, CHHO), 5.70 (s, 1H, CH(OEt)2); 13C NMR (75 MHz, DMSO): δ 14.6 
(CH3), 14.6 (CH3), 21.5 (CH3), 23.4 (CH3), 24.1 (CH), 42.2 (CH2), 50.3 (CH), 61.4 
(CH2), 61.9 (CH2), 68.0 (CH2), 101.9 (CH), 156.9 (C=O); MS (FAB) m/z (%): 268 
(MNa+, 100), 166 (56); HRMS: [MNa]+, found 268.15269, C12H23O4NNa requires 
268.15247. 
 
  Experimental 
 
166 
(S)-3-Diethoxymethyl-4-ethyloxazolidin-2-one 230 
 
N O
O
O
O
 
 
A mixture of the oxazolidinone 223 (908 mg, 7.89 mmol, 1 eq.) and triethyl 
orthoformate (13 ml, 78 mmol, 10 eq.) was heated at 160 °C for 48 hours. The reaction 
mixture was cooled to room temperature before being quenched with a saturated 
aqueous solution of sodium bicarbonate (15 ml). The separated aqueous phase was 
extracted with diethyl ether (2 × 25 ml) and the combined organic extracts washed with 
brine, dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
product was purified by column chromatography (petroleum ether:ethyl acetate 4:1) to 
give 230 as a pale yellow oil (932 mg, 55%). 
 
 
[α]
D
19
 +27.7 (c 1.18, EtOAc); IR (film): νmax 2976 (s), 1757 (s), 1412 (s), 1223, 1063 (s) 
cm-1; 1H NMR
 
(500 MHz, DMSO): δ  0.87 (d, J=7.5 Hz, 3H, CH3CH2), 1.19 (t, J=7.0 
Hz, 3H, CH3CH2O), 1.21 (t, J=7.0 Hz, 3H, CH3CH2O), 1.53-1.64 (m, 1H, CHHCH3), 
1.82-1.91 (m, 1H, CHHCH3) 3.52-3.69 (m, 4H, 2 × OCH2CH3), 3.93-3.99 (m, 1H, 
CHCH2O), 4.06 (dd, J=8.6, 6.0 Hz, 1H, CHHO), 4.44 (t, J=8.6, 1H, CHHO), 5.70 (s, 
1H, CH(OEt)2); 13 NMR (125 MHz, DMSO): δ 8.1 (CH3), 14.7 (CH3), 14.7 (CH3), 25.8 
(CH2), 52.4 (CH), 61.8 (CH2), 62.0 (CH2), 67.0 (CH2), 102.0 (CH), 157.0 (C=O); MS 
(EI) m/z (%): 240 (MNa+, 100), 172 (30); HRMS: [MNa]+, found 240.12164, 
C10H19O4NNa requires 240.12063. 
 
  Experimental 
 
167 
(S)-4-Benzyl-3-diethoxymethyloxazolidin-2-one 200 
 
N O
O
O
O
 
 
A mixture of the oxazolidinone 198 (1.00 g, 5.65 mmol, 1 eq.), aluminium chloride 
(112 mg, 0.84 mmol, 0.15 eq.) and triethyl orthoformate (28.0 ml, 168 mmol, 30 eq.) 
was heated at 155 °C for 18 hours. The reaction mixture was cooled to room 
temperature before being quenched with a saturated aqueous solution of sodium 
bicarbonate (20 ml). The separated aqueous phase was extracted with ethyl acetate (3 × 
25 ml) and the combined organic extracts washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude product was purified by column 
chromatography (petroleum ether:ethyl acetate 9:1) to give 200 as a pale yellow oil (833 
mg, 53%). 
 
 
[α] 20D  +51.5 (c 1.22, CH2Cl2); IR (film): νmax 2978 (w), 1753 (s), 1404, 1233, 1058 (s) 
cm-1; 1H NMR
 
(400 MHz, DMSO): δ  1.20 (t, J=7.0 Hz, 3H, CH2CH3), 1.21 (t, J=7.0 
Hz, 3H, CH2CH3), 2.78 (dd, J=13.6, 8.6 Hz, 1H, CHHPh), 3.25 (dd, J=13.6, 2.6 Hz, 1H, 
CHHPh), 3.52-3.71 (m, 4H, 2 × CH2CH3), 4.00-4.05 (m, 1H, CHHO), 4.17-4.22 (m, 
2H, CHHO, CHCH2Ph), 5.74 (br s, 1H, CH(OEt)2),  7.23-7.28 (m, 3H, H-Ar), 7.32 (t, 
J=7.6 Hz, 2H, H-Ar); 13C NMR (150 MHz, DMSO): δ 15.2 (CH3), 15.3 (CH3), 52.7 
(CH), 62.4 (CH2), 62.4 (CH2), 67.2 (CH2), 102.5 (CH), 127.1 (CH-Ar), 129.0 (CH-Ar), 
129.7 (CH-Ar), 136.9 (C-Ar), 157.1 (C=O); MS (FAB) m/z (%): 302 (MNa+, 74), 234 
(100), 200 (23), 176 (21), 154 (25); HRMS: [MNa]+, found 302.13687, C15H21O4NNa 
requires 302.13682. 
 
  Experimental 
 
168 
(4S,5R)-3-(Diethoxymethyl)-4-methyl-5-phenyloxazolidin-2-one 231 
 
N O
O
O
O
 
 
A mixture of the oxazolidinone 222 (1.00 g, 5.65 mmol, 1 eq.), aluminium chloride 
(113 mg, 0.85 mmol, 0.15 eq.) and triethyl orthoformate (28.0 ml, 168 mmol, 30 eq.) 
was heated at 155 °C for 18 hours. The reaction mixture was cooled to room 
temperature before being quenched with a saturated aqueous solution of sodium 
bicarbonate (20 ml). The separated aqueous phase was extracted with ethyl acetate (3 × 
25 ml) and the combined organic extracts washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude product was purified by column 
chromatography (petroleum ether:ethyl acetate 9:1) to give 231 as a pale yellow oil (843 
mg, 53%). 
 
 
[α] 20D  −38.03 (c 1.02, DCM); IR (film): νmax 2979 (w), 1750 (s), 1386, 1244, 1223, 1059 
(s) cm-1; 1H NMR
 
(600 MHz, DMSO): δ  0.74 (d, J=6.4 Hz, 3H, CH3), 1.24 (t, J=7.1 
Hz, 3H, CH2CH3), 1.37 (t, J=7.1 Hz, 3H, CH2CH3), 3.51 (dq, J=9.6, 7.1 Hz, 1H, 
CHHCH3), 3.57-3.67 (m, 3H, CHHCH3, CH2CH3), 4.31-4.36 (m, 1H, CHCH3), 5.73-
5.75 (m, 2H, CHPh, CH(OEt)2),  7.31-7.33 (m, 2H, H-Ar), 7.35-7.39 (m, 1H, H-Ar), 
7.41-7.45 (m, 2H, H-Ar); 13 NMR (150 MHz, DMSO): δ 15.2 (CH3), 15.2 (CH3), 16.7 
(CH3), 51.7 (CH), 62.2 (CH2), 62.5 (CH2), 79.0 (CH), 102.3 (CH), 126.7 (CH-Ar), 
128.8 (CH-Ar), 128.9 (CH-Ar), 135.8 (C-Ar), 156.6 (C=O); MS (FAB) m/z (%): 302 
(MNa+, 100), 234 (77), 200 (31), 190 (27), 176 (18); HRMS: [MNa]+, found 302.13635, 
C15H21O4NNa requires 302.13682. 
 
  Experimental 
 
169 
(7aR)-5-Ethoxy-dihydro-1H-oxazolo[3,4-c]oxazol-3(5H)-one 232 
 
 
 
para-Toluenesulfonic acid monohydrate (162 mg, 0.85 mmol, 0.15 eq.) was added to a 
solution of the alcohol 226 (650 mg, 5.55 mmol, 1 eq.) in triethyl orthoformate (11 ml). 
The reaction mixture was heated at reflux (150 °C) for 6 hours. The triethyl 
orthoformate was evaporated and the resulting mixture purified by column 
chromatography (ethyl acetate:petroleum ether 1:1) to give 232 as an unstable pale 
yellow liquid (205 mg, 22%).  
 
 
[α]
D
20
 +61.85 (c 1.24, CHCl3); IR (film): νmax 2925 (w), 1732 (s), 1410, 1242, 1033 cm-1; 
1H NMR
  
(400 MHz, DMSO): δ 1.19 (t, J=7.1 Hz, 3H, CH3CH2), 3.62 (q, J=7.1 Hz, 2H, 
CH2CH3), 3.76 (br t, J=7.8 Hz, 1H, CHHOCH), 4.26 (dd, J=8.3, 7.1 Hz, 1H, 
CHHOCH), 4.31-4.41 (m, 2H, CHHOCO, CHNCO), 4.63 (dd, J=9.1, 7.5 Hz, 1H, 
CHHOCO), 6.02 (s, 1H, EtOCHN); 13C NMR (75 MHz, DMSO): δ 14.6 (CH3), 54.8 
(CH), 60.4 (CH2), 67.7 (CH2), 69.8 (CH2), 107.1 (CH), 159.5 (C=O); MS (CI+) m/z (%): 
174 (MH+, 28), 146 (30), 128 (100), 118 (93), 100 (17); HRMS: [MH]+, found 
174.07685, C7H12O4N requires 174.07663. 
 
  Experimental 
 
170 
(S)-3-((1S,2S)-2-Benzylcyclopropyl)-4-isopropyloxazolidin-2-one 244 
 
N
H
H
O
O
Ph
 
 
A solution of (S)-3-diethoxymethyl-4-isopropyloxazolidin-2-one 201 (142 mg, 0.61 
mmol, 1.4 eq.) in diethyl ether (1.5 ml) was added dropwise via syringe pump (0.6 ml.h-
1) to a vigorously stirred refluxing mixture of zinc dust (400 mg, 6.12 mmol, 13.6 eq.), 
copper(I) chloride (40 mg, 0.4 mmol, 1.1 eq.), zinc chloride (1.0 M solution in diethyl 
ether, 0.6 ml, 0.6 mmol, 1.3 eq.), chlorotrimethylsilane (0.40 ml, 3.13 mmol, 7 eq.) and 
allylbenzene 153 (0.06 ml, 0.45 mmol, 1 eq.) in diethyl ether (6 ml). The reaction 
mixture was heated at reflux for 16 hours, then quenched by the addition of a saturated 
aqueous solution of sodium bicarbonate (5 ml), filtered and the solids washed with 
diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 × 7 ml) 
and the combined organic extracts washed with brine (7 ml), dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude product (244 and undefined minor 
diastereoisomers) was purified by column chromatography (diethyl ether:petroleum 
ether 1:1) to give the N-cyclopropyl oxazolidinone 244 as a beige oil (49 mg, 42%). 
 
 
[α] 20D  −42.1 (c 0.95, CHCl3); IR (trans, film): υmax 2962, 1755 (s), 1420 (s), 1227, 1051 
cm-1; 1H NMR (trans, 500 MHz, CDCl3) : δ 0.62 (d, J=7.0 Hz, 3H, CH3CCH3), 0.76 (d, 
J=7.0 Hz, 3H, CH3CCH3), 0.96-1.02 (m, 1H, CHHCHN), 1.17-1.24 (m, 2H, CHHCHN, 
CHCHN), 1.49-1.59 (m, 1H, CHMe2), 2.23 (dt, J=7.0, 3.5 Hz, 1H, CHN), 2.28-2.34 (m, 
1H, CHHPh), 2.86 (dd, J=14.5, 5.4 Hz, 1H, CHHPh), 3.32 (dt, J=8.9, 3.9 Hz, 1H, 
CHCH2O), 3.96 (dd, J=8.9, 3.9 Hz, 1H, CHHO), 4.03 (t, J=8.9 Hz, 1H, CHHO), 7.18-
7.24 (m, 3H, Ar-H), 7.27-7.32 (m, 2H, Ar-H); 13C NMR (trans, 125 MHz, CDCl3): δ 
14.1 (CH3), 15.6 (CH2), 17.6 (CH3), 20.5 (CH), 27.5 (CH), 29.6 (CH), 38.2 (CH2), 60.9 
(CH), 62.4 (CH2), 126.3 (CH-Ar), 128.3 (CH-Ar), 128.5 (CH-Ar), 140.7 (C-Ar), 158.0 
(C=O); MS (EI) m/z (%) : 260 (MH+, 100); HRMS: [MH]+, found 260.16466, 
C16H22O2N requires 260.16451. 
  Experimental 
 
171 
(4S)-3-((1S,2R)-1,1a,6,6a-Tetrahydrocyclopropa[a]inden-1-yl)-4-
isopropyloxazolidin-2-one 245 
 
 
 
A solution of (S)-3-diethoxymethyl-4-isopropyloxazolidin-2-one 201 (426 mg, 1.84 
mmol, 1.3 eq.) in diethyl ether (2.5 ml) was added dropwise via syringe pump (0.6 ml.h-
1) to a vigorously stirred refluxing mixture of zinc dust (1.20 g, 18.4 mmol, 13.4 eq.), 
copper(I) chloride (120 mg, 1.21 mmol, 0.9 eq.), zinc chloride (1.0 M solution in diethyl 
ether, 1.8 ml, 1.8 mmol, 1.3 eq.), chlorotrimethylsilane (1.20 ml, 9.39 mmol, 6.9 eq.) 
and indene 165 (157 mg, 1.37 mmol, 1 eq.) in diethyl ether (8 ml). The reaction mixture 
was heated at reflux for 16 hours, then quenched by the addition of a saturated aqueous 
solution of sodium bicarbonate (8 ml), filtered and the solids washed with diethyl ether 
(10 ml). The biphasic mixture was extracted with diethyl ether (2 × 10 ml) and the 
combined organic extracts washed with brine (10 ml), dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude product (245 and minor undetermined 
diastereoisomers) was purified by column chromatography (diethyl ether:petroleum 
ether 1:1) to give the N-cyclopropyl oxazolidinone 245 as a colourless solid (140 mg, 
40%). 
 
 
M.p. 87-89 °C (Et2O); [α] 20D  −13.5 (c 1.02, CHCl3); IR(cis, film): υmax 2964 (w), 1744 
(s), 1412, 1227, 1047 cm-1; 1H NMR (endo, 500 MHz, CDCl3):  δ 0.76 (d, J=7.0 Hz, 
3H, CH3CCH3), 0.89 (d, J=7.0 Hz, 3H, CH3CCH3), 2.00-2.07 (m, 1H, CHMe2), 2.34 
(qd, J=6.8, 1.2 Hz, 1H, CHCH2Ar), 2.41 (dt, J=8.6, 3.1 Hz, 1H, CHCH2O), 2.78 (td, 
J=6.8, 1.4 Hz, 1H, CHAr), 2.83 (t, J=6.8 Hz, 1H, CHN), 3.11 (br d, J=17.8 Hz, 1H, 
CHHAr), 3.19 (dd, J=17.8, 6.8 Hz, 1H, CHHAr) 3.48 (t, J=8.8 Hz, 1H, CHHO), 3.77 
(dd, J=8.8, 2.8 Hz, 1H, CHHO), 7.10-7.20 (m, 3H, Ar-H), 7.31 (d, J=6.6 Hz, 1H, Ar-
H); 13C NMR (endo, 125 MHz, CDCl3): δ 15.3 (CH3), 17.5 (CH3), 23.3 (CH), 29.0 
(CH), 29.2 (CH), 31.7 (CH2), 32.9 (CH), 58.8 (CH), 63.4 (CH2), 124.2 (CH-Ar), 124.5 
  Experimental 
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(CH-Ar), 126.0 (CH-Ar), 126.7 (CH-Ar), 139.4 (C-Ar), 144.2 (C-Ar), 159.2 (C=O). MS 
(CI+) m/z (%) : 258 (MH+, 100), 142 (34), 129 (47), 85 (68); HRMS: [MH]+, found 
258.14954, C16H20O2N requires 258.14886. Anal. Calcd for C16H19O2N.H2O: C, 69.79; 
H, 7.69; N, 5.09. Found: C, 69.89; H, 7.13; N, 4.78.  
 
  Experimental 
 
173 
(S)-3-((1S,2R)-2-tert-Butylcyclopropyl)-4-isopropyloxazolidin-2-one 246 
 
N
H
H
O
O
 
 
A solution of (S)-3-diethoxymethyl-4-isopropyloxazolidin-2-one 201 (448 mg, 1.94 
mmol, 1.25 eq.) in diethyl ether (2.5 ml) was added dropwise via syringe pump (0.6 
ml.h-1) to a vigorously stirred refluxing mixture of zinc dust (1.27 g, 19.4 mmol, 12.5 
eq.), copper(I) chloride (127mg, 1.3 mmol, 0.8 eq.), zinc chloride (1.0 M solution in 
diethyl ether, 1.6 ml, 1.6 mmol, 1 eq.), chlorotrimethylsilane (1.24 ml, 9.70 mmol, 6.25 
eq.) and 3,3-dimethylbut-1-ene 164 (0.20 ml, 1.55 mmol, 1 eq.) in diethyl ether (8 ml). 
The reaction mixture was heated at reflux for 16 hours, then quenched by the addition of 
a saturated aqueous solution of sodium bicarbonate (8 ml), filtered and the solids 
washed with diethyl ether (10 ml). The biphasic mixture was extracted with diethyl 
ether (2 × 10 ml) and the combined organic extracts washed with brine (10 ml), dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude product (246, 
227 and undefined minor diastereoisomers) was purified by column chromatography 
(diethyl ether:petroleum ether 3:2) to give a mixture of N-cyclopropyl oxazolidinone 
246 and (S)-4-isopropyl-N-formyloxazolidin-2-one 227 (92 mg, 246:227 2:1 as 
determined by 1H NMR spectrum) and the N-cyclopropyl oxazolidinone 246 as a 
colourless solid (31 mg). The yield of 246 (102 mg, 29%) was calculated from 1H NMR 
spectrum. 
 
 
M.p. 53-55 °C (petroleum ether); [α]19D  −49.3 (c 0.73, CHCl3); IR(trans, film): υmax 
2961, 1728 (s), 1423, 1236, 1055 (w) cm-1; 1H NMR (trans, 500 MHz, CDCl3): δ 0.86 
(br s, 9H, 3 × CCH3), 0.87-0.92 (m, 9H, 2 × CHCH3, CH2CHN, CHCHN), 2.20-2.25 
(m, 1H, CHMe2), 2.27 (dt, J=7.3, 3.6 Hz, 1H, CHN), 3.51-3.56 (m, 1H, CHCH2O), 
4.02-4.11 (m, 2H, CH2OCO); 13C NMR (trans, 125 MHz, CDCl3): δ 10.9 (CH2), 14.0 
(CH3), 17.7 (CH3), 26.6 (CH), 27.9 (CH), 28.4 (CH3), 29.0 (C), 30.7 (CH), 61.2 (CH), 
  Experimental 
 
174 
62.2 (CH2), 158.0 (C=O); MS (CI+) m/z (%) : 226 (MH+, 56), 170(100), 149 (46), 85 
(81); HRMS: [MH]+, found 226.17987, C13H24O2N requires 226.18070. 
 
  Experimental 
 
175 
((1S,2S)-2-((S)-4-isopropyl-2-oxooxazolidin-3-yl)cyclopropyl)methyl benzoate 247 
 
 
 
A solution of (S)-3-diethoxymethyl-4-isopropyloxazolidin-2-one 201 (448 mg, 1.94 
mmol, 1.25 eq.) in diethyl ether (2.5 ml) was added dropwise via syringe pump (0.6 
ml.h-1) to a vigorously stirred refluxing mixture of zinc dust (1.27 g, 19.4 mmol, 12.5 
eq), copper(I) chloride (127 mg mg, 1.30 mmol, 0.8 eq.), zinc chloride (1.0 M solution 
in diethyl ether, 1.94 ml, 1.94 mmol, 1.25 eq.), chlorotrimethylsilane (1.24 ml, 9.70 
mmol, 6.25 eq.) and alkene 243 (252 mg, 1.55 mmol, 1eq.) in diethyl ether (8 ml). The 
reaction mixture was heated at reflux for 16 hours, then quenched by the addition of a 
saturated aqueous solution of sodium bicarbonate (8 ml), filtered and the solids washed 
with diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 × 
10 ml) and the combined organic extracts washed with brine (10 ml), dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude product was purified twice 
by column chromatography (diethyl ether:petroleum ether 1:1 and petroleum:ethyl 
acetate 3:2) to give 247 as a colourless solid (60 mg, 13%). 
 
 
M.p. 58-59 °C (Et2O); [α] 20D  −9.6 (c 0.8, CHCl3); IR (trans, film): υmax 2885 (w), 1765 
(s), 1726 (s), 1425, 1281, 1117 (w), 1049 (w) cm-1; 1H NMR (trans, 500 MHz, CDCl3): 
δ 0.72 (d, J=7.0 Hz, 3H, CH3CCH3), 0.87 (d, J=7.0 Hz, 3H, CH3CCH3), 1.09-1.14 (m, 
1H, CHHCHN), 1.31-1.35 (m, 1H, CHHCHN), 1.46-1.54 (m, 1H, CHCHN), 2.18-2.25 
(m, 1H, CHMe2), 2.47 (dt, J=7.2, 3.6 Hz, 1H, CHN), 3.56 (dt, J=8.9, 3.9 Hz, 1H, 
CHCH2O), 3.88 (dd, J=11.7, 9.2 Hz, 1H, CHHOCOPh), 4.04 (dd, J=8.9, 3.9 Hz, 1H, 
CHHOCO), 4.12 (t, J=8.9 Hz, 1H, CHHOCO), 4.56 (dd, J=11.7, 5.5 Hz, 1H, 
CHHCOOPh), 7.42-7.48 (m, 2H, Ar-H), 7.55-7.60 (m, 1H, Ar-H), 8.02-8.05 (m, 2H, 
Ar-H); 13C NMR (trans, 125 MHz, CDCl3): δ 13.2 (CH2), 14.2 (CH3), 17.6 (CH3), 17.9 
(CH), 27.8 (CH), 29.3 (CH), 61.1 (CH), 62.5 (CH2), 66.5 (CH2), 128.4 (CH-Ar), 129.5 
(CH-Ar), 129.9 (C-Ar), 133.2 (CH-Ar), 157.8 (C=O), 166.4 (C=O); MS (EI) m/z (%) : 
  Experimental 
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326 (MNa+, 100), 301 (28), 247 (32), 212 (15), 182 (52), 166 (33); HRMS: [MNa]+, 
found 326.13712, C17H21O4NNa requires 326.13683. 
 
  Experimental 
 
177 
(S)-4-isopropyl-3-((1R,1aR,7bR)-1a,2,3,7b-tetrahydro-1H-
cyclopropa[a]naphthalen-1-yl)oxazolidin-2-one 249 and (S)-4-isopropyl-3-
((1S,1aR,7bR)-1a,2,3,7b-tetrahydro-1H-cyclopropa[a]naphthalen-1-yl)oxazolidin-
2-one 250 
 
 
 
A solution of (S)-3-diethoxymethyl-4-isopropyloxazolidin-2-one 201 (444 mg, 1.92 
mmol, 1.25 eq.) in diethyl ether (2.5 ml) was added dropwise via syringe pump (0.6 
ml.h-1) to a vigorously stirred refluxing mixture of zinc dust (1.26 g, 19.3 mmol, 12.5 
eq.), copper(I) chloride (126 mg, 1.30 mmol, 0.8 eq.), zinc chloride (1.0 M solution in 
diethyl ether, 1.92 ml, 1.92 mmol, 1.25 eq.), chlorotrimethylsilane (1.23 ml, 9.62 mmol, 
6.25 eq.) and alkene 166 (200 mg, 1.54 mmol, 1 eq.) in diethyl ether (8 ml). The 
reaction mixture was heated at reflux for 16 hours, then quenched by the addition of a 
saturated aqueous solution of sodium bicarbonate (8 ml), filtered and the solids washed 
with diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 × 
10 ml) and the combined organic extracts washed with brine (10 ml), dried (MgSO4), 
filtered and concentrated under reduced pressure. The crude product was purified by 
column chromatography (diethyl ether:petroleum ether 1:1) to give the N-cyclopropyl 
oxazolidinone 249 together with (S)-4-isopropyl-N-formyloxazolidin-2-one 227 (137 
mg, 249:227 1.1:1 as determined by 1H NMR spectrum) as a colourless solid, a mixture 
of diastereoisomers (24 mg) as an orange oil and the N-cyclopropyl oxazolidinone 250 
(57 mg) as a yellow-orange oil. The combined yield of diastereoisomers (169 mg, 40%) 
was calculated from 1H NMR spectrum.  
 
 
 
 
 
  Experimental 
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250: [α]17D  −50.6 (c 0.8, CHCl3); IR(film): υmax 2483 (w), 2928, 1747 (s), 1418 (s), 1229, 
1107, 1051 cm-1; 249: 1H NMR (endo, 500 MHz, CDCl3): δ 0.67 (d, J=7.0 Hz, 3H, 
CH3CCH3), 0.87 (d, J=7.0 Hz, 3H, CH3CCH3), 1.87-2.00 (m, 1H, CHCHN), 1.93-2.00 
(m, 1H, CHHCH2Ar), 2.00-2.08 (m, 1H, CHMe2), 2.26 (br t, J=8.2 Hz, 1H, CHN), 
2.42-2.52 (m, 2H, CHHAr, CHHCH2Ar), 2.58 (dt, J=8.7, 3.0 Hz, 1H, CHCH2O), 2.70-
2.76 (m, 1H, CHHAr), 2.81 (t, J=7.4 Hz, 1H, CHAr), 3.75 (t, J=8.8 Hz, 1H, CHHO), 
3.86 (dd, J=9.0, 2.9 Hz, 1H, CHHO), 7.08 (d, J=7.3 Hz, 1H, Ar-H), 7.13-7.17 (m, 2H, 
Ar-H), 7.29-7.30 (m, 1H, Ar-H); 249: 13C NMR (endo, 125 MHz, CDCl3): δ 15.0 
(CH3), 17.3 (CH2), 17.4 (CH3), 19.0 (CH), 19.5 (CH), 27.4 (CH2), 28.4 (CH), 35.4 
(CH), 58.7 (CH), 63.7 (CH2), 126.0 (CH-Ar), 126.4 (CH-Ar), 129.0 (CH-Ar), 130.0 
(CH-Ar), 132.6 (C-Ar), 135.6 (C-Ar), 159.2 (C=O); 250 : 1H NMR (exo, 500 MHz, 
CDCl3): δ 0.86 (d, J = 7.0 Hz, 3H, CH3CCH3), 0.90 (d, J=7.0 Hz, 3H, CH3CCH3), 1.77 
(tdd, J=13.4, 6.0, 3.0 Hz, 1H, CHHCH2Ar), 2.04-2.11 (m, 3H, CHAr, CHCHN, 
CHMe2), 2.42 (ddt, J=13.4, 6.6, 1.9 Hz, 1H, CHHCH2Ar), 2.46-2.57 (m, 1H, CHHAr), 
2.66 (t, J=3.0 Hz, 1H, CHN), 2.68-2.70 (m, 1H, CHHAr), 3.74 (dt, J=8.8, 3.9 Hz, 1H, 
CHCH2O), 4.08 (dd, J=9.0, 4.3 Hz, 1H, CHHO), 4.21 (t, J=8.9 Hz, 1H, CHHO), 7.02 
(d, J=7.3 Hz, 1H, Ar-H), 7.11-7.18 (m, 2H, Ar-H), 7.25-7.28 (m, 1H, Ar-H); 250: 13C 
NMR (exo, 125 MHz, CDCl3): δ 15.0 (CH3), 17.6 (CH3), 18.1 (CH2), 22.7 (CH), 24.3 
(CH), 26.0 (CH2), 28.4 (CH), 32.6 (CH), 60.8 (CH), 63.0 (CH2), 125.9 (CH-Ar), 126.2 
(CH-Ar), 128.5 (CH-Ar), 128.9 (CH-Ar), 134.2 (C-Ar), 134.9 (C-Ar), 157.8 (C=O); MS 
(CI+) m/z (%) : 272 (MH+, 100), 179 (37), 142 (40), 136 (24); HRMS: [MH]+, found 
272.16374, C17H22O2N requires 272.16505. 
 
  Experimental 
 
179 
(4S,5R)-3-((1S,2R)-2-tert-Butylcyclopropyl)-4-methyl-5-phenyloxazolidin-2-one 251 
 
N
H
H
O
O
Ph
 
 
A solution of (4S,5R)-3-diethoxymethyl-4-methyl-5-phenyloxazolidin-2-one 231 (386 
mg, 1.38 mmol, 1.25 eq.) in diethyl ether (2 ml) was added dropwise via syringe pump 
(0.6 ml.h-1) to a vigorously stirred refluxing mixture of zinc dust (903 mg, 13.8 mmol, 
12.5 eq.), copper(I) chloride (91.0 mg, 0.94 mmol; 0.9 eq.), zinc chloride (1.0 M 
solution in diethyl ether, 1.4 ml, 1.4 mmol, 1.3 eq.), chlorotrimethylsilane (0.88 ml, 6.93 
mmol, 6.3 eq.) and 3,3-dimethyl-but-1-ene 164 (93 mg, 1.1 mmol, 1 eq.) in diethyl ether 
(6 ml). The reaction mixture was heated at reflux for 16 hours, then quenched by the 
addition of a saturated aqueous solution of sodium bicarbonate solution (8 ml), filtered 
and the solids washed with diethyl ether (10 ml). The biphasic mixture was extracted 
with diethyl ether (2 × 10 ml) and the combined organic extracts washed with brine (10 
ml), dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
product was purified twice by column chromatography (diethyl ether:petroleum ether 
7:3) to give 251 together with (4S,5R)-4-methyl-5-phenyl-N-formyloxazolidin-2-one 
and (4S,5R)-3-(diethoxymethyl)-4-methyl-5-phenyloxazolidin-2-one 231 (127 mg, 
251:(4S,5R)-4-methyl-5-phenyl-N-formyloxazolidin-2-one:231 1.3:1:1.6 as 
determined by 1H NMR spectrum) and 251 together with (4S,5R)-4-methyl-5-phenyl-
N-formyloxazolidin-2-one (21 mg, 251:(4S,5R)-4-methyl-5-phenyl-N-
formyloxazolidin-2-one 1.6:1 as determined by 1H NMR spectrum). The yield of 251 
(59 mg, 20%) was calculated from 1H NMR spectrum.  
 
 
 
 
 
 
  Experimental 
 
180 
IR (film): υmax 2955, 1789, 1746, 1711, 1404, 1364, 1221, 1152, 1100 cm-1; 1H NMR 
(trans, 600 MHz, CDCl3): δ 0.86 (d, J=6.7 Hz, 3H, CHCH3), 0.91 (s, 9H, C(CH3)3), 
0.95-1.00 (m, 3H, CH2CHN, CHCHN), 2.39 (dt, J=6.8, 3.8 Hz, 1H, CHN), 3.91-3.94 
(m, 1H, CHCH3), 5.51 (d, J=7.5 Hz, 1H, CHO), 7.30-7.47 (m, 5H, Ar-H); 13C NMR 
(trans, 150 MHz, CDCl3): δ 11.2 (CH2), 14.2 (CH3), 26.7 (CH), 28.5 (CH3), 30.7 (CH), 
57.4 (CH), 78.3 (CH), 125.9 (C-Ar), 128.6 (C-Ar), 134.9 (C-Ar), 157.7 (C=O); MS 
(CI+) m/z (%) : 274 (MH+, 100), 230 (30), 178 (57), 134 (70); HRMS: [MH]+, found 
274.17962, C17H24O2N requires 274.18070. 
 
 
  Experimental 
 
181 
(S)-3-((1S,2S)-2-benzylcyclopropyl)-4-ethyloxazolidin-2-one 254 
 
N
H
H
O
O
Ph
 
 
A solution of (S)-3-diethoxymethyl-4-ethyloxazolidin-2-one 230 (345 mg, 1.59 mmol, 
1.25 eq.) in diethyl ether (2.5 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a 
vigorously stirred refluxing mixture of zinc dust (1.04 g, 15.9 mmol,12.5 eq.), copper(I) 
chloride (104mg, 1.10 mmol, 0.9 eq.), zinc chloride (1.0 M solution in diethyl ether, 1.6 
ml, 1.6 mmol, 1.25 eq.), chlorotrimethylsilane (1.0 ml, 7.8 mmol, 6.2 eq.) and 
allylbenzene 153 (150 mg, 1.27 mmol, 1 eq.) in diethyl ether (8 ml). The reaction 
mixture was heated at reflux for 16 hours, then quenched by the addition of a saturated 
aqueous solution of sodium bicarbonate (8 ml), filtered and the solids washed with 
diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 × 10 ml) 
and the combined organic extracts washed with brine (10 ml), dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude product (254 and minor 
undetermined diastereoisomers) was purified by column chromatography (diethyl 
ether:petroleum ether 1:1) to give 254 as a pale yellow oil (136 mg, 44%). 
 
 
[α] 22D  −34.2 (c 1.0, CHCl3); IR (trans, film): υmax 2966 (w), 1755 (s), 1420, 1219 (w), 
1061 cm-1; 1H NMR (trans, 500 MHz, CDCl3): δ 0.71 (t, J=7.5 Hz, 3H, CH3), 0.94-1.00 
(m, 1H, CHHCHN), 1.17-1.30 (m, 3H, CHHCHN, CHCHN, CHHCH3), 1.33-1.41 (m, 
1H, CHHCH3), 2.25 (dt, J=7.0, 3.5 Hz, 1H, CHN), 2.38 (dd, J=14.4, 7.8 Hz, 1H, 
CHHPh), 2.83 (dd, J=14.4, 6.0 Hz, 1H, CHHPh), 3.34-3.40 (m, 1H, CHCH2O), 3.88 
(dd, J=8.6, 4.6 Hz, 1H, CHHO), 4.17 (t, J=8.6 Hz, 1H, CHHO), 7.19-7.25 (m, 3H, Ar-
H), 7.28-7.33 (m, 2H, Ar-H); 13C NMR (trans, 125 MHz, CDCl3): δ 8.0 (CH3), 15.4 
(CH2), 20.4 (CH), 24.3 (CH2), 29.6 (CH), 38.2 (CH2), 57.6 (CH), 66.3 (CH2), 126.3 
(CH-Ar), 128.3 (CH-Ar), 128.5 (CH-Ar), 140.7 (C-Ar), 157.8 (C=O); MS (EI) m/z (%): 
268 (MNa+, 100), 246 (19); HRMS: [MNa]+, found 268.13074, C15H19O2Na requires 
268.13080. 
  Experimental 
 
182 
(S)-3-((1S,2R)-2-cyclohexylcyclopropyl)-4-isobutyloxazolidin-2-one 255 
 
N
H
H
O
O
 
 
A solution of (S)-3-diethoxymethyl-4-isobutyloxazolidin-2-one 228 (200 mg, 0.82 
mmol, 1.25 eq.) in diethyl ether (0.5 ml) was added dropwise via syringe pump (0.6 
ml.h-1) to a vigorously stirred mixture of zinc amalgam (534 mg, 8.20 mmol, 12.5 eq.), 
zinc chloride (1.0 M solution in diethyl ether, 0.82 ml, 0.82 mmol, 1.25 eq.), 
vinylcyclohexane 252 (0.09 ml, 0.66 mmol, 1 eq.), trimethylsilyl chloride (0.52 ml, 4.08 
mmol, 6.25 eq.), in diethyl ether (4 ml) at reflux. The resulting mixture was left to stir at 
reflux for 16 hours, cooled to room temperature and treated with a saturated aqueous 
solution of sodium bicarbonate (3 ml). The resulting mixture was stirred for 10 min, 
filtered and the separated zinc washed with ethyl acetate. The resulting aqueous phase 
was extracted with ethyl acetate (2 × 3 ml) and the combined organic extracts washed 
with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The 
residue was purified by column chromatography (diethyl ether:petroleum ether 1:1) to 
give the N-cyclopropyl oxazolidinone 255 as a pale yellow semi-solid (80 mg, 46%). 
 
 
[α]
D
20
 −74.0 (c 1.71, CHCl3); IR (film): νmax 2928, 1751, 1418, 1261, 1070, 1018 cm-1; 
1H NMR
  
(300 MHz, CDCl3): δ 0.55-0.64 (m, 1H, CHCHCHN), 0.70-0.77 (m, 2H, 
CHCHN, CHHCHN), 0.90 (d, J=6.6 Hz, 3H, CH3CCH3), 0.94 (d, J=6.6 Hz, 3H, 
CH3CCH3), 0.95-0.97 (m, 1H, CHHCHN), 1.00-1.05 (m, 1H, CHHCHCH2), 1.08-1.20 
(m, 4H, CHHCH2CH, CHHCH2CH, CHHCH2CH2, CHHCHCH2), 1.41 (ddd, J=13.3, 
11.0, 4.3 Hz, 1H, CHHCHMe2), 1.50-1.58 (m, 1H, CHMe2), 1.58-1.63 (m, 1H, 
CHHCH2CH2), 1.65-1.72 (m, 3H, CHHCH2CH, CHHCH2CH, CHHCHCH2), 1.76 (ddd, 
J=13.3, 9.8, 2.9 Hz, 1H, CHHCHMe2), 1.80-1.88 (m, 1H, CHHCHCH2), 2.15 (dt, 
J=6.5, 3.6 Hz, 1H, CHN), 3.56-3.66 (m, 1H, CHCH2O), 3.91 (dd, J=8.6, 4.6 Hz, 1H, 
CHHO), 4.19 (dd, J=8.7, 8.3 Hz, 1H, CHHO); 13C NMR (75 MHz, CDCl3): δ 13.7 
  Experimental 
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(CH2), 21.7 (CH3), 23.8 (CH3), 24.7 (CH), 25.5 (CH), 25.9 (CH2), 26.0 (CH2), 26.3 
(CH2), 28.8 (CH), 32.2 (CH2), 33.0 (CH2), 40.7 (CH), 40.8 (CH2), 55.5 (CH), 67.1 
(CH2), 157.7 (C=O); MS (EI) m/z (%): 266 (MH+, 26), 182 (100), 126 (31), 113 (23); 
HRMS: [M]+, found 265.20434, C16H27O2N requires 265.20417. 
 
  Experimental 
 
184 
(S)-3-((1S,2S)-2-(4-methoxybenzyl)cyclopropyl)-4-isobutyloxazolidin-2-one 256 
 
 
 
A solution of (S)-3-diethoxymethyl-4-isobutyloxazolidin-2-one 228 (328 mg, 1.34 
mmol, 1.02 eq.) in diethyl ether (5 ml) was added dropwise via syringe pump (0.6 ml.h-
1) to a vigorously stirred mixture of zinc amalgam (1.07 g, 16.4 mmol, 12.5 eq.), zinc 
chloride (1.0 M solution in diethyl ether, 1.63 ml, 1.63 mmol, 1.25 eq.), 4-allylanisole 
253 (193 mg, 1.31 mmol, 1 eq.), trimethylsilyl chloride (1.05 ml, 8.22 mmol, 6.28 eq.) 
in diethyl ether (10 ml) at reflux. The resulting mixture was heated at reflux for 16 
hours, cooled to room temperature and treated with a saturated aqueous solution of 
sodium bicarbonate (8 ml). The resulting mixture was stirred for 10 min, filtered and the 
separated zinc washed with ethyl acetate. The separated aqueous phase was extracted 
with ethyl acetate (2 × 7 ml) and the combined organic extracts washed with brine, 
dried (MgSO4), filtered and concentrated under reduced pressure. The residue was 
purified by column chromatography (diethyl ether:petroleum ether 1:1) to give 256 as a 
pale orange oil (173 mg, 44%). 
 
 
[α]
D
10
 +10.68 (c 1.46, CHCl3); IR (film): νmax 2959, 1755 (s), 1512, 1417 (w), 1248, 
1038 cm-1. 1H NMR (400 MHz, CDCl3): δ 0.67 (d, J=6.5 Hz, 3H, CH3CHCH3), 0.82 (d, 
J=6.5 Hz, 3H, CH3CHCH3), 0.90-1.00 (m, 2H, CH2CHN), 1.1-1.35 (m, 4H, CHMe2, 
CH2CHMe2, CHCHN), 2.29 (dt, J=6.9, 3.4 Hz, 1H, CHN), 2.31 (dd, J=14.4, 7.4 Hz, 
1H, CHHAr), 2.77 (dd, J=14.4, 5.8 Hz, 1H, CHHAr), 3.42-3.51 (m, 1H, CHCH2O), 
3.79 (s, 3H, OCH3), 3.89 (dd, J=8.5, 5.2 Hz, 1H, CHHO), 4.19 (t, J=8.5 Hz, 1H, 
CHHO), 6.85 (d, J=8.7 Hz, 2H, Ar-H), 7.13 (d, J=8.7 Hz, 2H, Ar-H); 13C NMR (75 
MHz, CDCl3): δ 15.4 (CH2), 21.0 (CH3), 21.2 (CH3), 23.6 (CH), 24.3 (CH), 29.2 (CH), 
37.6 (CH2), 40.5 (CH2), 55.2 (CH), 55.2 (CH3), 67.8 (CH2), 114.1 (CH-Ar), 129.4 (CH-
Ar), 132.7 (C-Ar), 157.7 (C-Ar), 158.1 (C=O); MS (CI+) m/z (%): 304 (MH+, 75), 182 
  Experimental 
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(22), 134 (58), 121 (100); HRMS: [MH]+, found 304.19154, C18H26O3N requires 
304.19126. 
 
  Experimental 
 
186 
(R)-3-((1R,2R)-2-(4-methoxybenzyl)cyclopropyl)-4-(hydroxymethyl)oxazolidin-2-
one 257 
 
N
H
H
O
O
OH
OMe
 
 
A solution of (7aR)-5-ethoxy-dihydro-1H-oxazolo[3,4-c]oxazol-3(5H)-one 232 (80.0 
mg, 0.46 mmol, 1.25 eq.) in diethyl ether (2 ml) was added dropwise via syringe pump 
(0.6 ml.h-1) to a vigorously stirred mixture of zinc (303 mg, 4.63 mmol, 12.5 eq.), zinc 
chloride (1.0 M solution in diethyl ether, 0.46 ml, 0.46 mmol, 1.25 eq.), 4-allylanisole 
253 (0.06 ml, 0.37 mmol, 1 eq.), trimethylsilyl chloride (0.30 ml, 2.36 mmol, 6.4 eq.) in 
diethyl ether (3 ml) at reflux. The resulting mixture was heated at reflux for 36 hours, 
cooled to room temperature and treated with a saturated aqueous solution of sodium 
bicarbonate (3 ml). The resulting mixture was stirred for 10 min, filtered and the 
separated zinc washed with ethyl acetate. The separated aqueous phase was extracted 
with ethyl acetate (2 × 5 ml) and the combined organic extracts washed with brine, 
dried (MgSO4), filtered and concentrated under reduced pressure. The residue was 
purified by column chromatography (ethyl acetate) to give the N-cyclopropyl 
oxazolidinone 257 as a yellow oil (24 mg, 23%).  
 
 
[α]
D
20
 +13.0 (c 0.55, CHCl3); IR (film): νmax 3408, 3057, 2924, 1736 (s), 1612 (w), 1512, 
1427, 1267, 1244, 1092 (w), 1036 cm-1; 1H NMR
  
(500 MHz, CDCl3): δ 0.91-0.96 (m, 
1H, CHHCHN), 1.12-1.17 (m, 1H, CHHCHN), 1.19-1.23 (m, 1H, CHCHN), 2.25 (dt, 
J=6.7, 3.5 Hz, 1H, CHN), 2.38 (dd, J=14.6, 7.6 Hz, 1H, CHHPh), 2.72 (dd, J=14.6, 6.4 
Hz, 1H, CHHPh), 3.33 (dd, J=10.7, 3.2 Hz, 1H, CHHOH). 3.36 (dd, J=10.7, 5.0 Hz, 
1H, CHHOH), 3.47-3.53 (m, 1H, CHCH2O), 3.79 (s, 3H, OCH3), 4.10 (dd, J=8.6, 4.2 
Hz, 1H, CHHOCO), 4.16 (t, J=8.6 Hz, 1H, CHHOCO), 6.84 (d, J=8.7 Hz, 2H, Ar-H), 
7.12 (d, J=8.7 Hz, 2H, Ar-H); 13C NMR (125 MHz, CDCl3): δ 15.4 (CH2), 20.4 (CH), 
29.6 (CH), 37.3 (CH2), 55.2 (CH3), 57.5 (CH), 60.7 (CH2), 64.6 (CH2), 113.9 (CH-Ar), 
  Experimental 
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129.3 (CH-Ar), 132.6 (C-Ar), 158.1 (C-Ar), 158.2 (C=O); MS (CI+) m/z (%): 278 
(MH+, 33), 161 (40), 134 (20), 121 (100); HRMS: [MH]+, found 278.13742, C15H20O4N 
requires 278.13868. 
 
  Experimental 
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(R)-3-((1R,2R)-2-benzylcyclopropyl)-4-(4-methoxyphenyl)oxazolidin-2-one 258 and  
(S)-3-((1R,2R)-2-benzylcyclopropyl)-4-(4-methoxyphenyl)oxazolidin-2-one 259 
 
 
 
A solution of (R)-3-diethoxymethyl-4-(4-methoxyphenyl)-oxazolidin-2-one (300 mg, 
1.01 mmol, 1.25 eq.) in diethyl ether (2 ml) was added dropwise via syringe pump (0.6 
ml.h-1) to a vigorously stirred refluxing mixture of zinc dust (664 mg, 10.2 mmol, 12.5 
eq.), copper(I) chloride (66.0 mg, 0.67 mmol, 0.8 eq.), zinc chloride (1.0 M solution in 
diethyl ether, 1.0 ml, 1.0 mmol, 1.25 eq.), chlorotrimethylsilane (0.65 ml, 5.12 mmol, 
6.4 eq.) and allylbenzene 153 (96 mg, 0.8 mmol, 1 eq.) in diethyl ether (4ml). The 
reaction mixture was heated at reflux for 16 hours, then quenched by the addition of a 
saturated aqueous solution of sodium bicarbonate (5 ml), filtered and the solids washed 
with diethyl ether (5 ml). The biphasic mixture was extracted with diethyl ether (2 × 3 
mL) and the combined organic extracts washed with brine (10 ml), dried (MgSO4), 
filtered and concentrated under reduced pressure. The residue was purified by column 
chromatography (diethyl ether:petroleum ether 1:1) to give an inseparable mixture of 
258 and 259 (70 mg, 29%, 258:259 5.9:1 as determined by 1H NMR spectrum) as a 
yellow oil.  
 
 
IR(mixture cyclopropanes, film): υmax 2917 (w), 1747 (s), 1612, 1513, 1407, 1245 (s), 
1176, 1028 (s) cm-1; 258: 1H NMR (500 MHz, CDCl3): δ 0.71-0.8 (m, 1H, CHHCHN), 
1.10-1.28 (m, 2H, CHHCHN, CHCH2Ph), 2.09 (dt, J=7.1, 3.5 Hz, 1H, CHN), 2.35 (dd, 
J=14.5, 6.2 Hz, 1H, CHHPh), 2.46 (dd, J=14.5, 6.4 Hz, 1H, CHHPh), 3.82 (s, 3H, 
OCH3), 4.02-4.08 (m, 1H, CHHO), 4.42-4.48 (m, 2H, CHHO, CHCH2O), 6.81-6.92 (m, 
2H, Ar-H), 6.96-7.08 (m, 3H, Ar-H), 7.09-7.30 (m, 4H, Ar-H); 258: 13C NMR (125 
MHz, CDCl3): δ 13.7 (CH2), 20.1 (CH), 30.6 (CH), 37.8 (CH2), 55.4 (CH3), 60.8 (CH), 
69.7 (CH2), 114.5 (C-Ar), 126.1 (C-Ar), 128.0 (C-Ar), 128.4 (C-Ar), 128.5 (C-Ar), 
130.6 (C-Ar), 140.2 (C-Ar), 157.9 (C-Ar), 159.9 (C=O); 259: 1H NMR (500 MHz, 
  Experimental 
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CDCl3): δ 0.50-0.56 (m, 1H, CHHCHN), 0.80-0.89 (m, 1H, CHHCHN), 1.31-1.39 (m, 
1H, CHCH2Ph), 2.14 (dt, J=7.1, 3.5 Hz, 1H, CHN), 2.23 (dd, J=14.7, 8.0 Hz, 1H, 
CHHPh), 2.78 (dd, J=14.7, 5.6 Hz, 1H, CHHPh), 3.81 (s, 3H, OCH3), 4.08-4.12 (m, 1H, 
CHHO), 4.50-4.60 (m, 2H, CHHO, CHCH2O), 6.81-6.92 (m, 2H, Ar-H), 6.96-7.08 (m, 
3H, Ar-H), 7.09-7.30 (m, 4H, Ar-H); 259: 13C NMR (125 MHz, CDCl3): δ 12.1 (CH2), 
20.6 (CH), 31.3 (CH), 38.0 (CH2), 55.4 (CH3), 61.0 (CH), 69.8 (CH2), 114.5 (C-Ar), 
126.1 (C-Ar), 128.1 (C-Ar), 128.2 (C-Ar), 128.3 (C-Ar), 130.7 (C-Ar), 140.3 (C-Ar), 
158.3 (C-Ar), 160.0 (C=O); MS (EI) m/z (%) : 323 (M+, 8), 232 (55), 134 (100), 121 
(50), 91 (25); HRMS: [M]+, found 323.15083, C20H21O3N requires 323.15083. 
 
  Experimental 
 
190 
Ethyl 2-((1S,2S,5R)-6-((S)-4-benzyl-2-oxooxazolidin-3-yl)bicyclo[3.1.0]hexan-2-
yl)acetate 260 
 
H
H
N
O
O
H
OEt
O
H
 
 
A solution of (S)-4-benzyl-3-diethoxymethyloxazolidin-2-one 200 (384 mg, 1.38 mmol, 
1.25 eq.) in diethyl ether (2 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a 
vigorously stirred refluxing mixture of zinc dust (900 mg, 13.8 mmol, 12.5 eq.), 
copper(I) chloride (90 mg, 0.9 mmol, 0.8 eq.), zinc chloride (1.0 M solution in diethyl 
ether, 1.4 ml, 1.4 mmol, 1.3 eq.), chlorotrimethylsilane (0.88 ml, 6.93 mmol, 6.25 eq.) 
and ethyl 2-(cyclopent-2-enyl)acetate 163 (170 mg, 1.10 mmol, 1 eq.) in diethyl ether (6 
ml). The reaction mixture was heated at reflux for 16 hours, then quenched by the 
addition of a saturated aqueous solution of sodium bicarbonate (8 ml), filtered and the 
solids washed with diethyl ether (10 ml). The biphasic mixture was extracted with 
diethyl ether (2 × 10 ml) and the combined organic extracts washed with brine (10 ml), 
dried (MgSO4), filtered and concentrated under reduced pressure. The residue was 
purified twice by column chromatography (diethyl ether:petroleum ether 7:3) to give the 
cyclopropane 260 (12 mg) as a pale yellow oil and a mixture of isomers containing the 
cyclopropane 260 as a pale yellow semi solid (85 mg). The total yield of isomers was 
26%. 
 
 
[α]
D
22
 +33.7 (c 0.35, CHCl3); IR(trans, film): υmax 2939 (w), 1754 (s), 1729 (s), 1414, 
1258, 1181, 1096, 1030 cm-1; 1H NMR (600 MHz, CDCl3): δ 0.73-0.81 (m, 1H, 
CHHCHCH2CO), 1.24 (t, J=7.1 Hz, 3H, CH3), 1.74 (ddd, J=6.6, 4.4, 1.9 Hz, 1H, 
CHCHCH2CO), 1.76-1.81 (m, 1H, CHHCHCH2CO), 1.86-1.93 (m, 2H, CHCHN, 
CHHCHCHN), 2.06-2.10 (m, 1H, CHHCHCHN), 2.34 (t, J=1.9 Hz, 1H, CHN), 2.37 
(dd, J=15.4, 9.1 Hz, 1H, CHHCO), 2.49 (dd, J=15.4, 5.7 Hz, 1H, CHHCO), 2.63-2.70 
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(m, 2H, CHHPh, CHCH2CO), 3.24 (dd, J=13.4, 4.0 Hz, 1H, CHHPh), 3.78-3.83 (m, 
1H, CHCH2O), 3.99-4.04 (m, 2H, CH2O), 4.11-4.22 (m, 2H, OCH2CH3), 7.20-7.23 (m, 
2H, Ar-H), 7.26-7.29 (m, 1H, Ar-H), 7.33-7.36 (m, 2H, Ar-H); 13C NMR (trans, 150 
MHz, CDCl3): δ 14.3 (CH3), 27.1 (CH2), 27.8 (CH2), 27.9 (CH), 28.5 (CH), 28.6 (CH), 
36.8 (CH), 38.0 (CH2), 38.1 (CH2), 57.6 (CH), 60.5 (CH2), 65.9 (CH2), 127.2 (CH-Ar), 
128.9 (CH-Ar), 129.3 (CH-Ar), 135.7 (C-Ar), 157.8 (C=O), 172.9 (C=O); MS (CI+) m/z 
(%) : 344 (MH+, 100), 298 (64); HRMS: [MH]+, found 344.18531, C20H25O4N requires 
344.18618. 
 
 
  Experimental 
 
192 
1-Benzyl-3-((1R,2R)-2-benzylcyclopropyl)imidazolidin-2-one 269 
 
N
H
H
N
O
Ph
 
 
Zinc chloride (1.0 M solution in diethyl ether, 2.8 ml, 2.8 mmol, 2 eq.) and 
chlorotrimethylsilane (2.50 ml, 19.6 mmol, 14 eq.) were added to a solution of 1-
benzylimidazolidin-2-one 268 (492 mg, 2.79 mmol, 2 eq.) in diethyl ether (5 ml) and 
the resulting mixture was heated at reflux for 10 min. The flask was removed from the 
oil bath, and zinc dust (1.37 g, 21.0 mmol, 15 eq.), copper(I) chloride (137 mg, 1.38 
mmol, 1 eq.) and allylbenzene 153 (165 mg, 1.39 mmol, 1 eq.) in diethyl ether (5 ml) 
were added to the mixture which was then heated at reflux. A solution of triethyl 
orthoformate (2.30 ml, 13.8 mmol, 10 eq.) was added dropwise via syringe pump (0.6 
ml.h-1) to the vigorously stirred refluxing mixture. After heating at reflux for 16 hours, 
the mixture was quenched by the addition of a saturated aqueous solution of sodium 
bicarbonate (10 ml), filtered and the solids washed with diethyl ether (10 ml). The 
biphasic mixture was extracted with diethyl ether (2 × 10 ml) and the combined organic 
extracts washed with brine (10 ml), dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue was purified by column chromatography twice (ethyl 
acetate:petroleum ether 6:4 then diethyl ether) to obtain 269 (90% pure by 1H NMR 
spectrum) as a yellow oil (84 mg, 20%). 
 
 
IR (film): νmax 3026, 2858, 1699 (s), 1489 (s), 1439 (s), 1356, 1263 (s) cm-1; 1H NMR 
(500 MHz, CDCl3): δ  0.70-0.75 (m, 1H, CHHCHN), 0.97 (ddd, J=9.2, 5.6, 3.6 Hz, 1H, 
CHHCHN), 1.25-1.33 (m, 1H, CHCHN), 2.32 (dt, J=6.9, 3.6 Hz, 1H, CHN), 2.53 (dd, 
J=14.7, 7.4 Hz, 1H, CHHPh), 2.79 (dd, J=14.7, 6.6 Hz, 1H, CHHPh), 3.10-3.15 (m, 2H, 
CH2N), 3.05-3.10 (m, 2H, CH2N), 4.31 (d, J=14.9 Hz, 1H, NCHHPh), 4.35 (d, J=14.9 
Hz, 1H, NCHHPh), 7.23-7.33 (m, 10H, H-Ar); 13C NMR (125 MHz, CDCl3): δ 12.8 
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(CH2), 19.9 (CH), 33.0 (CH), 38.1 (CH2), 42.2 (CH2), 43.6 (CH2), 48.2 (CH2), 126.0 
(CH-Ar), 127.3 (CH-Ar), 128.2 (CH-Ar), 128.3 (CH-Ar), 128.4 (CH-Ar), 128.5 (CH-
Ar), 129.0 (CH-Ar), 137.3 (C-Ar), 141.0 (C-Ar), 161.5 (C=O); MS (EI) m/z (%): 329 
(MNa+, 100); HRMS: [MNa]+, found 329.16199, C20H22ON2Na requires 329.16243. 
 
 
  Experimental 
 
194 
4-(But-3-enyl)azetidin-2-one 279 134 
 
 
 
A mixture of hexa-1,5-diene 278 (3.65 ml, 30.8mmol, 1 eq.) and chlorosulfonyl 
isocyanate (2.70 ml, 31.0 mmol., 1 eq.) was stirred at room temperature for 7 days. The 
reaction mixture was dissolved in dichloromethane (10 ml) and added to a solution of 
sodium sulphite (5.25 g, 41.7 mmol, 1.6 eq.) in water (25 ml) and dichloromethane 
(12.5 ml). The pH was maintained between 7 and 9 by the addition of a solution of 10% 
KOH (approx. 50 ml). Ethyl acetate (50 ml) was added, and the organic layer separated. 
The aqueous phase was extracted with ethyl acetate (3 × 25 ml) and the combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure. 
The residue was purified by column chromatography (diethyl ether) to give 279 as an 
orange oil (1.406 g, 37%). 
 
IR (film): νmax 3258, 3258, 2934, 1744 (s), 1641, 1416, 1188 cm-1; 1H NMR  (500 MHz, 
CDCl3): δ 1.70-1.77 (m, 2H, CH2CHNH), 2.09-2.15 (m, 2H, CH2CH=CH2), 2.29 (ddd, 
J=14.8, 2.4, 1.3 Hz, 1H, CHHCO), 3.06 (ddd, J=14.8, 5.0, 2.3 Hz, 1H, CHHCO), 3.61-
3.66 (m, 1H, CHNH), 5.00 (ddd, J=10.2, 3.0, 1.3 Hz, 1H, CHH=CH), 5.05 (dq, J=17.1, 
1.7 Hz, 1H, CHH=CH), 5.75-5.84 (m, 1H, CH=CH2), 5.99 (s, 1H, NH); 13C NMR (125 
MHz, CDCl3): δ  30.7 (CH2), 34.5 (CH2), 43.6 (CH2), 47.8 (CH), 115.6 (CH2=CH), 
137.2 (CH=CH2), 167.8 (C=O); MS (CI+) m/z (%) : 126 (MH+, 100), 83 (99); HRMS: 
[MH]+ found 126.09147, C7H11ON requires 126.09188. 
 
 
  Experimental 
 
195 
5-(But-3-enyl)pyrrolidin-2-one 280 171 
 
 
 
Magnesium (3.92 g, 161 mmol, 5.3 eq.) was stirred at room temperature for 1 hour 
before being suspended in tetrahydrofuran (40 ml). A solution of 1-bromobut-3-ene 
(12.3 ml, 121 mmol, 4 eq.) in tetrahydrofuran (40 ml) was added dropwise and the 
resulting mixture heated at reflux for 30 min. After cooling to room temperature, the 
mixture was added dropwise via cannula to a solution of succinimide (3.00 g, 30.3 
mmol, 1 eq.) in tetrahydrofuran (60 ml) at 0 °C. The mixture was allowed to warm to 
room temperature, stirred for 16 hours before sodium cyanoborohydride (1.90 g, 30.2 
mmol,1 eq.) and a few drops of methyl orange were added. The mixture was acidified 
with acetic acid until the indicator changed from yellow to pink and stirred for 1.5 
hours. Neutralisation (5% aq. NaOH) and removal of the solvents in vacuo gave a solid 
residue that was dissolved in a saturated aqueous solution of sodium bicarbonate (150 
ml) and extracted with ethyl acetate (3 × 100 ml). The combined extracts were washed 
with water (100 ml), brine (100 ml), dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue was purified by column chromatography (1% methanol in 
ethyl acetate) to give the title product 280 as a yellow oil (2.7g, 64%).  
 
 
IR (film): νmax 3219 (w), 2928 (w), 1692 (s), 1266 cm-1; 1H NMR  (400 MHz, CDCl3): δ 
1.55-1.66 (m, 2H, CH2CHNH), 1.70-1.77 (m, 1H, CHHCH2CO), 2.07-2.17 (m, 2H, 
CH2CH=CH2), 2.29-2.36 (m, 3H, CH2CO, CHHCH2CO), 3.60-3.70 (m, 1H, CHNH), 
5.0 (dd, J=10.6, 1.5 Hz, 1H, CHH=CH), 5.05 (dd, J=19.0, 1.5 Hz, 1H,  CHH=CH), 
5.71-5.87 (m, 1H, CH=CH2), 6.14 (s, 1H, NH); 13C NMR (75 MHz, CDCl3): δ  27.3 
(CH2), 30.0 (CH2), 30.4 (CH2), 35.8 (CH2), 54.0 (CH), 115.6 (CH2=CH), 137.5 
(CH=CH2), 179.5 (C=O); MS (CI+) m/z (%) : 140 (MH+, 100), 138 (93), 100 (10); 
HRMS: [MH]+ found 140.10761, C8H14ON requires 140.10753. 
 
  Experimental 
 
196 
5-(Pent-4-enyl)pyrrolidin-2-one 281 171 
 
 
 
Magnesium (1.72 g, 70.8 mmol, 7 eq.) was stirred at room temperature for 40 min 
before being suspended in tetrahydrofuran (60 ml). A solution of 5-bromopent-1-ene 
(6.00 ml, 50.6 mmol, 5 eq.) in tetrahydrofuran (20 ml) was added dropwise and the 
resulting mixture heated at reflux for 30 min. After cooling to room temperature, the 
mixture was added dropwise via cannula to a solution of succinimide (1.00 g, 10.0 
mmol, 1 eq.) in tetrahydrofuran (20 ml) at 0 °C. The mixture was allowed to warm to 
room temperature, stirred for 16 hours before sodium cyanoborohydride (634 mg, 10.09 
mmol, 1 eq.) and a few drops of methyl orange were added. The mixture was acidified 
with acetic acid until the indicator changed from yellow to pink and stirred for another 1 
hour. Neutralisation (5% aq. NaOH) and removal of the solvents in vacuo gave a solid 
residue that was dissolved in a saturated aqueous solution of sodium bicarbonate (80 
ml) and extracted with ethyl acetate (3 × 60 ml). The combined extracts were washed 
with water (60 ml), brine (60 ml), dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue was purified by column chromatography (1% methanol in 
ethyl acetate) to give 281 as a yellow oil (1.126 g, 73%).  
 
 
IR (film): νmax 3227, 2930, 1693 (s), 1460, 1265 cm-1; 1H NMR  (500 MHz, CDCl3): δ 
1.34-1.57 (m, 4H, CH2CHNH, CH2CH2CHNH), 1.65-1.73 (m, 1H, CHHCH2CO),  2.04-
2.10 (m, 2H, CH2CH=CH2), 2.20-2.27 (m, 1H, CHHCH2CO), 2.28-2.35 (m, 2H, 
CH2CO), 3.59-3.66 (m, 1H, CHNH), 4.90 (dd, J=10.2, 1.5 Hz, 1H, CHH=CH), 5.00 
(dd, J=17.1, 1.5 Hz, 1H, CHH=CH), 5.72-5.82 (m, 1H, CH=CH2), 6.55 (s, 1H, NH); 13C 
NMR (125 MHz, CDCl3): δ  25.1 (CH2), 27.2 (CH2), 30.2 (CH2), 33.5 (CH2), 36.1 
(CH2), 54.5 (CH), 115.0 (CH2=CH), 138.1 (CH=CH2), 178.4 (C=O); MS (EI) m/z (%) : 
154 (MH+, 7), 124 (9), 110 (73), 97 (34), 84 (100), 56 (24); HRMS: [M]+ found 
153.11421, C9H15ON requires 153.11482. 
  Experimental 
 
197 
5-(4-Methylpent-3-enyl)pyrrolidin-2-one 282 
 
 
 
Magnesium (894 mg, 36.8 mmol, 6 eq.) was stirred at room temperature for 16 hours 
before being suspended in tetrahydrofuran (30 ml). A solution of 5-bromo-2-methyl-
pent-2-ene (4.00 g, 24.5 mmol, 4 eq.) in tetrahydrofuran (5 ml) was added dropwise and 
the resulting mixture heated at reflux for 45 min. After cooling to room temperature, the 
mixture was added dropwise via cannula to a solution of succinimide (607 mg, 6.13 
mmol, 1 eq.) in tetrahydrofuran (15 ml) at 0 °C. The mixture was allowed to warm to 
room temperature, stirred for 16 hours before sodium cyanoborohydride (385 mg, 6.13 
mmol, 1 eq.) and a few drops of methyl orange were added. The mixture was acidified 
with acetic acid until the indicator changed from yellow to pink and stirred for another 
1.5 hours. Neutralisation (5% aq. NaOH) and removal of the solvents under vacuum 
gave a solid residue that was dissolved in a saturated aqueous solution of sodium 
bicarbonate (40 ml) and extracted with ethyl acetate (3 × 30 ml). The combined extracts 
were washed with water (60 ml), brine (60 ml), dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue was purified by column 
chromatography (5% methanol in ethyl acetate) to give the product 282 as a pale yellow 
oil (481 mg, 47%).  
 
 
IR (film): νmax 3209, 2918, 2359, 1693 (s), 1423, 1263 cm-1; 1H NMR  (400 MHz, 
CDCl3): δ 1.50-1.59 (m, 2H, CH2CHNH), 1.61 (s, 3H, CH3CCH3), 1.70 (s, 3H, 
CH3CCH3), 1.72 (m, 1H, CHHCH2CO), 2.00-2.07 (m, 2H, CH2CH=C),  2.20-2.38 (m, 
3H, CH2CO, CHHCH2CO), 3.60-3.68 (m, 1H, CHNH), 5.05-5.12 (m, 1H, CH=C), 5.76 
(s, 1H, NH); 13C NMR (125 MHz, CDCl3): δ 24.7 (CH3), 25.7 (CH2), 27.4 (CH2), 30.0 
(CH2), 36.7 (CH2), 54.1 (CH), 123.0 (CH=C), 136.9 (C=CH), 169.1 (C=O); MS (EI) 
m/z (%) : 167 (M+, 13), 124 (14), 110 (45), 97 (22), 24(100); HRMS: [M]+ found 
167.13060, C10H17ON requires 167.13101. 
  Experimental 
 
198 
6-(But-3-enyl)-piperidin-2-one 283171 
 
 
 
Magnesium (1.72 g, 70.8 mmol, 7 eq.) was stirred at room temperature for 1 hour 
before being suspended in diethyl ether (50 ml). A solution of 4-bromobut-1-ene (5.10 
ml, 50.2 mmol, 5 eq.) in diethyl ether (10 ml) was added dropwise and the resulting 
mixture heated at reflux for 45 min. After cooling to room temperature, the mixture was 
added dropwise via cannula to a solution of glutarimide (1.01 g, 10.1 mmol, 1 eq.) in 
tetrahydrofuran (30 ml) at 0 °C. The mixture was allowed to warm to room temperature, 
stirred for 16 hours before sodium cyanoborohydride (634 mg, 10.1 mmol, 1 eq.) and a 
few drops of methyl orange were added. The mixture was acidified with acetic acid 
until the indicator changed from yellow to pink and stirred for another 1 hour. 
Neutralisation (5% aq. NaOH) and removal of the solvents in vacuo gave a solid residue 
that was dissolved in a saturated aqueous solution of sodium bicarbonate (80 ml) and 
extracted with ethyl acetate (3 × 60 ml). The combined extracts were washed with water 
(60 ml), brine (60 ml), dried (MgSO4), filtered and concentrated under reduced pressure. 
The residue was purified by column chromatography (1% methanol in ethyl acetate) to 
give the product 283 as a yellow oil (1.01 g, 66%).  
 
 
IR (film): νmax 3209 (s), 2943 (s), 1663 (s), 1408, 1346 cm-1; 1H NMR  (500 MHz, 
CDCl3): δ 1.32-1.40 (m, 1H, CHHCH2CH2CO), 1.54-1.61 (m, 2H, CH2CH2CH=CH2), 
1.62-1.74 (m, 1H, CHHCH2CO), 1.84-1.95 (m, 2H, CHHCH2CH2CO, CHHCH2CO), 
2.08-2.15 (m, 2H, CH2CH=CH2), 2.27 (ddd, J=17.8, 10.6, 5.9 Hz, 1H, CHHCO), 2.34-
2.42 (m, 1H, CHHCO), 3.34-3.42 (m, 1H, CHN),  5.00 (d, J=10.1 Hz, 1H, CHH=CH), 
5.05 (dd, J=17.2, 1.3 Hz, 1H, CHH=CH), 5.73-5.83 (m, 1H, CH=CH2), 5.95 (s, 1H, 
NH); 13C NMR (125 MHz, CDCl3): δ  19.7 (CH2), 28.3 (CH2), 29.6 (CH2), 31.3 (CH2), 
35.9 (CH2), 52.6 (CH), 115.6 (CH2=CH), 137.2 (CH=CH2), 172.3 (C=O); MS (EI) m/z 
(%) : 154 (MH+, 100), 98 (8); HRMS: [MH]+ found 154.12271, C9H16ON requires 
154.12319. 
  Experimental 
 
199 
6-(Pent-4-enyl)piperidin-2-one 284171 
 
 
 
Magnesium (1.72 g, 70.8 mmol, 7 eq.) was stirred at room temperature for 1 hour 
before being suspended in diethyl ether (50 ml). A solution of 5-bromopent-1-ene (5.95 
ml, 50.2 mmol, 5 eq.) in diethyl ether (10 ml) was added dropwise and the resulting 
mixture heated at reflux for 45 min. After cooling to room temperature, the mixture was 
added dropwise via cannula to a solution of glutarimide (1.14 g, 10.1 mmol, 1 eq.) in 
tetrahydrofuran (30 ml) at 0 °C. The mixture was allowed to warm to room temperature, 
stirred for 16 hours before sodium cyanoborohydride (634 mg, 10.1 mmol, 1 eq.) and a 
few drops of methyl orange were added. The mixture was acidified with acetic acid 
until the indicator changed from yellow to pink and stirred for another 1.5 hours. 
Neutralisation (5% aq. NaOH, 60 ml) and removal of the solvents in vacuo gave a solid 
residue that was dissolved in a saturated aqueous solution of sodium bicarbonate (80 
ml) and extracted with ethyl acetate (3 × 60 ml). The combined extracts were washed 
with water (60 ml), brine (60 ml), dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue was purified by column chromatography (1% methanol in 
ethyl acetate) to give the product 284 as a pale yellow oil (1.0 g, 68%).  
 
 
IR (film): νmax 2937 (s), 2943 (s), 2360, 1666 (s), 1408, 1182 (w) cm-1; 1H NMR  (500 
MHz, CDCl3): δ 1.30-1.39 (m, 1H, CHHCH2CH2CO), 1.40-1.52 (m, 4H, 
CH2CH2CH=CH2, CH2CHNH), 1.62-1.73 (m, 1H, CHHCH2CO), 1.84-1.95 (m, 2H, 
CHHCH2CH2CO, CHHCH2CO), 2.04-2.1 (m, 2H, CH2CH=CH2), 2.27 (ddd, J=17.8, 
10.8, 6.0 Hz, 1H, CHHCO), 2.35-2.42 (m, 1H, CHHCO), 3.32-3.39 (m, 1H, CHN),  
4.95-5.04 (m, 2H, CH2=CH), 5.73-5.82 (m, 1H, CH=CH2), 5.85 (s, 1H, NH); 13C NMR 
(125 MHz, CDCl3): δ  19.8 (CH2), 24.5 (CH2), 28.4 (CH2), 31.3 (CH2), 33.4 (CH2), 36.3 
(CH2), 53.1 (CH), 115.1 (CH2=CH), 138.0 (CH=CH2), 172.3 (C=O); MS (EI) m/z (%) : 
168 (MH+, 100), 97 (5); HRMS: [MH]+ found 168.13890, C10H18ON requires 
168.13884. 
  Experimental 
 
200 
5-(But-3-enyl)-1-(diethoxymethyl)pyrrolidin-2-one 285 
 
N
O
O
O
 
 
A stirred mixture of the amide 280 (713 mg, 5.13 mmol, 1 eq.), aluminium chloride 
(103 mg, 0.77 mmol, 0.15 eq.) and triethyl orthoformate (25.0 ml, 150 mmol, 29 eq.) 
was heated at 155 °C for 18 hours. The reaction mixture was cooled to room 
temperature before being quenched with a saturated aqueous solution of sodium 
bicarbonate (15 ml). The separated aqueous phase was extracted with ethyl acetate (4 × 
20 ml) and the combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The triethyl orthoformate was 
evaporated under high vacuum and as analysis by NMR, the residue indicated only 50% 
conversion, the reaction was restarted by mixing the residue with AlCl3 (0.15 eq) in 
triethyl orthoformate (36 ml), and heating at 155 °C for 18 hours. After a similar work-
up, the residue was purified by column chromatography (diethyl ether:petroleum ether 
3:1) to give 285 as a yellow oil (565 mg, 46%). 
 
 
IR (film): νmax 2980, 1694 (s), 1418, 1262 (s), 1063 cm-1; 1H NMR  (400 MHz, DMSO): 
δ 1.13-1.24 (m, 6H, 2 × CH2CH3), 1.49-1.62 (m, 1H, CHHCHN), 1.65-1.75 (m, 1H, 
CHHCHN), 1.99-2.18 (m, 4H, CH2CH2CO, CH2CH=CH2), 2.26-2.36 (m, 1H, 
CHHCO), 2.39-2.47 (m, 1H, CHHCO), 3.43-3.67 (m, 4H, 2 × CH2CH3), 3.75-3.80 (m, 
1H, CHN), 5.10 (dd, J=10.2, 1.6 Hz, 1H, CHH=CH), 5.20 (dd, J=17.2, 1.6 Hz, 1H, 
CHH=CH), 5.82-5.92 (m, 2H, CH(OEt)2, CH=CH2); 13C NMR (75 MHz, DMSO): δ 
14.7 (CH3), 23.5 (CH2), 28.8 (CH2), 29.9 (CH2), 33.1 (CH2), 53.8 (CH), 61.6 (CH2), 
61.7 (CH2), 99.1 (CH), 114.7 (CH2=CH), 138.2 (CH=CH2), 174.8 (C=O); MS (CI+) m/z 
(%) : 264(MNa+, 34), 196 (100), 182 (19), 168 (55); HRMS: [MNa]+ found 264.15684, 
C13H23O3NNa requires 264.15701. 
  Experimental 
 
201 
1-(Diethoxymethyl)-5-(pent-4-enyl)pyrrolidin-2-one 286 
 
N
O
O
O
 
 
A mixture of the amide 281 (894 mg, 5.84 mmol, 1 eq.), aluminium chloride (116 mg, 
0.87 mmol, 0.15 eq.) and triethyl orthoformate (42.0 ml, 253 mmol, 43 eq.) was heated 
at 155 °C for 18 hours. The reaction mixture was cooled to room temperature before 
being quenched with a saturated aqueous solution of sodium bicarbonate (30 ml). The 
separated aqueous phase was extracted with ethyl acetate (3 × 40 ml) and the combined 
organic extracts were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The triethyl orthoformate was evaporated under high vacuum 
and the residue was purified by column chromatography (diethyl ether:petroleum ether 
3:1) to give 286 as a yellow-orange oil (875 mg, 59%). 
 
 
IR (film): νmax 3076, 2976, 1705 (s), 1414 (s), 1105 (s) cm-1; 1H NMR  (500 MHz, 
DMSO): δ 1.17 (t, J=7.0 Hz, 3H, OCH2CH3), 1.19 (t, J=7.0 Hz, 3H, OCH2CH3), 1.33-
1.50 (m, 3H, CH2CH2CH=CH2, CHHCHN), 1.64-1.72 (m, 1H, CHHCH2CO), 1.88-1.96 
(m, 1H, CHHCHN), 2.04-2.15 (m, 3H, CH2CH=CH2, CHHCH2CO), 2.29 (ddd, J=16.9, 
9.7, 5.8 Hz, 1H, CHHCO), 2.40 (ddd, J=16.9, 9.4, 7.3 Hz, 1H, CHHCO), 3.45-3.64 (m, 
4H, 2 × OCH2),  3.73-3.80 (m, 1H, CHN), 4.99-5.03 (m, 1H, CHH=CH), 5.04-5.10 (m, 
1H, CHH=CH), 5.80-5.90 (m, 2H, CH(OEt)2, CH=CH2); 13C NMR (125 MHz, DMSO): 
δ  14.7 (CH3), 14.8 (CH3), 23.7 (CH2), 30.1 (CH2), 33.2 (CH2), 33.7 (CH2), 54.2 (CH), 
61.6 (CH2), 61.8 (CH2), 100.0 (CH), 114.8 (CH2=CH), 138.6 (CH=CH2), 175.2 (C=O); 
MS (FAB) m/z (%) : 278 (MNa+, 100), 248 (7), 199 (7), 173 (19); HRMS: 
[MNa]+,found 278.17284, C14H25O3NNa requires 278.17320. 
  Experimental 
 
202 
1-(Diethoxymethyl)-5-(4-methylpent-3-enyl)pyrrolidin-2-one 287 
 
N
O
O
O
 
 
A mixture of the amide 282 (130 mg, 0.78 mmol, 1 eq.), aluminium chloride (20.0 mg, 
0.15 mmol, 0.19 eq.) and triethyl orthoformate (15 ml, 30 mmol, 38.5 eq.) was heated at 
155 °C for 18 hours. The reaction mixture was cooled to room temperature before being 
quenched with a saturated aqueous solution of sodium bicarbonate (15 ml). The 
separated aqueous phase was extracted with ethyl acetate (4 × 20 ml) and the combined 
organic extracts were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The triethyl orthoformate was evaporated under high vacuum 
and the residue was purified by column chromatography (diethyl ether:petroleum ether  
3:1) to give 287 as a yellow-orange oil (189 mg, 90%). 
 
 
IR (film): νmax 2976, 1705 (s), 1413, 1263 (s), 1062 cm-1; 1H NMR  (400 MHz, DMSO): 
δ 1.17 (t, J=7.1 Hz, 3H, OCH2CH3), 1.19 (t, J=7.1 Hz, 3H, OCH2CH3), 1.41-1.51 (m, 
1H, CHHCH2CO), 1.63 (s, 3H, CH3CCH3), 1.71 (s, 3H, CH3CCH3), 1.72-1.76 (m, 1H, 
CHHCH2CO), 1.88-2.06 (m, 3H, CHHCH=C, CH2CHN), 2.09-2.16 (m, 1H, 
CHHCH=C),  2.30 (ddd, J=16.9, 9.6, 6.0 Hz, 1H, CHHCO), 2.41 (ddd, J=16.9, 9.5, 7.1 
Hz, 1H, CHHCO), 3.42-3.65 (m, 4H, 2 × CH2CH3), 3.69-3.78 (m, 1H, CHN), 5.10-5.17 
(m, 1H, CH=C), 5.85 (s, 1H, CH(OEt)2); 13C NMR (125 MHz, DMSO): δ  14.7 (CH3), 
14.8 (CH3), 17.5 (CH3), 23.4 (CH2), 23.7 (CH2), 25.5 (CH3), 30.1 (CH2), 34.3 (CH2), 
54.1 (CH), 61.7 (CH2), 61.8 (CH2), 100.0 (CH), 123.9 (CH=C), 131.6 (C=CH), 175.2 
(C=O); MS (FAB) m/z (%) : 292 (MNa+, 100), 190 (12), 173 (27); HRMS: [MNa]+, 
found 292.18933, C15H27O3N requires 292.18885. 
  Experimental 
 
203 
6-(But-3-enyl)-1-(diethoxymethyl)piperidin-2-one 288 
 
N
O
O
O
 
 
A mixture of the amide 283 (965 mg, 6.30 mmol, 1 eq.), aluminium chloride (126 mg, 
0.95 mmol, 0.15 eq.) and triethyl orthoformate (46.0 ml, 276 mmol, 44 eq.) was heated 
at 155 °C for 18 hours. The reaction mixture was cooled to room temperature before 
being quenched with Et3N (0.2 ml) and a saturated aqueous solution of sodium 
bicarbonate (30 ml). The separated aqueous phase was extracted with ethyl acetate (3 × 
40 ml) and the combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The triethyl orthoformate was 
evaporated under high vacuum and the residue was purified by column chromatography 
(diethyl ether:petroleum ether 4:1) to give 288 as a pale yellow oil (671 mg, 42%). 
 
 
IR (film): νmax 2976 (s), 2359 (w), 1655 (s), 1439 (s), 1412, 1292, 1103 (s), 1063 cm-1; 
1H NMR
  
(500 MHz, DMSO): δ 1.17 (t, J=7.0 Hz, 3H, OCH2CH3), 1.18 (t, J=7.0 Hz, 
3H, OCH2CH3), 1.55-1.73 (m, 3H, CHHCH2CO, CHHCHN, CHHCH2CH2CO), 1.80-
1.95 (m, 3H, CHHCH2CO, CHHCHN, CHHCH2CH2CO), 1.96-2.06 (m, 1H, 
CHHCH=CH2), 2.07-2.16 (m, 1H, CHHCH=CH2), 2.26-2.43 (m, 2H, CH2CO), 3.40-
3.47 (m, 1H, OCHHCH3), 3.49-3.57 (m, 2H, OCHHCH3, OCHHCH3), 3.62-3.68 (m. 
1H, OCHHCH3), 3.68-3.74 (m, 1H, CHN), 5.01 (dd, J=10.4, 1.3 Hz, 1H, CHH=CH), 
5.10 (dq, J=17.2, 1.7 Hz, 1H, CHH=CH), 5.80-5.88 (m, 1H, CH=CH2), 6.25 (s, 1H, 
CH(OEt)2); 13C NMR (125 MHz, DMSO): δ  14.8 (CH3), 15.4 (CH2), 24.6 (CH2), 30.0 
(CH2), 30.8 (CH2), 32.0 (CH2), 48.7 (CH), 61.6 (CH2), 62.0 (CH2), 100.2 (CH), 114.9 
(CH2=CH), 138.2 (CH=CH2), 170.1 (C=O); MS (CI+) m/z (%) : 278 (MNa+, 100), 232 
(17), 176 (31); HRMS: [MNa]+, found 278.17413, C14H25O3NNa requires 278.17321. 
 
 
  Experimental 
 
204 
1-(Diethoxymethyl)-6-(pent-4-enyl)piperidin-2-one 289 
 
N
O
O
O
 
 
A mixture of the amide 284 (975 mg, 5.83 mmol, 1 eq.), aluminium chloride (117 mg, 
0.88 mmol, 0.15 eq.) and triethyl orthoformate (43.0 ml, 258 mmol, 44 eq.) was heated 
at 155 °C for 18 hours. The reaction mixture was cooled to room temperature before 
being quenched with Et3N (0.2 ml) and a saturated aqueous solution of sodium 
bicarbonate (30 ml). The separated aqueous phase was extracted with ethyl acetate (3 × 
40 ml) and the combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The triethyl orthoformate was 
evaporated under high vacuum and the residue was purified by column chromatography 
(diethyl ether:petroleum ether 4:1) to give 289 as a pale yellow oil (859 mg, 55%). 
 
 
IR (film): νmax 3481 (w), 3076, 2976 (s), 2930 (s), 2359, 1659 (s), 1439 (s), 1414 (s), 
1292 cm-1; 1H NMR
  
(500 MHz, DMSO): δ 1.17 (t, J=7.0 Hz, 3H, OCH2CH3), 1.18 (t, 
J=7.0 Hz, 3H, OCH2CH3), 1.28-1.36 (m, 1H, CHHCH2CH=CH2), 1.36-1.45 (m, 1H, 
CHHCH2CH=CH2), 1.51-1.63 (m, 2H, CHHCHN, CHHCH2CH2CO), 1.63-171 (m, 1H, 
CHHCH2CO), 1.77-1.90 (m, 3H, CHHCHN, CHHCH2CH2CO, CHHCH2CO), 2.03-
2.09 (m, 2H, CH2CH=CH2), 2.28-2.44 (m, 2H, CH2CO), 3.40-3.47 (m, 1H, 
OCHHCH3), 3.47-3.55 (m, 2H, OCHHCH3, OCHHCH3), 3.60-3.67 (m, 1H, 
OCHHCH3), 3.67-3.75 (m, 1H, CHN), 4.95-5.02 (m, 1H, CHH=CH), 5.07 (ddd, J=17.2, 
3.6, 1.7 Hz, 1H, CHH=CH), 5.81-5.90 (m, 1H, CH=CH2), 6.25 (s, 1H, CH(OEt)2); 13C 
NMR (125 MHz, DMSO): δ  14.8 (CH3), 15.4 (CH2), 24.8 (CH2), 25.0 (CH2), 30.8 
(CH2), 32.6 (CH2), 33.1 (CH2), 49.0 (CH), 61.5 (CH2), 61.9 (CH2), 100.1 (CH), 114.9 
(CH2=CH), 138.5 (CH=CH2), 170.0 (C=O); MS (EI) m/z (%) : 292 (MNa+, 100), 278 
(12), 246 (22), 190 (22); HRMS: [MNa]+, found 292.18912, C15H27O3NNa requires 
292.18886 
  Experimental 
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4-(But-3-enyl)-1-(diethoxymethyl)azetidin-2-one 290 
 
 
 
A mixture of the amide 279 (1.0g, 8.0 mmol, 1 eq.), aluminium chloride (168 mg, 1.26 
mmol, 0.16 eq.) and triethyl orthoformate (59.0 ml, 355 mmol, 44 eq.) was heated at 
155 °C for 36 hours. The reaction mixture was cooled to room temperature before being 
quenched with a saturated aqueous solution of sodium bicarbonate (30 ml). The 
separated aqueous phase was extracted with ethyl acetate (3 × 40 ml) and the combined 
organic extracts were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The triethyl orthoformate was evaporated under high vacuum 
and the residue was purified by column chromatography (diethyl ether:petroleum ether 
1:1) to give 290 as a pale yellow oil (580 mg, 32%). 
 
 
IR (film): νmax 2978, 1765 (s), 1641, 1381, 1063 cm-1; 1H NMR  (500 MHz, DMSO): δ 
1.18 (t, J=7.0 Hz, 3H, OCH2CH3), 1.19 (t, J=7.0 Hz, 3H, OCH2CH3), 1.57-1.66 (m, 1H, 
CHHCHN), 1.90-1.98 (m, 1H, CHHCHN), 2.08-2.20 (m, 2H, CH2CH=CH2), 2.63 (dd, 
J=14.9, 2.7 Hz, 1H, CHHCO), 3.04 (dd, J=14.9, 5.4 Hz, 1H, CHHCO), 3.52-3.65 (m, 
4H, 2 × OCH2CH3),  3.71-3.76 (m, 1H, CHN), 5.0-5.04 (m, 1H, CHH=CH), 5.09 (ddd, 
J=17.2, 3.6, 1.7 Hz, 1H, CHH=CH), 5.59 (s, 1H, CH(OEt)2), 5.83-5.92 (m, 1H, 
CH=CH2); 13C NMR (125 MHz, DMSO): δ 14.8 (CH3), 29.4 (CH2), 33.0 (CH2), 41.2 
(CH2), 49.0 (CH), 61.2 (CH2), 61.4 (CH2), 97.4 (CH), 115.0 (CH2=CH), 138.0 
(CH=CH2), 166.2 (C=O); MS (CI+) m/z (%) : 228 (MH+, 10), 182 (10), 155 (10), 103 
(10); HRMS: [MH]+ found 228.15915, C12H22O3N requires 228.15996. 
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Hexahydro-1H-cyclopropa[e]indolizin-6(7aH)-8-one 291 
 
 
 
A solution of 285 (142 mg, 0.59 mmol, 1 eq.) in diethyl ether (2 ml) was added 
dropwise via syringe pump (0.6 ml.h-1) to a vigorously stirred mixture of zinc amalgam 
(481 mg, 7.36 mmol, 12.5 eq.), zinc chloride (1.0 M solution in diethyl ether, 0.74 ml, 
0.74 mmol, 1.25 eq.), trimethylsilyl chloride (0.47 ml, 3.68 mmol, 6.2 eq.) in diethyl 
ether (2 ml) at reflux. The resulting mixture was stirred at reflux for 16 hours. A 
mixture of zinc dust (481 mg) and copper(I) chloride (50 mg) was then added and the 
resulting mixture was stirred for an additional 4 hours, cooled to room temperature, 
treated with Et3N (1 ml) and was stirred for a further 30 min. The resulting mixture was 
treated with a saturated aqueous solution of sodium bicarbonate (5 ml), stirred for a 
further 10 min, filtered and the separated zinc washed with ethyl acetate. The separated 
aqueous phase was extracted with ethyl acetate (2 × 7 ml) and the combined organic 
extracts were washed with brine, dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue was purified by column chromatography (2% methanol in 
ethyl acetate) to give 291 (36 mg, >95 % purity, 41%), contaminated by trace of 5-(but-
3-enyl)pyrrolidin-2-one 280 (<5%), as a colourless oil. 
 
 
IR (film): νmax 3441, 2928, 2858, 1666 (s), 1444, 1279, 1014 cm-1; 1H NMR  (500 MHz, 
CDCl3): δ 0.29 (ddd, J=6.7, 5.6, 3.3 Hz, 1H, H-1’), 0.90 (ddd, J=9.5, 6.8, 5.6 Hz, 1H, 
H-1), 1.02 (dddd, J=13.4, 12.8, 11.5, 4.5 Hz, 1H, H-3), 1.23 (dddd, J=9.5, 7.8, 6.7, 1.2 
Hz, 1H, H-1a), 1.45 (dddd, J=12.7, 10.9, 9.7, 8.8 Hz, 1H, H-4), 1.75 (dddd, J=13.4, 5.4, 
2.6, 2.2 Hz, 1H, H-3’), 1.82 (ddd, J=13.9, 12.8, 5.4 Hz, 1H, H-2), 1.99 (dddd, J=13.9, 
4.5, 2.2, 1.2 Hz, 1H, H-2’), 2.13 (dddd, J=12.7, 9.2, 6.7, 2.2 Hz, 1H, H-4’), 2.24 (ddd, 
J=16.8, 9.7, 2.2 Hz, 1H, H-5), 2.33 (ddd, J=16.8, 10.9, 9.2 Hz, 1H, H-5’), 2.92 (ddd, 
J=7.8, 6.8, 3.3 Hz, 1H, H-6b), 3.24 (dddd, J=11.5, 8.8, 6.7, 2.6 Hz, 1H, H-3a); 13C 
NMR (125 MHz, CDCl3): δ 10.1 (CH), 11.2 (CH2), 20.7 (CH2), 26.0 (CH), 26.3 (CH2), 
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29.2 (CH2), 30.2 (CH2), 55.2 (CH), 176.1 (C=O); MS (CI+) m/z (%) : 151 (M+, 100), 
136 (38), 96 (63); HRMS: [M]+, found 151.09928, C9H13ON requires 151.09971. 
 
  Experimental 
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Octahydro-7a-aza cyclopropa[e]azulen-7-one 292 
 
N
O
H4a
H1aH7b
H1' H1
H2
H2'
H3
H3'
H4
H4'
H5'
H5
H6'
H6
 
 
A solution of 286 (239 mg, 0.94 mmol, 1 eq.) in diethyl ether (2 ml) was added 
dropwise via syringe pump (0.6 ml.h-1) to a vigorously stirred mixture of zinc amalgam 
(765 mg, 11.5 mmol, 12.2 eq.), zinc chloride (1.0 M solution in diethyl ether, 1.17 ml, 
1.17 mmol, 1.25 eq.), trimethylsilyl chloride (0.75 ml, 5.87 mmol, 6.24 eq.) in diethyl 
ether (4 ml) at reflux. The resulting mixture was stirred at reflux for 16 hours, cooled to 
room temperature, treated with Et3N (1 ml) and stirred for a further 30 min. The 
resulting mixture was treated with a saturated aqueous solution of sodium bicarbonate 
(5 ml), stirred for a further 20 min, filtered and the separated zinc washed with ethyl 
acetate (5 ml). The aqueous phase was separated and extracted with ethyl acetate (3 × 
10 ml) and the combined organic extracts were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. The residue was purified by column 
chromatography (dichloromethane:acetone 4:1) to give a mixture of the cyclopropane 
292 and 1-methyl-5-(pent-4-enyl)pyrrolidin-2-one (73 mg, 292:1-methyl-5-(pent-4-
enyl)pyrrolidin-2-one 8:1 as determined by 1H NMR spectrum) as a yellow solid. The 
yield of 292 (65 mg, 41%) was calculated from 1H NMR spectrum. 
 
 
IR (film): νmax 2922, 1782 (s), 1425, 1325, 1242 cm-1; 1H NMR  (500 MHz, CDCl3): δ 
0.89 (ddd, J=6.1, 5.5, 4.1 Hz, 1H, H-1’), 0.91 (dddd, J=14.2, 11.3, 10.0, 1.4 Hz, 1H, H-
2), 0.94 (ddddd, J=10.8, 7.2, 6.5, 6.1 Hz, 1H, H-1a), 1.13 (ddd, J=8.0, 7.6, 5.5 Hz, 1H, 
H-1), 1.38 (dddd, J=13.4, 12.3, 11.4, 3.1 Hz, 1H, H-4) 1.49 (ddddd, J=14.0, 12.3, 11.3, 
2.6, 1.3 Hz, 1H, H-3), 1.56 (dddd, J=12.7, 10.1, 2.9, 2.8 Hz, 1H, H-5), 1.74 (ddddd, 
J=14.0, 6.5, 4.7, 3.1, 1.4 Hz, 1H, H-3’), 1.87 (dddd, J=13.4, 4.7, 2.9, 2.6 Hz, 1H, H-4’), 
2.21 (dddd, J=12.7, 9.9, 9.6, 8.5 Hz, 1H, H-5’), 2.24 (ddd, J=16.7, 9.9, 2.8 Hz, 1H, H-
6’), 2.29 (dddd, J=14.2, 6.5, 6.5, 1.3 Hz, 1H, H-2’), 2.34 (ddd, J=7.6, 7.2, 4.1 Hz, 1H, 
H-7b), 2.48 (ddd, J=16.7, 10.1, 9.6 Hz, 1H, H-6), 3.65 (dddd, J=11.4, 8.5, 2.9, 2.9 Hz, 
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1H, H-4a); 13C NMR (125 MHz, CDCl3): δ  15.7 (CH2), 17.3 (CH), 26.2 (CH2), 26.7 
(CH2), 29.3 (CH), 30.7 (CH2), 31.2 (CH2), 39.0 (CH2), 62.4 (CH), 177.2 (C=O); MS 
(EI) m/z (%) : 165 (M+, 55), 150 (86), 98 (97), 84 (100); HRMS: [M]+, found 
165.11536, C10H15ON requires 165.11482. 
 
 
  Experimental 
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Octahydro-7a-aza cyclopropa[α]naphtalene-7-ene 293 
 
 
 
A solution of the 288 (503 mg, 1.97 mmol, 1 eq.) in diethyl ether (2 ml) was added 
dropwise via syringe pump (0.6 ml.h-1) to a vigorously stirred mixture of zinc (1.61 g, 
24.6 mmol, 12.5 eq.), copper(I) chloride (161 mg, 1.63 mmol, 0.8 eq.), zinc chloride 
(1.0 M solution in diethyl ether, 2.46 ml, 2.46 mmol, 1.25 eq.), trimethylsilyl chloride 
(1.57 ml, 12.4 mmol, 6.3 eq.) in diethyl ether (5 ml) at reflux. The resulting mixture was 
stirred at reflux for 16 hours, cooled to room temperature, treated with Et3N (1.7ml) and 
stirred for a further 30 min. The resulting mixture was treated with a saturated aqueous 
solution of sodium bicarbonate (5 ml), stirred for a further 20 min. The solution was 
filtered and the separated zinc washed with ethyl acetate. The aqueous phase was 
separated, extracted with ethyl acetate (3 × 10 ml) and the combined organic extracts 
were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue was purified by column chromatography (methanol:acetone:ethyl 
acetate :1:1:50) to give a mixture of the cyclopropane 293 and 6-(but-3-enyl)-
piperidin-2-one 283 (300 mg, 293: 283 1:3.7 as determined by 1H NMR spectrum) as a 
yellow oil. The yield of 293 (68 mg, 21%) was calculated from 1NMR spectrum. 4 mg 
of 293 were also isolated (77% purity).  
 
 
IR (film): νmax 3458, 2939 (s), 1671 (s), 1447, 1416, 1344, 1180 cm-1; 1H NMR  (500 
MHz, CDCl3): δ 0.31 (ddd, J=6.9, 5.5, 3.7 Hz, 1H, H-1’), 0.94 (ddd, J=9.4, 7.3, 5.5 Hz, 
1H, H-1), 1.13 (dddd, J=13.8, 13.2, 11.4, 5.0 Hz, 1H, H-3), 1.26 (ddddd, J=9.4, 7.8, 6.9, 
5.4, 1.2 Hz, 1H, H-1a), 1.32 (dddd, J=13.4, 12.7, 10.7, 3.1 Hz, 1H, H-4), 1.60 (dddd, 
J=13.8, 5.4, 2.1, 2.0 Hz, 1H, H-3’), 1.66 (ddddd, J=13.0, 12.7, 12.2, 5.4, 2.6 Hz, 1H, H-
5), 1.80 (ddddd, J=13.0, 6.2, 4.6, 3.1, 2.6 Hz, 1H, H-5’), 1.84 (dddd, J=13.6, 13.2, 5.4, 
5.4 Hz, 1H, H-2), 1.85 (dddd, J=13.4, 4.6, 2.6, 2.1 Hz, 1H, H-4’), 1.96 (dddd, J=13.6, 
5.0, 2.1, 1.2 Hz, 1H, H-2’), 2.32 (ddd, J=17.7, 12.2, 6.2 Hz, 1H, H-6), 2.50 (dddd, 
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J=17.7, 5.4, 2.6, 2.1 Hz, 1H, H-6’), 3.08 (ddd, J=7.8, 7.3, 3.7 Hz, 1H, H-7b), 3.11 
(dddd, J=11.4, 10.7, 4.6, 2.0 Hz, 1H, H-3a); 13C NMR (125 MHz, CDCl3): δ  10.4 
(CH2), 11.4 (CH), 20.0 (CH2), 21.0 (CH2), 29.3 (CH2), 29.4 (CH), 30.7 (CH2), 33.7 
(CH2), 55.3 (CH), 171.2 (C=O); MS (CI+) m/z (%) : 166 (MH+, 100); HRMS: [MH]+ 
found 166.12275, C10H16ON requires 166.12319. 
 
  Experimental 
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Decahydro-8a-aza benzo[α]cyclopropa[c]cyclohepten-8-one 294 
 
 
 
A solution of 289 (400 mg, 1.49 mmol, 1 eq.) in diethyl ether (2 ml) was added 
dropwise via syringe pump (0.6 ml.h-1) to a vigorously stirred mixture of zinc (1.94 g, 
29.7 mmol, 20 eq.), copper(I) chloride (194 mg, 1.96 mmol, 1.3 eq. ), zinc chloride (1.0 
M solution in diethyl ether, 2.97 ml, 2.97 mmol, 2 eq.), trimethylsilyl chloride (1.88 ml, 
14.8 mmol, 10 eq.) in diethyl ether (5 ml) at reflux. The resulting mixture was stirred at 
reflux for 16 hours, cooled to room temperature, then treated with a saturated aqueous 
solution of sodium bicarbonate (5 ml), stirred for a further 20 min, filtered and the 
separated zinc washed with ethyl acetate (5 ml). The aqueous phase was separated, 
extracted with ethyl acetate (3 × 10 ml) and the combined organic extracts were washed 
with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The 
residue was purified by column chromatography (methanol:acetone:ethylacetate 
:1:1:50) to give the cyclopropane 294 together with 6-(pent-4-enyl)piperidin-2-one 
284 (70 mg, 294: 284 2.7:1 as determined by 1H NMR spectrum) and pure 294 (34 mg) 
as a yellow solid. The yield of 294 (70 mg, 26%) was calculated from 1H NMR 
spectrum. 
 
 
M.p. 54-58 °C (MeOH); IR (film): νmax 2930, 1663 (s), 1411, 1331, 1186 cm-1; 1H 
NMR
  
(500 MHz, CDCl3): δ 0.74 (ddd, J=6.1, 5.8, 4.3 Hz, 1H, H-1’), 0.97 (m, 1H, H-
1a), 1.01 (dddd, J=14.3, 11.5, 9.4, 1.9 Hz, 1H, H-2), 1.14 (ddd, J=8.3, 7.8, 6.1 Hz, 1H, 
H-1), 1.51 (m, 1H, H-3), 1.64 (m, 1H, H-4), 1.66 (m, 1H, H-5’), 1.69 (m, 1H, H-4’), 
1.70 (m, 1H, H-6’), 1.73 (m, 1H, H-3’), 1.80 (m, 1H, H-5), 1.85 (m, 1H, H-6), 2.22 (m, 
1H, H-2’), 2.35 (dd, J=18.3, 10.0, 1.1 Hz, 1H, H-7), 2.40 (m, 1H, H-8b), 2.41 (m, 1H, 
H-7’), 3.58 (m, 1H, H-4a); 13C NMR (125 MHz, CDCl3): δ 16.4 (CH2), 17.2 (CH2), 
17.5 (CH), 26.4 (CH2), 30.0 (CH2), 30.1 (CH2), 32.3 (CH2), 34.4 (CH), 36.5 (CH2), 60.5 
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(CH), 172.6 (C=O); MS (CI+) m/z (%) : 180 (MH+, 14), 168 (100), 98 (5); HRMS: 
[MH]+ found 180.13868, C11H18ON requires 180.13884. 
 
 
  Experimental 
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1-Azatricyclo[5.2.0.02,4]nonan-9-one 295 
 
 
 
A solution of 290 (256 mg, 1.13 mmol, 1 eq.) in diethyl ether (2.5 ml) was added 
dropwise via syringe pump (0.6 ml.h-1) to a vigorously stirred mixture of zinc (921 mg, 
14.1 mmol, 12.5 eq.), copper(I) chloride (92.0 mg, 0.83 mmol, 0.8 eq.), zinc chloride 
(1.0 M solution in diethyl ether, 1.4 ml, 1.4 mmol), trimethylsilyl chloride (0.9 ml, 7.0 
mmol, 6.2 eq.) in diethyl ether (7 ml) at reflux. The resulting mixture was stirred at 
reflux for 16 hours, then cooled to room temperature, treated with Et3N (1 ml) and 
stirred for a further 30 min. The resulting mixture was treated with a saturated aqueous 
solution of sodium bicarbonate (5 ml), stirred for a further 20 min, filtered and the 
separated zinc washed with ethyl acetate. The aqueous phase was separated, extracted 
with ethyl acetate (3 × 10 ml) and the combined organic extracts were washed with 
brine, dried (MgSO4), filtered and concentrated under reduced pressure. The residue 
was purified by column chromatography (diethyl ether:petroleum ether 1:1) to give the 
cyclopropane 295 as a yellow oil (32 mg, > 90% purity, 21%) contaminated by trace of 
4-(but-3-enyl)azetidin-2-one 279(<10 %). 
 
 
IR (film): νmax 2932, 1747 (s), 1394, 1192 cm-1; 1H NMR  (500 MHz, CDCl3): δ 0.52 
(ddd, J=6.7, 5.8, 3.1 Hz, 1H, H-3’), 0.85 (ddd, J=9.3, 6.2, 5.8 Hz, 1H, H-3), 1.07 (dddd, 
J=13.2, 12.9, 11.1, 4.6 Hz, 1H, H-6), 1.12 (ddddd, J=9.3, 7.9, 6.7, 4.8, 1.7 Hz, 1H, H-4), 
1.87 (dddd, J=14.1, 12.9, 4.8, 4.7 Hz, 1H, H-5), 1.90 (dddd, J=12.3, 4.7, 3.3, 3.2 Hz, 
1H, H-6’), 2.03 (dddd, J=14.1, 4.6, 3.2, 1.7 Hz, 1H, H-5’), 2.34 (dd, J=14.8, 1.8 Hz, 1H, 
H-8’), 2.64 (dddd, J=7.9, 6.2, 3.1, 1.7 Hz, 1H, H-2), 3.00 (ddd, J=14.8, 4.6, 1.7 Hz, 1H, 
H-8), 3.10 (dddd, J=11.1, 4.6, 3.3, 1.8 Hz, 1H, H-7); 13C NMR (125 MHz, CDCl3): δ  
9.4 (CH), 12.3 (CH2), 19.7 (CH2), 24.0 (CH), 26.4 (CH2), 43.5 (CH2), 45.7 (CH), 170.9 
(C=O); MS (CI+) m/z (%) : 138 (MH+, 100), 126 (13), 112 (8), 89 (94); HRMS: [MH]+ 
found 138.09216, C8H12ON requires 138.09188. 
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6-Isopropyl-1,7,8,8a-tetrahydro-2H-indolizin-3-one 296 
 
 
 
A solution of 287 (150 mg, 0.56 mmol, 1 eq.) in diethyl ether (2 ml) was added 
dropwise via syringe pump (0.6 ml.h-1) to a vigorously stirred mixture of zinc amalgam 
(455 mg, 6.96 mmol, 12.5 eq.), zinc chloride (1.0 M solution in diethyl ether, 0.7 ml, 
0.7 mmol, 1.25 eq.), trimethylsilyl chloride (0.45 ml, 3.52mmol, 6.3 eq.) in diethyl ether 
(5 ml) at reflux. The resulting mixture was stirred at reflux for 16 hours, cooled to room 
temperature, treated with Et3N (0.6 ml) and was stirred for a further 30 min. The 
resulting mixture was treated with a saturated aqueous solution of sodium bicarbonate 
(5 ml), stirred for a further 20 min, filtered and the separated zinc washed with ethyl 
acetate (5 ml). The separated aqueous phase was extracted with ethyl acetate (3 × 10 
ml) and the combined organic extracts were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The residue was purified by column 
chromatography to give 296 as a yellow oil (< 5%). 
 
 
IR (film): νmax 2928, 1693 (s), 1410, 1315 cm-1; 1H NMR  (400 MHz, CDCl3): δ 1.03 (d, 
J=6.5 Hz, 3H, CH3CCH3), 1.04 (d, J=6.5 Hz, 3H, CH3CCH3), 1.46-1.52 (m, 1H, 
CHHCHN), 1.57-1.66 (m, 2H, CHHCH2CO, CHHCHN), 2.08-2.11 (m, 1H, 
CHHC=CH), 2.16-2.29 (m, 3H, CHMe2, CHHC=CH, CHHCH2CO), 2.37-2.51 (m, 2H, 
CH2CO), 3.59-3.66 (m, 1H, CHN),  6.64 (s, 1H, NCH=C); 13C NMR (125 MHz, 
CDCl3): δ  21.0 (CH3), 21.6 (CH3), 24.2 (CH2), 26.4 (CH2), 29.0 (CH2), 31.5 (CH2), 
32.7 (CH), 55.8 (CH), 114.9 (CH=C), 127.9 (C=CH), 170.8 (C=O); MS (EI) m/z (%) : 
178 (M-H, 77), 164 (100), 138 (79), 127(25); HRMS: [M]+, found 179.13122, 
C11H17ON requires 179.13047. 
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(S)-2-((1S,2S)-2-(4-Methoxybenzyl)cyclopropylamino)-4-methylpentan-1-ol 304 
 
 
 
Lithium hydroxide monohydrate (789 mg, 18.8 mmol, 33 eq.) was added in one portion 
to a suspension of the N-cyclopropyl oxazolidinone 256 (190 mg, 0.57 mmol, 1 eq.) in a 
mixture of ethanol (8.55 ml) and water (3.8 ml). The reaction was heated at 84 °C for 36 
hours and then allowed to cool to room temperature. The solution was concentrated to 
ca. one third of its volume and an aqueous saturated solution of ammonium chloride (6 
ml) was added. The separated aqueous phase was extracted with dichloromethane (3 × 5 
ml) and the combined organic extracts dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue was purified by column chromatography (2% 
triethylamine in ethyl acetate) to give the aminocyclopropane 304 as a yellow solid (106 
mg, 67%); 
 
 
M.p. 56-59 °C (EtOAc); [α]
D
20
 +31.3 (c 1.01, CHCl3); IR (film): νmax 3364 (w), 2959, 
1612 (w), 1512, 1468 (w), 1265, 1246, 1177 (w), 1036 cm-1; 1H NMR
  
(400 MHz, 
CDCl3): δ 0.41-0.48 (m, 1H, CHHCHN), 0.62 (ddd, J=8.8, 4.9, 3.8 Hz, 1H, CHHCHN), 
0.85 (d, J = 6.6 Hz, 3H, CH3CHCH3), 0.87 (d, J=6.6 Hz, 3H, CH3CHCH3), 0.92-1.00 
(m, 1H, CHCHN), 1.16 (dt, J=13.9, 7.0 Hz, 1H, CHHCHMe2), 1.36 (ddd, J=13.9, 7.6, 
6.6 Hz, 1H, CHHCHMe2), 153-1.63 (m, 1H, CHMe2), 2.04 (dt, J=6.7, 3.3 Hz, 1H, 
CHN), 2.10 (br s, 2H, NH, OH), 2.41-2.53 (m, 2H, CH2Ar), 2.62-2.70 (m, 1H, 
CHCH2OH), 3.11 (dd, J=10.5, 6.7 Hz, 1H, CHHOH), 3.50 (dd, J=10.5, 4.2 Hz, 1H, 
CHHOH), 3.79 (s, 3H, OCH3), 6.82 (d, J=8.7 Hz, 2H, Ar-H), 7.12 (d, J=8.7 Hz, 2H, Ar-
H); 13C NMR (75 MHz, CDCl3): δ 13.7 (CH2), 22.6 (CH3), 23.0 (CH3), 22.4 (CH), 24.9 
(CH), 35.2 (CH), 37.5 (CH2), 41.5 (CH2), 55.3 (CH3), 57.4 (CH), 63.2 (CH2), 113.8 
(CH-Ar), 129.3 (CH-Ar), 133.5 (C-Ar), 157.9 (C-Ar), MS (CI+) m/z (%): 278 (MH+, 
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100), 260 (18), 220 (12), 170 (14), 156 (90); HRMS: [MH]+, found 278.21125, 
C17H28O2N requires 278.21199. 
 
  Experimental 
 
218 
N-tert-Butoxycarbonyl-(S)-2-((1S,2S)-2-(4-methoxybenzyl)cyclopropylamino)-4-
methylpentan-1-ol 305 
 
 
 
A solution of di-tert-butyl dicarbonate (96.0 mg, 0.44 mmol, 1.2 eq.) in 
dichloromethane (2.5 ml) was added to a solution of aminocyclopropane 304 (104 mg, 
0.37 mmol, 1 eq.) in dichloromethane (2.5 ml). The resulting mixture was stirred at 
reflux for 24 hours. The cooled reaction mixture was treated with a saturated aqueous 
solution of sodium bicarbonate (3 ml) and the separated aqueous phase was extracted 
with dichloromethane (2 × 4 ml). The combined organic extracts were washed with 
water (8 ml), brine (8 ml), dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue was purified by column chromatography (petroleum ether:ethyl 
acetate 3:1) to give the boc-protected aminocyclopropane 305 as a pale yellow oil (111 
mg, 80%). 
 
 
[α]
D
27
 −48.11 (c 0.846, CHCl3); IR (film): νmax 3019, 1685 (w), 1653 (w), 1513, 1216 (s) 
cm-1; 1H NMR (500 MHz, CDCl3): δ 0.68-0.74 (m, 1H, CHHCHN), 0.85 (d, J=6.6 Hz, 
3H, CH3CCH3), 0.87 (d, J=6.6 Hz, 3H, CH3CCH3), 0.86-0.89 (m, 1H, CHHCHN), 1.19-
1.28 (m, 1H, CHCHN), 1.47 (s, 9H, 3 × CCH3), 1.48-1.55 (m, 2H, CHMe2, 
CHHCHMe2), 1.61 (ddd, J=13.8, 8.7, 5.8 Hz, 1H, CHHCHMe2), 2.30 (dt, J=6.9, 3.4 
Hz, 1H, CHN), 2.35 (dd, J=14.5, 8.2 Hz, 1H, CHHAr), 2.81 (dd, J=14.5, 5.6 Hz, 1H, 
CHHAr), 3.45-3.58 (m, 2H, CHCH2OH, CHHOH), 3.59-3.67 (m, 1H, CHHOH), 3.78 
(s, 3H, OCH3), 6.83 (d, J=8.7 Hz, 2H, Ar-H), 7.11 (d, J=8.7 Hz, 2H, Ar-H); 13C NMR 
(125 MHz, CDCl3): δ 16.2 (CH2), 22.6 (CH3), 22.9 (CH3), 25.0 (CH), 28.3 (CH), 28.5 
(CH3), 36.4 (CH), 37.0 (CH2), 37.1 (CH2), 55.2 (CH3), 60.1 (CH), 65.6 (CH2), 80.0 (C), 
113.8 (CH-Ar), 129.7 (CH-Ar), 132.6 (C-Ar), 157.9 (C-Ar), 158.0 (C=O); MS (CI+) m/z 
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(%): 378 (MH+, 97), 322 (99), 306 (65), 278 (100), 156 (54), 121 (27); HRMS: [MH]+, 
found 378.26454, C22H36O4N requires 378.26442. 
 
  Experimental 
 
220 
N-tert-Butoxycarbonyl-((S)-2-((1R,2S)-2-(4-methoxybenzyl)cyclopropylamino)-4-
methylpentanoic acid 306 
 
 
 
Sodium (meta)periodate (250 mg, 1.17 mmol, 4 eq.) was added portionwise to a mixture 
of aminocyclopropane 305 (110 mg, 0.29 mmol, 1 eq.), ruthenium (IV) oxide hydrate 
(2.2 mol%) in carbon tetrachloride (0.58 ml), acetonitrile (0.58 ml) and water (0.87 ml). 
The resulting mixture was stirred vigorously for 45 min at room temperature. Then 
dichloromethane (3 ml) was added, and the phases separated. The aqueous phase was 
extracted with dichloromethane (3 × 3 ml) and the combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting residue was 
diluted with diethyl ether (6 ml), filtered through a celite pad and concentrated under 
reduced pressure. The crude product was purified by column chromatography (acetic 
acid:ethanol:dichloromethane 1:19:380) to give the cyclopropyl amino acid 306 as a 
pale brown oil (74 mg, 65%). 
 
 
[α]
D
27
 –38.08 (c 0.73, CHCl3); IR (film): νmax 3018, 1691 (w), 1512 (w),1215 (s) cm-1; 
1H NMR
 
(500 MHz, CDCl3): δ 0.69-0.75 (m, 1H, CHHCHN), 0.85 (d, J=6.6 Hz, 3H, 
CH3CHCH3), 0.89 (d, J=6.6 Hz, 3H, CH3CHCH3), 0.93-1.00 (m, 1H, CHHCHN), 1.33-
1.41 (m, 1H, CHCHN), 1.47 (s, 9H, 3 × CH3), 1.51-1.59 (m, 2H, CHMe2, 
CHHCHMe2), 1.71-1.81 (m, 1H, CHHCHMe2), 2.33 (dd, J=14.6, 8.5 Hz, 1H, CHHAr), 
2.36-2.41 (m, 1H, CHN), 2.86 (dd, J=14.6, 5.3 Hz, 1H, CHHAr), 3.79 (s, 3H, OCH3), 
3.92-4.09 (m, 1H, CHCO2H) 6.83 (d, J=8.5 Hz, 2H, Ar-H), 7.12 (d, J=8.5 Hz, 2H, Ar-
H); 13C NMR (125 MHz, CDCl3): δ 15.6 (CH2), 21.8 (CH3), 22.9 (CH3), 25.1 (CH), 
28.4 (CH3), 29.7 (CH), 36.9 (CH2), 36.9 (CH2), 38.0 (CH), 55.2 (CH3), 61.2 (CH), 81.1 
(C), 113.8 (CH-Ar), 129.4 (CH-Ar), 132.9 (C-Ar), 158.0 (C-Ar), 179.6 (C=O); MS 
  Experimental 
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(CI+) m/z (%): 392 (MH+, 5), 336 (32), 292 (72), 170 (52), 121 (37); HRMS: [MH]+, 
found 392.24436, C22H34O5N requires 392.24369. 
 
 
  Experimental 
 
222 
Ethyl 2-(hydroxymethyl)acrylate 315146 
 
 
 
A saturated aqueous solution of potassium carbonate (5.39 g, 39.0 mmol, 1.7 eq.) was 
added dropwise over 1 hour to a mixture of triethylphosphonoacetate 314 (4.44 ml, 22.4 
mmol, 1 eq.) and an aqueous solution of formaldehyde (37%, 7.24 ml, 89.2 mmol, 4 
eq.). At the end of the addition the temperature reached 35 °C and stirring was 
continued for 1 hour. A saturated aqueous solution of ammonium chloride (20 ml) was 
then added and the mixture was extracted with diethyl ether (3 × 15 ml). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure. 
The residue was purified by column chromatography (diethyl ether:petroleum ether 7:3) 
to give 315 as a pale yellow oil (2.04 g, 70%) 
 
 
IR (film): νmax 3437, 2983, 1718 (s), 1468, 1446, 1386, 1235 (s), 1149 (s), 1020 (s) cm-
1; 1H NMR
 
(500 MHz, CDCl3): δ  1.30 (t, J=7.1 Hz, 3H, CH3), 2.21 (br s, 1H, OH), 4.22 
(q, J=7.1 Hz, 2H, OCH2CH3), 4.30-4.31 (m, 2H, CH2OH), 5.80-5.81 (m, 1H, CHH=C), 
6.23-6.24 (m, 1H, CHH=C); 13C NMR (125 MHz, CDCl3): δ 14.1 (CH3), 60.9 (CH2), 
62.6 (CH2), 125.6 (CH2), 139.5 (C), 166.3 (C=O); MS (CI+) m/z (%): 131 (MH+, 100), 
133 (12), 85 (40); HRMS: [MH]+, found 131.07043, C6H11O3 requires 131.07082. 
 
 
  Experimental 
 
223 
2-Methylenepropane-1,3-diol 316172 
 
 
 
A solution of DIBAL-H (1.0 M in hexane, 33 ml, 33 mmol, 4.3 eq.) was added 
dropwise to a solution of 315 (1.0 g, 7.7 mmol, 1 eq.) in diethyl ether (30 ml) at –78 °C. 
The resulting mixture was allowed to warm to room temperature and was stirred for a 
further 1.5 hours. After cooling to 0 °C, the mixture was quenched by the addition of 
acetone (15 ml) followed by powdered sodium sulphate hexahydrate (ground with a 
pestle and mortar) until all reaction stopped. The resulting mixture was left to warm to 
room temperature and stirred for a further 16 hours. An excess of magnesium sulphate 
was added, the mixture was filtered, solids washed with ethyl acetate, and the resulting 
solution was evaporated under reduced pressure to give 316 as a yellow oil (602 mg, 
89%). 
 
 
IR (film): νmax 3294 (br), 2970, 1709, 1658, 1454, 1011 (s) cm-1; 1H NMR (500 MHz, 
CDCl3): δ  2.16 (br s, 2H, 2 × OH), 4.20 (t, J=1.0 Hz, 4H, 2 × CH2OH), 5.11 (t, J=1.0 
Hz, 2H, CH2=C); 13C NMR (150 MHz, CDCl3): δ 64.8 (CH2), 112.4 (CH2=C), 147.4 
(C=CH2). 
 
 
  Experimental 
 
224 
(2-Methylenepropane-1,3-diyl)bis(oxy)bis(methylene)dibenzene 317147 
 
 
 
To a stirred solution of sodium hydride (60% in mineral oil, 382 mg, 9.55 mmol, 9.4 
eq.) in N,N dimethylformamide (4 ml) were added a solution of diol 316 (300 mg, 3.41 
mmol, 3.3 eq.) in N,N dimethylformamide (2ml), benzyl bromide (1.12 ml, 9.50 mmol, 
9.3 eq.) and n-tetrabutylammonium iodide (377 mg, 1.02 mmol, 1 eq.). The resulting 
mixture was stirred at 40 °C for 16 hours and then quenched by the addition of brine 
and water. The separated organic phase was washed with brine, dried (MgSO4), filtered 
and concentrated under vacuum. The residue was purified twice by column 
chromatography (petroleum ether: diethyl ether 3 :7 to 9 : 1) to give 317 as a yellow oil 
(663 mg, 72%). 
 
 
IR (film): νmax 3030, 2854, 1496, 1453, 1364, 1071 (s) cm-1; 1H NMR (600 MHz, 
CDCl3): δ  4.09 (t, J=1.1 Hz, 4H, 2 × OCH2C), 4.53 (br s, 4H, 2 × CH2Ph), 5.29 (t, 
J=1.1 Hz, 2H, CH2=C), 7.29-7.33 (m, 2H, H-Ar), 7.33-7.38 (m, 8H, H-Ar); 13C NMR 
(150 MHz, CDCl3): δ 70.9 (CH2), 72.2 (CH2), 114.4 (CH2), 127.7 (CH-Ar), 128.2 (CH-
Ar), 128.4 (CH-Ar), 138.3 (C-Ar), 142.6 (C); MS (CI+) m/z (%): 269 (MH+, 100), 233 
(28), 181 (15), 143 (17), 92 (11); HRMS: [MH]+, found 269.15347, C18H21O2 requires 
269.15415. 
 
 
  Experimental 
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(E)-3-Bromoprop-1-enylbenzoate 321149 
 
 
 
A solution of benzoyl bromide 319 (2.36 ml, 20.0 mmol, 1 eq.) was added to a solution 
of freshly distilled acrolein 318 (1.33 ml, 20.0 mmol, 1 eq.) in dichloromethane (20 ml) 
at 0 °C. The resulting mixture was allowed to warm to room temperature and was 
stirred for a further 72 hours. The reaction mixture was then cooled to 0 °C and 
quenched by the addition of a saturated aqueous solution of sodium bicarbonate (30 ml). 
The biphasic mixture was extracted with dichloromethane (15 ml), and the extract dried 
(MgSO4), filtered and concentrated under vacuum. The residue was recrystallised 
(hexane) to give 321 as a colourless solid (1.46 mg, 30%). 
 
 
M.p. 64-70 °C (hexane), lit.,149 74-76 °C (pentane); IR (film): νmax 2831 (w), 2555 (w), 
1664, 1600, 1453, 1264 cm-1; 1H NMR
 
(600 MHz, CDCl3): δ  4.09 (dd, J=8.5, 1.0 Hz, 
2H, CH2Br), 5.9 (dt, J=12.4, 8.5 Hz, 1H, CHCH2Br), 7.48-7.52 (m, 2H, H-Ar), 7.62-
7.66 (m, 1H, H-Ar), 7.69 (dt, J=12.4, 1.0 Hz, 1H, CHO), 8.11 (dd, J=8.3, 1,4 Hz, 2H, 
H-Ar); 13C NMR (150 MHz, CDCl3): δ 28.7 (CH2), 111.8 (CH), 128.5 (C-Ar), 128.7 
(C-Ar), 130.1 (C-Ar), 133.9 (C-Ar), 139.4 (CH), 163.2 (C=O); MS (CI+) m/z (%): 241 
(M+ 79Br, 14), 243 (M+ 81Br, 14), 161 (36), 137 (29), 106 (100); HRMS: [MH]+, found 
240.098650, C10H9O2Br requires 240.98642. 
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(E)-3-Acetoxyprop-1-enyl benzoate 322 and (E)-prop-1-ene-1,3-diyl dibenzoate 323 
 
O
O
O
O
O
O
O
O
 
 
Potassium acetate (210 mg, 2.14 mmol, 1.1 eq.), pulverised in a pestle and mortar, and 
aliquat (78.0 mg, 0.19 mmol, 0.2 eq.) were stirred for 10 min. A solution of (E)-3-
bromoprop-1-enyl benzoate 321 (465 mg, 1.94 mmol, 1 eq.) in toluene (8 ml) was then 
added and the resulting mixture was left to stir for 16 hours followed by heating at 85 
°C for 16 hours. After SiO2 (1 g) was added, the mixture was filtered, the solids washed 
with diethyl ether (15 ml) and solvents evaporated under reduced pressure. The residue 
was purified by column chromatography (petroleum ether: diethyl ether 9 :1) to give 
322 (223 mg, 52%) as a yellow solid and 323 (116 mg, 20%) as a yellow oil.  
 
 
322 
M.p. 51-53 °C (Et2O); IR (film): νmax 3086 (w), 2951 (w), 1734 (s), 1677, 1602, 1452, 
1228 (s), 1124 (s), 1048 cm-1; 1H NMR
 
(600 MHz, CDCl3): δ  2.10 (s, 3H, CH3), 4.66 
(dd, J=7.4, 1.2 Hz, 2H, CH2O), 5.78 (dt, J=12.5, 7.4 Hz, 1H, CHCH2O), 7.48-7.52 (m, 
2H, H-Ar), 7.62-7.64 (m, 1H, H-Ar), 7.65-7.68 (m, 1H, CHOCO), 8.11 (dd, J = 8.4, 1.2 
Hz, 2H, H-Ar); 13C NMR (150 MHz, CDCl3): δ 21.1 (CH3), 61.2 (CH2), 109.1 (CH), 
128.5 (CH-Ar), 128.6 (CH-Ar), 130.1 (CH-Ar), 133.8 (C-Ar), 140.3 (CH), 163.4 
(C=O), 170.8 (C=O). 
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323173 
IR (film): νmax 2359, 1737 (s), 1453, 1256 (s), 1097 cm-1; 1H NMR (600 MHz, CDCl3): 
δ  4.92 (d, J=7.6 Hz, 2H, CH2O), 5.91 (dt, J=12.5, 7.6 Hz, 1H, CHCH2O), 7.47 (t, J=7.7 
Hz, 2H, H-Ar), 7.50 (t, J=7.7 Hz, 2H, H-Ar), 7.59 (t, J=7.6 Hz, 1H, H-Ar), 7.64 (t, 
J=7.6 Hz, 1H, H-Ar), 7.80 (d, J=12.5 Hz, 1H, CHOCO), 8.10 (d, J=7.8 Hz, 2H, H-Ar), 
8.12 (d, J=7.8 Hz, 2H, H-Ar); 13C NMR (150 MHz, CDCl3): δ 61.7 (CH2), 109.2 (CH), 
128.4 (CH-Ar), 128.6 (CH-Ar), 129.7 (CH-Ar), 130.0 (CH-Ar), 133.1 (C-Ar), 133.9 (C-
Ar), 140.4 (C-H), 163.4 (C=O), 166.4 (C=O); MS (FAB) m/z (%): 283 (MH+, 22), 176 
(17); HRMS: [MH]+, found 283.09652, C17H15O4 requires 283.09703. 
 
 
  Experimental 
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9-(Diethoxymethyl)-9H-carbazole 336156 
 
N
O
O
 
 
A mixture of carbazole 329 (1.0 g, 6.0 mmol, 1 eq.), triethyl orthoformate (10 ml, 60 
mmol, 10 eq.) and p-toluene sulfonic acid (100 mg, 0.60 mmol, 0.1 eq.) was heated at 
85 °C for 36 hours. The cooled reaction mixture was poured into a mixture of a 
saturated aqueous solution of ammonium chloride and ice (ammonical ice/water), and 
then extracted with dichloromethane (4 × 8 ml). The combined organic extracts were 
concentrated under reduced pressure and the residue purified by column 
chromatography (petroleum ether:acetone 9:1) to give 336 as an orange oil (675mg, 
42%).  
 
 
IR (film): νmax 2977, 1699 (w), 1599, 1484, 1449 (s), 1318 (s), 1227 (s) cm-1; 1H NMR 
(400 MHz, DMSO): δ  1.11 (t, J=7.1 Hz, 6H, 2 × OCH2CH3), 3.45 (dq, J=9.7, 7.1 Hz, 
2H, CH2CH3), 3.70 (dq, J=9.7, 7.1 Hz, 2H, CH2CH3), 6.80 (s, 1H, CH(OEt)2), 7.20-7.24 
(m, 2H, H-Ar), 7.39-7.44 (m, 2H, H-Ar), 7.83 (d, 2H, J=8.3 Hz, H-Ar), 8.13 (d, 2H, 
J=7.8 Hz, H-Ar); 13C NMR (125 MHz, DMSO): δ 15.3 (CH3), 62.1 (CH2), 102.3 (CH), 
111.9 (CH-Ar), 120.3 (CH-Ar), 120.6 (CH-Ar), 123.3 (C-Ar), 126.3 (CH-Ar), 139.0 (C-
Ar); MS (EI) m/z (%): 269 (M+, 22), 224 (38), 196 (33); 167 (90), 140 (28), 103 (100), 
75 (36); HRMS: [M]+, found 269.13643, C17H19O2N requires 269.13607. 
 
 
  Experimental 
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1-(Diethoxymethyl)-1H-pyrazole 337157 
 
N N
O
O
 
 
A mixture of pyrazole 330 (3.4 g, 50 mmol, 1 eq.) and triethyl orthoformate (8.3 ml, 50 
mmol, 1 eq.) was heated at 140 °C and ethanol distilled from the reaction during 16 
hours. The resulting product was distilled under vacuum and purified by column 
chromatography (petroleum ether: diethyl ether 1:1) to give 337 as a colourless oil (4.30 
g, 50%). 
 
 
IR (film): νmax 2980 (w), 1513 (w), 1445.6 (w), 1373, 1316, 1066 (s) cm-1; 1H NMR 
(400 MHz, DMSO): δ  1.11 (t, J=7.1 Hz, 6H, 2 × OCH2CH3), 3.49 (dq, J=9.7, 7.1 Hz, 
2H, CH2CH3), 3.59 (dq, J=9.7, 7.1 Hz, 2H, CH2CH3), 6.22 (s, 1H, CH(OEt)2), 6.33 (t, 
J=2.0 Hz, 1H, CH=N), 7.50-7.52 (m, 1H, CH=CHN), 7.82 (d, J=2.40 Hz, 1H, CHN); 
13C NMR (125 MHz, DMSO): δ 14.6 (CH3), 61.5 (CH2), 104.4 (CH), 106.0 (CH-Ar), 
126.6 (CH-Ar), 139.0 (CH-Ar). 
 
  Experimental 
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1-(Diethoxymethyl)-1H-indole 338154 
 
N
O
O
 
 
A mixture of indole 331 (1.50 g, 12.8 mmol, 1 eq.) and triethyl orthoformate (21.2 ml, 
128 mmol, 10 eq.) was heated at 160 °C for 48 hours. The resulting mixture was 
concentrated under reduced pressure and the residue purified by column 
chromatography (petroleum ether: diethyl ether 1:1) to give 338 as a pale pink oil (354 
mg, 13%).  
 
 
IR (film): νmax 2978 (w), 1459, 1303, 1222, 1103 (s), 1052 (s), 1013 (s) cm-1; 1H NMR 
(500 MHz, DMSO): δ  1.19 (t, J=7.1 Hz, 6H, 2 × OCH2CH3), 3.55 (dq, J=9.7, 7.1 Hz, 
2H, CH2CH3), 3.66 (dq, J=9.7, 7.1 Hz, 2H, CH2CH3), 6.52 (s, 1H, CH(OEt)2), 6.54 (dd, 
J=3.4, 0.7 Hz, 1H, CH=CHN), 7.12 (td, J=7.3, 1.1 Hz, 1H, H-Ar), 7.20 (ddd, J=8.2, 7.1, 
1.2 Hz, 1H, H-Ar), 7.52 (d, J=3.4 Hz, 1H, CH=CHN), 7.61 (dt, J=7.8, 1.0 Hz, 1H, H-
Ar), 7.69 (dd, J=8.3, 0.9 Hz, 1H, H-Ar); 13C NMR (125 MHz, DMSO): δ 14.8 (CH3), 
61.1 (CH2), 101.8 (CH), 101.9 (CH-Ar), 111.4 (CH-Ar), 119.9 (CH-Ar), 120.5 (CH-
Ar), 121.6 (CH-Ar), 125.3 (CH-Ar), 128.7 (C-Ar), 134.4 (C-Ar). 
 
 
  Experimental 
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1-Diethoxymethyl-1H-pyridin-2-one 339 
 
N
O
O
O
 
 
A mixture of 2-hydroxypyridine 332 (1.00 g, 10.5 mmol, 1 eq.) and triethyl 
orthoformate (27.0 ml, 162 mmol, 15.4 eq.) was heated at 155 °C for 24 hours. The 
cooled mixture was poured into a saturated aqueous solution of sodium bicarbonate (20 
ml) and the resulting mixture was extracted with ethyl acetate (15 ml). The combined 
organic extracts were washed with brine (15 ml), concentrated under reduced pressure 
and the residue purified by column chromatography (petroleum ether:ethyl acetate 1:1) 
to give 339  as a pale yellow oil (950 mg, 46%).  
 
 
IR (film): νmax 2979 (w), 1738 (w), 1661 (s), 1594, 1538, 1376, 1250, 1059 (s) cm-1; 1H 
NMR
 
(500 MHz, DMSO): δ  1.13 (t, J=7.1 Hz, 6H, 2 × OCH2CH3), 3.51 (dq, J=9.7, 7.1 
Hz, 2H, 2 × CHHCH3), 3.66 (dq, J=9.7, 7.1 Hz, 2H, 2 × CHHCH3), 6.27 (td, J=7.1, 1.1 
Hz, 1H, CH=CH), 6.37 (dt, J=9.2, 1.1 Hz, 1H, CH=CH), 6.58 (s, 1H, CH(OEt)2), 7.40-
7.44 (m, 1H, CH=CH), 7.55 (dd, J=7.1, 2.1 Hz, 1H, CH=CH); 13C NMR (125 MHz, 
DMSO): δ 15.1 (CH3), 63.0 (CH2), 99.8 (CH), 106.2 (CH-Ar), 120.4 (CH-Ar), 132.7 
(CH-Ar), 141.0 (CH-Ar), 161.5 (C=0); MS (EI) m/z (%): 197 (M+, 97), 152 (97), 124 
(66); 103 (100), 95 (92), 75 (60), 67 (70); HRMS: [M]+, found 197.09990, C10H15O3N 
requires 197.9969. 
 
 
  Experimental 
 
232 
1-(Diethoxymethyl)-1H-imidazole 340155 
 
N
N
O
O
 
 
A mixture of imidazole 333 (1.28 g, 18.8 mmol, 1 eq.), p-toluene sulfonic acid (100 mg, 
0.58 mmol, 0.03 eq.) and triethyl orthoformate (13.3 ml, 80.0 mmol, 4.25 eq.) was 
heated at 130 °C until no more ethanol distilled from the reaction mixture and then 
heated at 160 °C for 16 hours. After excess triethyl orthoformate was removed under 
vacuum, sodium carbonate (100 mg) was added to the residue which was then 
fractionally distilled to give 340 as a colourless oil (1.45 g, 45%). 
 
 
B.p 117-119 °C (0.7 mbar), lit.,155 b.p 52 °C (0.02 Torr); IR (film): νmax 2979 (w), 1739 
(w), 1218, 1060 (s) cm-1; 1H NMR
 
(500 MHz, CDCl3): δ  1.22 (t, J=7.2 Hz, 6H, 2 × 
OCH2CH3), 3.56 (q, J=7.2 Hz, 4H, OCH2CH3), 6.02 (s, 1H, CH(OEt)2), 7.06 (dd, 
J=10.2, 1.1 Hz, 2H, CH=CH, CH=CH), 7.70 (s, 1H, NCHN); 13C NMR (125 MHz, 
CDCl3): δ 14.7 (CH3), 60.9 (CH2), 101.4 (CH), 116.1 (CH-Ar), 129.5 (CH-Ar), 135.1 
(CH-Ar); MS (EI) m/z (%): 170 (M+, 6), 125 (77), 103 (100), 75 (85); HRMS: [M]+, 
found 170.10006, C8H14O2N2 requires 170.10002. 
 
 
  Experimental 
 
233 
Ethyl 1-(diethoxymethyl)-1H-pyrrole-2-carboxylate 341153 
 
N
O
O
O
O
 
 
A mixture of ethyl pyrrole-2-carboxylate 334 (2.00 g, 14.4 mmol, 1 eq.) and triethyl 
orthoformate (24.0 ml, 144 mmol, 10 eq.) was heated at 165 °C for 6 days. The 
resulting mixture was concentrated under reduced pressure and the residue purified by 
column chromatography (petroleum ether:ethyl acetate (9:1) to give 341 as a slightly 
yellow oil (2.54 g, 73%). 
 
 
IR (film): νmax 2979 (w), 1699 (s), 1419, 1285, 1232, 1207, 1089 (s), 1057 (s) cm-1; 1H 
NMR
 
(400 MHz, DMSO): δ  1.22 (t, J=7.1 Hz, 6H, 2 × OCH2CH3), 1.35 (t, J=7.1 Hz, 
3H, CH3), 3.55 (dq, J=9.5, 7.1 Hz, 2H, CHOCH2CH3), 3.67 (dq, J=9.5, 7.1 Hz, 2H, 
CHOCH2CH3), 4.28 (q, J=7.2 Hz, 2H, OCH2CH3), 6.19 (br t, J=3.2 Hz, 1H, H4), 6.98 
(dd, J=3.8, 1.8 Hz, 1H, H3), 7.02 (s, 1H, CH(OEt)2), 7.34 (dd, J=2.7, 1.8 Hz, 1H, H2); 
13C NMR (150 MHz, DMSO): δ 14.2 (CH3), 14.7 (CH3), 59.8 (CH2), 62.0 (CH2), 101.3 
(CH), 108.7 (CH-Ar), 118.6 (CH-Ar), 121.4 (C), 124.3 (CH-Ar), 160.1 (C=O).; MS (EI) 
m/z (%): 264 (Mna+, 29), 196 (74), 182 (100); HRMS: [Mna]+, found 264.12174, 
C12H19O3Nna requires 264.12063. 
 
 
  Experimental 
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Methyl 1-(diethoxymethyl)-1H-indole-3-carboxylate 342154 
 
N
O
O
O
O
 
 
A mixture of methyl indole-3-carboxylate 335 (5.00 g, 28.5 mmol, 1 eq.) and triethyl 
orthoformate (50.0 ml, 301 mmol, 10 eq.) was heated at 160 °C for 60 hours. The 
resulting mixture was concentrated under reduced pressure and the residue purified 
twice by column chromatography (petroleum ether:diethyl ether 1:1) to give 342 as a 
pale orange oil (6.74 g, 85%).  
 
 
IR (film): νmax 2980, 1709 (s), 11537, 1460, 1377, 1205 (s), 1072 cm-1; 1H NMR (500 
MHz, DMSO): δ  1.23 (t, J=7.1 Hz, 6H, 2 × OCH2CH3), 3.55-3.63 (m, 4H, CH2CH3), 
3.92 (s, 3H, OCH3), 6.29 (s, 1H, CH(OEt)2), 7.27-7.32 (m, 2H, H-Ar), 7.58-7.62 (m, 
1H, H-Ar), 8.11 (s, 1H, CHN), 8.16-8.19 (m, 1H, H-Ar); 13C NMR (75 MHz, DMSO): 
δ 14.6 (CH3), 50.8 (CH3), 61.4 (CH2), 102.3 (CH), 106.5 (C-Ar), 112.5 (CH-Ar), 120.6 
(CH-Ar), 122.2 (CH-Ar), 122.9 (CH-Ar), 126.4 (C-Ar), 131.7 (CH-Ar), 134.5 (C-Ar), 
164.3 (C=O); MS (EI) m/z (%): 300 (Mna+, 38), 232 (100), 218 (37), 204 (69), 198 (20), 
176 (38); HRMS: [MNa]+, found 300.12117, C15H19O4NNa requires 300.12063. 
 
  Experimental 
 
235 
trans-Methyl 1-(2-benzylcyclopropyl)-1H-indole-3-carboxylate 343 and cis-methyl 
1-(2-benzylcyclopropyl)-1H-indole-3-carboxylate 344 
 
 
 
A solution of 1-diethoxymethyl-1H-indole-3-carboxylic acid methyl ester 342 (703 mg, 
2.54 mmol, 2 eq.) in diethyl ether (3 ml) was added dropwise via syringe pump (0.6 
ml.h-1) to a vigorously stirred refluxing mixture of zinc dust (1.66 g, 25.4 mmol, 20 eq.), 
copper(I) chloride (166 mg, 1.68 mmol, 1.3 eq.), zinc chloride (1.0 M solution in diethyl 
ether, 2.5 ml, 2.5 mmol, 2 eq.), chlorotrimethylsilane (1.62 ml, 12.7 mmol, 1.3 eq.) and 
allylbenzene 153 (150 mg, 1.27 mmol, 1 eq.) in diethyl ether (6 ml). The reaction 
mixture was heated at reflux for 16 hours, then quenched by the addition of a saturated 
aqueous solution of sodium bicarbonate (8 ml), filtered and the solids washed with 
diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 × 10 ml) 
and the combined organic extracts were washed with brine (10 ml), dried (MgSO4), 
filtered and concentrated under vacuum. The residue was purified by column 
chromatography (diethyl ether:petroleum ether 7:3) to give an inseparable mixture of  
343 and 344 (70 mg, 18%, trans:cis 1.4:1 as determined by 1H NMR spectrum) as a 
pale yellow oil. 
 
 
IR (mixture of trans and cis, film): νmax 3005, 2947, 1699 (s), 1605 (w), 1533 (s), 1464 
(s), 1375, 1317, 1196 (s) cm-1; 343: 1H NMR (trans, 500 MHz, CDCl3): δ 1.07-1.13 (m, 
1H, CHHCHN), 1.31 (ddd, J=9.6, 5.8, 3.8 Hz, 1H, CHHCHN), 1.60-1.68 (m, 1H, 
CHCHN), 2.77 (dd, J=14.4, 7.4 Hz, 1H, CHHPh), 2.90 (dd, J=14.4, 6.7, 1H, CHHPh), 
3.22 (dt, J=7.2, 3.6 Hz, 1H, CHN), 3.89 (s, 3H, OCH3), 7.10-7.15 (m, 2H, H-Ar), 7.21-
7.25 (m, 2H, H-Ar), 7.28-7.33 (m, 2H, H-Ar), 7.35-7.39 (m, 2H, H-Ar), 7.74 (s, 1H, 
CH=C), 8.11-8.13 (m, 1H, H-Ar); 343: 13C NMR (trans, 125 MHz, CDCl3): δ 13.3 
  Experimental 
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(CH), 21.5 (CH), 32.7 (CH2), 33.5 (CH2), 51.0 (CH3), 107.0 (C-Ar), 110.8 (C-Ar), 
121.6 (C-Ar), 122.1 (C-Ar), 122.7 (C-Ar), 126.2 (C-Ar), 126.7 (C-Ar), 128.6 (C-Ar), 
128.8 (C-Ar), 134.3 (C-Ar), 137.7 (C-Ar), 139.8 (C-Ar), 165.5 (C=O); 344: 1H NMR 
(cis, 500 MHz, CDCl3): δ 1.15 (td, J=6.2, 4.4 Hz, 1H, CHHCHN), 1.37-1.43 (m, 1H, 
CHHCHN), 1.67-1.72 (m, 1H, CHCHN), 1.90 (dd, J=15.1, 9.6 Hz, 1H, CHHPh), 2.79 
(dd, J=15.1, 5.0, 1H, CHHPh), 3.55 (td, J=7.3, 4.3 Hz, 1H, CHN), 3.92 (s, 3H, OCH3), 
7.05-7.07 (m, 2H, H-Ar), 7.16-7.19 (m, 1H, H-Ar), 7.28-7.33 (m, 4H, H-Ar), 7.52-7.55 
(m, 1H, H-Ar), 7.84 (s, 1H, CH=C), 8.18-8.20 (m, 1H, H-Ar); 344: 13C NMR (cis, 125 
MHz, CDCl3): δ 11.1 (CH), 19.3 (CH), 32.7 (CH2), 33.5 (CH2), 51.0 (CH3), 107.1 (C-
Ar), 111.0 (C-Ar), 121.6 (C-Ar), 122.3 (C-Ar), 123.0 (C-Ar), 126.6 (C-Ar), 126.8 (C-
Ar), 128.3 (C-Ar), 128.4 (C-Ar), 134.8 (C-Ar), 138.2 (C-Ar), 140.2 (C-Ar), 165.4 
(C=O); MS (EI) m/z (%): 306 (MH+, 100), 274 (17); HMRS: [MH]+, found 306.14782, 
C20H20O2N requires 306.14886. 
 
 
  Experimental 
 
237 
trans-Methyl 1-(2-tert-butylcyclopropyl)-1H-indole-3-carboxylate 345 
 
N
H
H
O
O
 
 
A solution of 1-diethoxymethyl-1H-indole-3-carboxylic acid methyl ester 342 (687 mg, 
2.48 mmol, 2 eq.) in diethyl ether (2 ml) was added dropwise via syringe pump (0.6 
ml.h-1) to a vigorously stirred refluxing mixture of zinc dust (1.62 g, 24.8 mmol, 20 eq.), 
copper(I) chloride (162 mg, 1.64 mmol, 1.3 eq.), zinc chloride (1.0 M solution in diethyl 
ether, 2.5 ml, 2.5 mmol, 2 eq.), chlorotrimethylsilane (1.60 ml, 12.5 mmol, 10 eq.) and 
3,3 dimethylbut-1-ene 164 (0.16 ml, 1.24 mmol, 1 eq.) in diethyl ether (6 ml). The 
reaction mixture was heated at reflux for 16 hours, then quenched by the addition of a 
saturated aqueous solution of sodium bicarbonate (8 ml), filtered and the solids washed 
with diethyl ether (10 ml). The biphasic mixture was extracted with diethyl ether (2 × 
10 ml) and the combined organic extracts were washed with brine (10 ml), dried 
(MgSO4), filtered and concentrated under vacuum. The residue was purified by column 
chromatography (petroleum ether: diethyl ether 1:1) to give 342 as a yellow solid (35 
mg, 10%). 
 
 
M.p. 65-70 °C (Et2O); IR (film): νmax 2948, 1691 (s), 1534, 1463, 1435, 1374, 1259, 
1193 (s) cm-1; 1H NMR (trans, 600 MHz, CDCl3): δ 1.06 (s, 9H, C(CH3)3), 1.07-1.14 
(m, 2H, CH2CHN), 1.38-1.42 (m, 1H, CHC(CH3)3), 3.29 (dt, J=7.6, 3.7 Hz, 1H, CHN), 
3.92 (s, 3H, OCH3), 7.29-7.31 (m, 2H, H-Ar), 7.61-7.63 (m, 1H, H-Ar), 7.81 (s, 1H, 
CH=C), 8.15-8.17 (m, 1H, H-Ar); 13C NMR (trans, 150 MHz, CDCl3): δ 9.7 (CH2), 
28.5 (C(CH3)3), 29.4 (C(CH3)3), 30.6 (CH), 31.4 (CH), 51.0 (CH3), 106.8 (C-Ar), 110.8 
(CH-Ar), 121.7 (CH-Ar), 122.1 (CH-Ar), 122.7 (CH-Ar), 126.7 (C-Ar), 134.5 (CH-Ar), 
137.7 (C-Ar), 165.5 (C=O); MS (EI) m/z (%): 271 (M+, 100), 240 (30), 214 (100), 201 
(27), 182 (22), 170 (28), 154 (53); HMRS: [M]+, found 271.15197, C17H21O2N requires 
271.15172. 
  Experimental 
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1-(Pent-4-enyl)pyrrolidine-2,5-dione 351174 
 
 
 
Sodium hydride (60% in mineral oil, 2.24 g, 56.0 mmol, 1.1 eq.) was added portionwise 
to a solution of succinimide (5.00 g, 50.5 mmol, 1 eq.) in N,N dimethylformamide (30 
ml) at 0 °C and stirred at 0 °C for 5 minutes before warming to room temperature and 
stirring for a further 1 hour. 5 Bromopentene (6.00 ml, 50.6 mmol, 1 eq.) was added 
dropwise to the mixture and the reaction mixture was stirred for 16 hours before being 
poured into water (50 ml) and a saturated aqueous solution of ammonium chloride (50 
ml). The resulting mixture was extracted with diethyl ether (3 × 25 ml) and the 
combined organic extracts were washed with water (3 × 50 ml), dried (MgSO4) and 
evaporated under reduced pressure. The residue was purified by column 
chromatography (hexane:ethyl acetate 6:4 ) to give 351 as a yellow oil (7.18g, 85%). 
 
 
IR (film): νmax 2941 (w), 1773 (w), 1690 (s), 1438, 1399, 1341, 1250, 1162, 1131 cm-1; 
1H NMR
 
(500 MHz, CDCl3): δ  1.66 (dt, J=15.0, 7.4 Hz, 2H, CH2CH2N), 2.02-2.07 (m, 
2H, CH2CH=CH), 2.67 (s, 4H, 2 × CH2CO), 3.50 (t, J=7.4 Hz, 2H, CH2N), 4.96 (ddd, 
J=10.2, 3.1, 1.3 Hz, 1H, CHH=CH), 5.02 (ddd, J=17.2, 3.4, 1.7 Hz, 1H, CHH=CH), 
5.77 (ddt, J=17.2, 10.3, 6.6 Hz, 1H, CH=CH2); 13C NMR (150 MHz, CDCl3): δ 26.7 
(CH2), 28.1 (CH2), 31.0 (CH2), 38.4 (CH2), 115.3 (CH2=CH), 137.4 (CH=CH2), 177.3 
(C=O); MS (CI+) m/z (%):  168 (MH+,59), 114 (19), 101 (100); HRMS: [MH]+, found 
168.10254, C9H14O2N requires 168.10245. 
 
 
  Experimental 
 
239 
1,1a,2,3-Tetrahydro-3a-aza cyclopropa[1,5]cyclopenta[1,2-a]inden-4-one 354 
 
N
O
 
 
A solution of 2-(but-3-enyl)isoindoline-1,3-dione 353 (200 mg, 1.00 mmol, 1 eq.) in 
dichloromethane (3 ml) was added dropwise via syringe pump (0.6 ml.h-1) to a 
vigorously stirred refluxing mixture of zinc dust (1.38 g, 21.1 mmol, 21.1 eq.), 
copper(I) chloride (138 mg, 1.39 mmol, 1.4 eq.), zinc chloride (1.0 M solution in diethyl 
ether, 2.0 ml, 2.0 mmol, 2 eq.) and chlorotrimethylsilane (1.90 ml, 14.9 mmol, 15 eq.) 
in diethyl ether (5 ml). The reaction mixture was heated at reflux for 16 hours, then 
quenched by the addition of a saturated aqueous solution of sodium bicarbonate (15 ml), 
filtered and the solids washed with diethyl ether (10 ml). The biphasic mixture was 
extracted with diethyl ether (2 × 10 ml) and the combined organic extracts were washed 
with brine (10 ml), dried (MgSO4) and concentrated in vacuo. The residue was purified 
by column chromatography (diethyl ether:petroleum ether 4:1) to give 354 as a orange 
oil (15 mg, 8%) 
 
 
IR (film): νmax 2956, 1679 (s), 1474, 1398, 1347, 1265, 1083 cm-1; 1H NMR (500 MHz, 
CDCl3): δ  1.54 (dd, J=6.6, 5.6 Hz, 1H, CHHCN), 1.62 (dd, J=8.9, 6.6 Hz, 1H, 
CHHCN), 2.02 (dt, J=8.9, 5.3 Hz, 1H, CHCN); 2.22 (ddd, J=12.9, 7.8, 1.4 Hz, 1H, 
CHHCH2N), 2.36-2.45 (m, 1H, CHHCH2N), 3.04 (ddd, J=12.5, 9.9, 7.8 Hz, 1H, 
CHHN), 4.09 (ddd, J=12.5, 9.9, 1.4 Hz, 1H, CHHN), 7.14 (d, J=7.6 Hz, 1H, H-Ar), 
7.41 (td, J=7.5, 1.0 Hz, 1H, H-Ar), 7.48 (td, J=7.5, 1.1 Hz, 1H, H-Ar), 7.82 (d, J=7.6 
Hz, 1H, H-Ar); 13C NMR (125 MHz, CDCl3): δ 15.6 (CH2), 22.3 (CH), 31.4 (CH2), 
38.4 (CH2), 54.7 (C), 119.0 (CH-Ar), 124.0 (CH-Ar), 125.5 (C-Ar), 127.6 (CH-Ar), 
131.2 (CH-Ar), 144.8 (C-Ar), 168.6 (C=O); MS (CI+) m/z (%): 186 (MH+, 100); 
HRMS: [MH]+, found 186.09093, C12H11ON requires 186.09189. 
 
  Experimental 
 
240 
Ethyl 2-oxo-2-(2-oxooxazolidin-3-yl)acetate 361 
 
 
 
A solution of oxazolidin-2-one 180 (3.00 g, 34.5 mmol, 1 eq.) in tetrahydrofuran (20 
ml) was added dropwise to a solution of sodium hydride (60% in mineral oil, 4.13 g, 
103 mmol, 3 eq.) in tetrahydrofuran (80 ml) at 0 °C. The reaction mixture was stirred 
for 1 hour at 0 °C. Ethyloxalyl chloride (5.75 ml, 51.6 mmol, 1.5 eq.) was then added 
dropwise at 0 °C and the resulting mixture allowed to warm to room temperature and 
stirred for 16 hours before being partitioned between water (50 ml) and ethyl acetate 
(100 ml). The aqueous phase was separated and extracted with ethyl acetate (50 ml). 
The combined organic extracts were washed with a saturated aqueous solution of 
sodium carbonate (3 × 50 ml), dried (MgSO4), filtered and concentrated under reduced 
pressure to give 361 together with 2-ethoxy-2-oxoacetic acid (1.9g, 361: 2-ethoxy-2-
oxoacetic acid 1:3 as determined by 1H NMR spectrum) as a yellow oil, which was 
used without further purification. The yield of 361 (1.60 g, 25%) was calculated from 
1H NMR spectrum. 
 
 
IR (film): νmax 2989 , 2925, 1792 (s), 1751 (s), 1705 (s), 1475, 1402 (s), 1236 (s), 1018 
(s) cm-1; 1H NMR
  
(400 MHz, CDCl3): δ 1.36 (t, J=7.2 Hz, 3H, CH3), 4.04 (t, J= 8.0 Hz, 
2H, CH2N), 4.40 (q, J= 7.2 Hz, 2H, CH2CH3), 4.56 (t, J=8.0 Hz, 2H, CH2O); 13C NMR 
(75 MHz, CDCl3): δ 13.6 (CH3), 40.7 (CH2), 62.9 (CH2), 63.7 (CH2), 152.8 (C=O), 
160.0 (C=O), 160.3 (C=O); MS (CI+) m/z (%): 188 (MH+, 66), 160 (37), 142 (51), 114 
(62), 88 (100); HRMS : [MH]+, found 188.05586, C7H10O5N requires 188.05535. 
 
 
  Experimental 
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Ethyl 2-oxo-2-(2-oxopyrrolidin-1-yl)acetate 362 
 
 
 
A solution of pyrrolidin-2-one 215 (3.00 g, 35.3 mmol, 1 eq.) in tetrahydrofuran (20 ml) 
was added dropwise to a solution of sodium hydride (60% in mineral oil, 4.23 g, 106 
mmol, 3 eq.) in tetrahydrofuran (80 ml) at 0 °C. The reaction mixture was stirred for 1 
hour at 0 °C. Ethyloxalyl chloride (5.90 ml, 52.9 mmol, 1.5 eq.) was then added 
dropwise at 0 °C and the resulting mixture allowed to warm to room temperature and 
stirred for 16 hours before being partitioned between water (50 ml) and ethyl acetate 
(100 ml). The aqueous phase was separated and extracted with ethyl acetate (50 ml). 
The combined organic extracts were washed with a saturated aqueous solution of 
sodium carbonate (3 × 50 ml), dried (MgSO4), filtered and concentrated under reduced 
pressure to give a pale brown semi-solid mixture of 362 and 2-ethoxy-2-oxoacetic acid 
(2.14 g, 362:2-ethoxy-2-oxoacetic acid 5:1 as determined by 1H NMR spectrum) which 
was used without further purification. The yield of 362 (1.87g, 29%) was calculated 
from the 1H NMR spectrum. 
 
 
IR (film): νmax 2914, 1750 (s), 1699 (s), 1355 (s), 1220 (s), 1018 cm-1; 1H NMR (400 
MHz, CDCl3): δ 1.37 (t, J=7.2 Hz, 3H, CH3), 2.18 (tt, J=8.1, 7.3 Hz, 2H, CH2CH2N), 
2.62 (t, J=8.1 Hz, 2H, CH2CO), 3.82 (t, J=7.3 Hz, 2H, CH2N), 4.39 (q, J=7.2 Hz, 2H, 
OCH2CH3); 13C NMR (75 MHz, CDCl3): δ  13.6 (CH3), 17.7 (CH2), 31.7 (CH2), 43.3 
(CH2), 62.4 (CH2), 160.2 (C=O), 161.3 (C=O), 175.2 (C=O); MS (CI+) m/z (%): 186 
(MH+, 8), 112 (26), 31 (100); HRMS : [MH]+, found 186.07679, C8H12O4N requires 
186.07608. 
 
 
  Experimental 
 
242 
Ethyl 2-hydroxy-2-(2-oxooxazolidin-3-yl)acetate 365 
 
O N
O
OH
O O
 
 
Oxazolidin-2-one 180 (430 mg, 4.94 mmol, 1 eq.) was added to a solution of ethyl 
glyoxalate (55% in toluene, 1.00 g, 4.94 mmol, 1 eq.), acetic acid (0.28 ml, 4.94 mmol, 
1 eq.) and toluene (10 ml). The resulting mixture was stirred at room temperature for 3 
hours before being concentrated, diluted with toluene and evaporated under reduced 
pressure to give 365 as a colourless oil (778 mg, 83%). 
 
 
IR (film): νmax 3354 (br) , 2985, 1739 (s), 1485, 1425, 1252 (s), 1071, 1028 cm-1; 1H 
NMR
  
(500 MHz, CDCl3): δ 1.35 (t, J=7.2 Hz, 3H, CH3), 3.51 (dd, J= 8.4, 6.9 Hz, 1H, 
CHHN), 3.77 (dd, 1H, J=8.4, 7.6 Hz, 1H, CHHN), 4.30-4.38 (m, 2H, OCH2CH3), 4.39-
4.43 (m, 2H, CH2OCO), 5.64 (s, 1H, CHN); 13C NMR (75 MHz, CDCl3): δ 14.1 (CH3), 
40.5 (CH2), 62.5 (CH2), 63.0 (CH2), 74.9 (CH), 157.8 (C=O), 169.2 (C=O); MS (CI+) 
m/z (%): 190 (MH+, 69), 173 (68), 134 (95), 114 (41), 103 (77), 89 (100); HRMS : 
[MH]+, found 190.07101, C7H12O5N requires 190.07154. 
 
 
  Experimental 
 
243 
Ethyl 2-(5-allyl-2-methoxyphenyl)-2-(2-oxopyrrolidin-1-yl)acetate 366 
 
 
 
A solution of oxo-(2-oxo-pyrrolidin-1-yl)-acetic acid ethyl ester 362 (469 mg, 2.21 
mmol, 1.3 eq.) in diethyl ether (5 ml) was added via syringe pump over 4 hours to a 
vigorously stirred mixture of zinc amalgam (1.38 g, 21.1 mmol, 12.5 eq.), zinc chloride 
(1.0 M solution in diethyl ether, 2.5 ml, 2.5 mmol, 1.5 eq.), 4-allylanisole 253 (250 mg, 
1.69 mmol, 1 eq.), trimethylsilyl chloride (1.35 ml, 10.6 mmol, 6.25 eq.) in diethyl ether 
(8 ml) at reflux. Zinc dust (1.00 g, 15.3 mmol, 9 eq.) and copper(I) chloride (138 mg, 
1.39 mmol, 0.8 eq.) were added and the resulting mixture heated at reflux for 16 hours. 
After cooling to room temperature, a saturated aqueous solution of sodium bicarbonate 
was added and the mixture stirred for 10 min. The solution was filtered and the 
separated zinc washed with ethyl acetate. The aqueous layer was separated and 
extracted with ethyl acetate (3 × 5 ml) and the combined organic extracts were washed 
with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The 
residue was purified by column chromatography (diethyl ether:petroleum ether 4:1) to 
give 366 as a yellow oil (128 mg, 24%). 
 
 
IR (film): νmax 2968, 1739 (s), 1688 (s), 1502, 1420, 1263 cm-1; 1H NMR    (400 MHz, 
CDCl3): δ 1.22 (t, J=7.1 Hz, 3H, CH2CH3), 1.80-1.91 (m, 1H, CHHCH2N), 1.99-2.08 
(m, 1H, CHHCH2N), 2.32-2.51 (m, 2H, CH2N), 2.89-3.00 (m, 1H, CHHCO), 3.31 (d, 
J=6.7 Hz, 2H, CH2CH=CH2), 3.54-3.59 (m, 1H, CHHCO), 3.78 (s, 3H, OCH3), 4.14-
4.25 (m, 2H, CH2CH3), 5.01-5.07 (m, 2H, CH2=CH), 5.87-5.97 (m, 1H, CH=CH2), 6.03 
(s, 1H, CHN), 6.83 (d, J= 8.4 Hz, 1H, H-Ar), 7.0 (d, J= 2.2 Hz, 1H, H-Ar), 7.14 (dd, J= 
8.4, 2.2 Hz, 1H, H-Ar); 13C NMR (75 MHz, CDCl3): δ 14.1 (CH3), 17.9 (CH2), 30.7 
(CH2), 39.1 (CH2), 44.4 (CH2), 54.1 (CH), 55.4 (CH3), 61.0 (CH2), 110.9 (CH-Ar), 
115.7 (CH2=CH), 122.7 (C-Ar), 129.8 (CH-Ar), 131.0 (CH-Ar), 132.3 (C-Ar), 137.2 
  Experimental 
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(CH=CH2), 155.7 (C=O), 170.2 (C-Ar), 175.1 (C=O); MS (EI) m/z (%): 317 (M+, 2), 
271 (15), 244 (100); HRMS : [M]+, found 317.161128, C18H23O4N requires 317.16216. 
 
 
  Experimental 
 
245 
Ethyl 2-hydroxy-2-(2-oxopyrrolidin-1-yl)acetate 367175 
 
N
O
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Pyrrolidin-2-one 215 (420 mg, 4.94 mmol, 1 eq.) was added to a solution of ethyl 
glyoxalate (55% in toluene (1.00 g, 4.94 mmol, 1 eq.), acetic acid (0.28 ml, 4.94 mmol, 
1 eq.) and toluene (10 ml). The resulting mixture was stirred at room temperature for 3 
hours before being concentrated, diluted in toluene and evaporated under reduced 
pressure to give 367 as an orange semi-solid (787 mg, 85%). 
 
 
IR (film): νmax 3257 (br), 2983, 1751 (s), 1678 (s), 1421, 1271, 1099, 1035 cm-1; 1H 
NMR
  
(400 MHz, CDCl3): δ 1.31 (t, J=7.1 Hz, 3H, CH3), 2.02-2.11 (m, 2H, CH2CH2N), 
2.43 (t, J=8.1 Hz, 2H, CH2CO), 3.21-3.27 (m, 1H, CHHN), 3.52.3.58 (m, 1H, CHHN), 
3.93 (s, 1H, OH), 4.30 (q, J=7.1 Hz, 2H, OCH2CH3), 5.74 (s, 1H, CHN); 13C NMR (100 
MHz, CDCl3): δ 14.2 (CH3), 18.0 (CH2), 30.9 (CH2), 43.1 (CH2), 62.8 (CH2), 73.0 
(CH), 170.1 (C=O), 175.8 (C=O); MS (EI) m/z (%): 188 (MH+, 37), 170 (73), 142 (22), 
114 (75), 86 (100); HRMS : [M]+, found 187.08488, C8H13O4N requires 187.08445. 
 
 
  Experimental 
 
246 
Ethyl 2-(3,4-dimethoxyphenyl)-2-(2-oxo-oxazolidin-3-yl)acetate 370 
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A solution of oxo-(2-oxo-oxazolidin-3-yl)-acetic acid ethyl ester 361 (230 mg, 0.98 
mmol, 1.1 eq.) in diethyl ether (3 ml) was added dropwise via syringe pump (0.6 ml.h-1) 
to a vigorously stirred mixture of zinc amalgam (0.69 mg, 10.6 mmol, 12.3 eq.), zinc 
chloride (1.0 M solution in diethyl ether, 1.25 ml, 1.25 mmol, 1.45 eq.), 1,2 
dimethoxybenzene 369 (0.11 ml, 0.86 mmol, 1 eq.), trimethylsilyl chloride (0.68 ml, 
5.32 mmol, 6.2 eq.) in diethyl ether (3 ml) at reflux. The resulting mixture was heated at 
reflux for 16 hours, cooled to room temperature and treated with a saturated aqueous 
solution of sodium bicarbonate. After stirring for 10 min, the reaction mixture was 
filtered and the separated zinc washed with ethyl acetate. The aqueous phase was 
separated and extracted with ethyl acetate (2 × 7 ml) and the combined organic extracts 
were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue was purified by column chromatography (diethyl ether:petroleum 
ether 4:1) to give 370 as a yellow oil (150 mg, 56%). 
 
 
IR (film): νmax 2912, 2837 (w), 1740 (s), 1737 (s), 1593, 1518, 1421, 1246, 1198, 1145, 
1076, 1024 cm-1; 1H NMR
  
(500 MHz, CDCl3): 1.25 (t, J=7.2 Hz, 3H, OCH2CH3), 3.06-
3.14 (m, 1H, CHHN), 3.86 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 3.89-4.00 (m, 1H, 
CHHN), 4.19-4.28 (m, 3H, CHHOCO, OCH2CH3), 4.33.4.39 (m, 1H, CHHOCO), 5.64 
(s, 1H, CHN), 6.77-6.80 (m, 2H, H-Ar), 6.84 (d, J=8.1 Hz, 1H, H-Ar); 13C NMR (100 
MHz, CDCl3): δ 14.0 (CH3), 41.7 (CH2), 55.9 (CH3), 59.4 (CH), 61.6 (CH2), 62.4 
(CH2), 120.7 (CH-Ar), 111.8 (CH-Ar), 111.2 (CH-Ar), 125.6 (C-Ar), 149.3 (C-Ar), 
158.2 (C=O), 170.1 (C=O); MS (EI) m/z (%): 309 (M+, 7), 263 (13), 236 (36), 220 (19), 
205 (49), 192 (7), 174(42), 129 (76), 100 (100); HRMS : [M]+, found 309.12018, 
C15H19O6N requires 309.12123. 
  Experimental 
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3-(2,2,2-Trifluoroacetyl)oxazolidin-2-one 359176 
 
 
 
A mixture of 2-oxazolidinone 180 (1.00 g, 11.5 mmol, 1 eq.) and trifluoroacetic 
anhydride (539 ml, 276 mmol, 24 eq.) was heated at reflux for 24 hours. The resulting 
mixture was concentratred in vacuo and the residue was recrystallised from ethyl acetate 
to give 359 as a colourless solid (0.92 g, 80%). 
 
 
M.p. 74-78 °C (EtOAc), lit.,176 90-93.5 °C; IR (film): νmax 1716 (s), 1699, 1475, 1416 
(s), 1169 (s) , 1039 cm-1; 1H NMR
  
(400 MHz, CDCl3): δ 4.14 (t, J=7.9 Hz, 2H, CH2N), 
4.55 (t, J=7.9 Hz, 2H, CH2O); 13C NMR (75 MHz, CDCl3): δ 43.1 (CH2), 62.8 (CH2), 
114.8 (q, JC-F  284 Hz, CF3), 149.8 (q, JC-F  43 Hz, C=OCF3), 155.9 (C=O); MS (EI) 
m/z (%): 183 (M+, 32), 114 (93), 96 (13), 87 (17), 70 (100), 56 (37); HRMS: [M]+, 
found 183.01480, C5H4O3NF3 requires 183.01433. 
 
 
  Experimental 
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Ethyl 2-(2-(but-3-enyl)-6-oxopiperidin-1-yl)-2-oxoacetate 374 
 
N
O
O
O
O
 
 
A solution of 283 (397 mg, 2.59 mmol, 1 eq.) in tetrahydrofuran (10 ml) was added to a 
mixture of sodium hydride (311 mg, 13.0 mmol, 5 eq.), which was washed with hexane 
three times, in tetrahydrofuran (3 ml) at 0 °C. The reaction mixture was stirred for 1 
hour at 0 °C. Ethyl oxalyl chloride (0.44 ml, 5.20 mmol, 2 eq.) was added dropwise and 
the mixture was allowed to warm to room temperature then stirred for 16 hours before 
the addition of water (20 ml) and ethyl acetate (15 ml). The aqueous phase was 
separated and extracted with ethyl acetate (3 × 15 ml). The combined organic extracts 
were washed with a saturated aqueous solution of sodium bicarbonate (20 ml), brine (20 
ml), dried (MgSO4), filtered and concentrated under vacuum. The residue was purified 
by column chromatography (petroleum ether:ethyl acetate 1:1) to give 374 as a yellow 
oil (429 mg, 65%). 
 
 
IR (film): νmax 2958, 1742, 1690 (s), 1389, 1371, 1328, 1267, 1185 (s), 1163 (s), 1018 
(s) cm-1; 1H NMR
 
(600 MHz, CDCl3): δ  1.38 (t, J=7.2 Hz, 3H, CH3), 1.63 (ddd, J=13.6, 
9.7, 5.6, 1H, CHHCH2CH=CH2), 1.80-1.90 (m, 3H, CHHCH2CH2CO, CHHCH2CO, 
CHHCH2CH=CH2), 1.93-2.03 (m, 2H, CHHCH2CH2CO, CHHCH2CO), 2.07-2.19 (m, 
2H, CH2CH=CH2), 2.55-2.66 (m, 2H, CH2CO), 4.32-4.40 (m, 2H, OCH2CH3), 4.40-
4.45 (m, 1H, CHN), 5.02 (ddd, J=10.3, 3.0, 1.3 Hz, 1H, CHH=CH), 5.08 (dq, J=17.2, 
1.6 Hz, 1H, CHH=CH), 5.82 (ddt, J=17.2, 10.3, 6.6 Hz, 1H, CH=CH2); 13C NMR (150 
MHz, CDCl3): δ 13.8 (CH3), 15.9 (CH2), 24.3 (CH2), 30.2 (CH2), 31.6 (CH2), 32.7 
(CH2), 52.6 (CH), 62.3 (CH2), 115.6 (CH2=CH), 136.9 (CH=CH2), 161.6 (C=O), 163.2 
(C=O), 173.0 (C=O); MS (CI+) m/z (%): 254 (MH+, 100), 208 (55), 180 (59), 139 (31), 
99 (21); [MH]+, found 254.13855, C13H20O4N requires 254.13923. 
  Experimental 
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N-Benzyl-4-methylbenzenesulfonamide 381160 
 
 
 
Benzylamine 380 (2.2 ml, 20 mmol, 2 eq.) was added dropwise to a solution of tosyl 
chloride (1.9 g, 10 mmol, 1 eq.) in diethyl ether (50 ml) at 0 °C. The resulting mixture 
was allowed to warm to room temperature and stirred for 1 hour. An aqueous solution 
of HCl (0.5 M, 50 ml) was added to the reaction mixture to dissolve the amine salt, and 
the organic phase was separated and washed with an aqueous solution of HCl (0.5 M, 3 
× 50 ml). The organic phase was dried (MgSO4) and concentrated under reduced 
pressure and the residue was purified by column chromatography (petroleum ether: 
diethyl ether 3:2) to give 381 as a colourless solid (2.07 g, 79%). 
 
 
M.p. 112-118 °C (Et2O), lit.,160 111-113 °C (EtOH); IR (film): νmax 3270, 1455, 1423, 
1323 (s), 1178, 1165, 1060 cm-1; 1H NMR
 
(500 MHz, CDCl3): δ  2.43 (s, 3H, CH3), 
4.10 (d, J=6.2 Hz, 2H, CH2Ph), 4.65 (br t, J=5.8 Hz, 1H, NH), 7.16-7.19 (m, 2H, H-Ar), 
7.21-7.27 (m, 3H, H-Ar), 7.29 (d, J=8.0 Hz, 2H, H-Ar), 7.74 (d, J=8.3 Hz, 2H, H-Ar); 
13C NMR (125 MHz, CDCl3): δ 21.5 (CH3), 47.3 (CH2), 127.2 (CH-Ar), 127.8 (CH-
Ar), 127.9 (CH-Ar), 128.7 (CH-Ar), 129.7 (CH-Ar), 136.2 (C-Ar), 136.8 (C-Ar), 143.5 
(C-Ar); MS (CI+) m/z (%): 262 (MH+, 10), 155 (26), 139 (31), 106 (100), 91 (94); 
HRMS: [MH]+, found 262.08965, C14H16O2NS requires 262.09017. 
 
  Experimental 
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N-Benzyl-N-diethoxymethyl-4-methylbenzenesulfonamide 382 
 
 
 
A mixture of N-benzyl-4-methyl-benzenesulfonamide 381 (1.0 g, 3.8 mmol, 1 eq.), 
triethyl orthoformate (30.0 ml, 180 mmol, 47 eq.) and aluminium chloride (77.0 mg, 
0.58 mmol) was heated at 160 °C for 16 hours. After cooling the mixture was poured 
into a saturated aqueous solution of sodium bicarbonate (20 ml), and the resulting 
mixture was extracted with ethyl acetate (15 ml). The combined organic extracts were 
washed with brine (15 ml), concentrated under reduced pressure and the residue purified 
by column chromatography (petroleum ether: diethyl ether 9:1) to give 382 as a yellow 
oil (700 mg, 51%).  
 
 
IR (film): νmax 2978, 1496, 1455, 1340 (s), 1163 (s), 1055 (s) cm-1; 1H NMR (500 MHz, 
CDCl3): δ  0.92 (t, J=7.0 Hz, 6H, 2 × CH2CH3), 2.46 (s, 3H, CH3), 3.34-3.41 (m, 2H, 2 
× CHHCH3), 3.53 (dq, J=9.5, 7.0 Hz, 2H, 2 × CHHCH3), 4.26 (s, 2H, CH2Ph), 5.8 (s, 
1H, CH(OEt)2), 7.26-7.31 (m, 1H, H-Ar), 7.35 (t, J=7.5 Hz, 2H, H-Ar), 7.41 (d, J=8.0 
Hz, 2H, H-Ar), 7.45 (d, J=8.1 Hz, 2H, H-Ar), 7.75 (d, J=8.4 Hz, 2H, H-Ar); 13C NMR 
(125 MHz, CDCl3): δ 14.2 (CH3), 21.0 (CH3), 45.0 (CH2), 61.8 (CH2), 104.3 (CH-Ar), 
126.8 (CH-Ar), 127.4 (CH-Ar), 127.8 (CH-Ar), 128.0 (CH-Ar), 129.4 (CH-Ar), 136.3 
(C-Ar), 138.3 (C-Ar), 143.4 (C-Ar); MS (EI) m/z (%): 386 (MNa+, 38), 325 (75), 318 
(100), 295 (50); HRMS: [MNa]+, found 386.14020, C19H25O4NSNa requires 386.14190. 
 
  Experimental 
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N-Benzyl-4-methylbenzenesulfinamide 384162,163 
 
 
 
To a suspension of sodium para-toluenesulfinate 384 (2.92 g, 16.4 mmol, 1 eq.) in 
diethyl ether (15 ml) was added thionyl chloride (1.20 ml, 16.4 mmol, 1 eq.) at 0 °C 
over 15 min. The reaction mixture was allowed to warm to room temperature, stirred for 
3 hours before being filtered and concentrated under vacuum. The residue (1.74 g, 10.0 
mmol, 1 eq.) was dissolved in diethyl ether (50 ml) and cooled to 0 °C.176 Benzylamine 
380 (2.2 ml, 20 mmol, 2 eq.) was then added dropwise and the resulting mixture 
allowed to warm to room temperature. An aqueous solution of HCl (0.5 M, 50 ml) was 
added to dissolve the amine salt, and the organic phase was separated and washed with 
an aqueous solution of HCl (0.5 M, 2 × 50 ml). The organic phase was dried (MgSO4), 
filtered and concentrated under reduced pressure and the residue was purified by 
column chromatography (petroleum ether:ethyl acetate 3:2) to give 386 as a pale yellow 
solid (1.32g, 33%). 
 
 
M.p. 81-85 °C (petroleum ether) ,lit.,163 80-81 °C (MeOH); IR (film): νmax 3213, 1597 
(w), 1497, 1455, 1417, 1086, 1051 (s) cm-1; 1H NMR
 
(300 MHz, CDCl3): δ  2.41 (s, 3H, 
CH3), 3.90 (dd, J=14.7, 8.4 Hz, 1H, NH), 4.21-4.30 (m, 2H, CH2Ph), 7.26-7.36 (m, 7H, 
H-Ar), 7.65 (d, J=8.0 Hz, 2H, H-Ar); 13C NMR (150 MHz, CDCl3): δ 21.4 (CH3), 44.6 
(CH2), 126.0 (CH-Ar), 127.7 (CH-Ar), 128.3 (CH-Ar), 128.7 (CH-Ar), 129.7 (CH-Ar), 
137.8 (C-Ar), 140.8 (C-Ar), 141.4 (C-Ar); MS (CI+) m/z (%): 246 (MH+, 32), 197 (68), 
140 (53), 107 (100), 92 (52); HRMS: [MH]+, found 246.09566, C14H16ONS requires 
246.09256. 
 
  Experimental 
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N-(3-Methylbut-2-enyl)acetamide 392164 
 
 
 
2-Methyl but-3-ene-2 ol (861 mg, 10.0 mmol, 1 eq) and acetic anhydride (1.23 g,12.0 
mmol, 1.2 eq.) were added to a solution of cobalt(II) chloride (65 mg, 0.5 mmol, 0.05 
eq.) in acetonitrile (120 ml) and then heated at 80 °C for 48 hours. After removal of the 
solvent under reduced pressure, the residue was dissolved in ethyl acetate (50 ml), 
washed with a saturated aqueous solution of sodium bicarbonate (5 × 20 ml), water (3 × 
20 ml) and brine (30 ml). The organic phase was dried (Na2SO4), filtered and 
evaporated under vacuum. The residue was purified by column chromatography 
(petroleum ether:ethyl acetate 1:1) to give 392 as a yellow oil (220 mg, 17%).  
 
 
IR (film): νmax 3280, 1647 (s), 1546 (s), 1440, 1374, 1284 (s) cm-1; 1H NMR (600 MHz, 
CDCl3): δ  1.69 (s, 3H, CCH3), 1.74 (s, 3H, CCH3), 2.00 (s, 3H, COCH3), 3.84 (t, J= 5.9 
Hz, 2H, CH2N), 5.2 (tt, J=7.2, 1.4 Hz, 1H, CH=C), 5.47 (br s, 1H, NH); 13C NMR (125 
MHz, CDCl3): δ 17.9 (CH3), 23.2 (CH3), 25.7 (CH3), 37.7 (CH2), 119.9 (CH=C), 136.7 
(C=CH), 170.0 (C=O). 
 
 
  Experimental 
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N-(Diethoxymethyl)-N-(3-methylbut-2-enyl)acetamide 393 
 
 
 
A mixture of 392 (217 mg, 1.70 mmol, 1 eq), triethyl orthoformate (15 ml, 90 mmol, 53 
eq.) and aluminium chloride (34.0 mg, 0.25 mmol, 0.15 eq.) was heated at 165 °C for 16 
hours. After cooling the resulting mixture was poured into a saturated aqueous solution 
of sodium bicarbonate (10 ml), and extracted with ethyl acetate (3 × 10 ml). The 
combined organic extracts were washed with brine (15 ml), dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (petroleum ether: diethyl ether 1:1) to give a yellow oil which was a 1 : 
1 mixture of amide rotamers 393 (163mg, 42%). 
 
 
IR (mixture of rotamers 1:1, film): νmax 3457 (w), 2971, 1739 (s), 1660, 1373 (s), 1217 
(s), 1096, 1058 (s) cm-1; 1H NMR (mixture of rotamers 1:1, 600 MHz, CDCl3): δ  1.09-
1.15 (m, 6H, 2 × OCH2CH3), 1.61-1.69 (m, 6H, 2 × CCH3), 1.99 (s, 1.5 H, COCH3), 
2.07 (s, 1.5 H, COCH3), 3.38-3.46 (m, 2H, OCH2CH3), 3.48-3.59 (m, 2H, OCH2CH3), 
3.75-3.83 (m, 2H, CH2N), 5.07-5.11 (m, 1H, CH=C), 5.68 (s, 0.5 H, CH(OEt)2), 6.20 (s, 
0.5 H, CH(OEt)2); 13C NMR (mixture of rotamers 1:1, 150 MHz, CDCl3): δ 15.0, 15.1, 
15.2, 18.1, 22.3, 22.5, 25.9, 61.6, 61.8, 61.9, 99.8, 104.4, 105.0, 121.0, 122.4, 122.9, 
132.6, 133.3, 134.0, 162.3, 169.5, 171.6; MS (FAB) m/z (%): 252 (MNa+, 38), 230 (37), 
185 (94), 177 (42), 155 (100); HRMS: [MNa]+, found 252.15704, C12H23O3N requires 
252.15755. 
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